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Secondary metabolites are produced by numerous organisms and can either be
benign to humans or harmful. Genes involved in the synthesis and transport of these
secondary metabolites are frequently found in gene clusters, which are often located in
subtelomeric regions of the chromosome. These clusters are often coordinately regulated,
being almost exclusively dependent on transcription factors that are located within the
clusters themselves. Secondary metabolites are also regulated by a variety of factors,
including nutritional factors, environmental factors and developmental processes. Gliotoxin,
which is produced by a variety of Aspergillus species, Trichoderma species, and Penicillium
species, exhibits immunosuppressive properties and has therefore been the subject of
research for many laboratories. There have been a few proteins shown to regulate the
gliotoxin cluster, most notably GliZ, a Zn2Cys6 binuclear finger transcription factor that lies
within the cluster, and LaeA, a putative methyltransferase that globally regulates secondary
metabolism clusters within numerous fungal organisms, although no study has
demonstrated the direct binding of any protein to a promoter region in the gliotoxin cluster.
I report here two novel proteins, GipA, a C2H2 transcription factor and GipB, a hybrid
sensor kinase, which are involved in regulating the gliotoxin biosynthetic cluster. GipA plays
v

an important role in gliotoxin production, as high-copy expression of gipA induces gliotoxin
biosynthesis and loss of gipA reduces gliotoxin biosynthesis by 50%. GipB is also involved
in regulating gliotoxin production, as high-copy expression of gipB induces gliotoxin
biosynthesis, but only during certain stages of asexual development. Furthermore, loss of
gipB reduces gliotoxin biosynthesis by 10%. Based on data obtained from this project, I
propose a model for the regulation of gliA, the efflux pump of the gliotoxin cluster, which
involves GipB signaling through both GliZ and GipA. I propose that GliZ and GipA are
interdependent, as mutation of the GipA DNA binding site in the gliA promoter negatively
affects both GliZ-mediated and GipA-mediated induction of gliA. This is further supported
by the fact that GliZ cannot fully induce gliA in the absence of GipA and vice versa. This is
the first time that anyone has shown evidence of a protein directly binding to the gliotoxin
cluster.

Even though biosynthetic clusters are often coordinately regulated, my model

raises the possibility that gliA is independently regulated, as the layout of the binding site in
the gliA promoter is not present upstream of any other genes in the gliotoxin cluster, except
for gliZ.
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Chapter 1:
General Introduction

1

1.1 Secondary Metabolism
Secondary metabolites are small, low-molecular weight molecules made by
numerous organisms that are not essential for normal growth, but can play important roles
in defense or signaling [1-4]. Oftentimes, there is a link between production of secondary
metabolites and specific stages of morphological differentiation [1, 5].

Although these

compounds are manufactured by a plethora of organisms, especially soil-dwelling bacteria
and fungi, each individual metabolite is subject to restricted taxonomic distribution, as
metabolites are not produced in a highly conserved fashion [1-3]. For example, gliotoxin is
produced by Aspergillus fumigatus and A. oryzae, but not A. nidulans [6, 7].
Secondary metabolites can be benign in nature, such as pigments or molecules
used in interspecies communication, but they can also be malignant, exhibiting
antimicrobial or toxic activities to eliminate competing organisms [5, 8]. Some of these
compounds have been exploited by scientists because of their potential benefit to humans.
For example, penicillin, produced by Penicillium chrysogenum, is used as an antibiotic and
lovastatin, produced by A. terreus, reduces cholesterol [9]. Indeed, a literature survey
examining 1,500 fungal metabolites between 1993 and 2001 discovered that more than half
of these molecules had antibacterial, antifungal, and antitumor activity [2]. While some of
these secondary metabolites benefit humans, others cause harm. Aflatoxin, produced by
A.

flavus,

is

carcinogenic,

and

gliotoxin,

produced

by

A.

fumigatus,

exhibits

immunosuppressive properties [3, 6, 10, 11]. There are also compounds produced by
fungal species that are both harmful and beneficial to humans, such as ergot alkaloids.
These compounds, when consumed by humans, can cause convulsions, vasoconstriction,
and hallucinations, yet have been used medically to hasten labor and treat migraines [2].
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Several classes of fungal secondary metabolites exist: polyketides, non-ribosomal
peptides, terpenes, and indole alkaloids [1-3] (Fig. 1.1). Polyketides are produced by type I
polyketide synthases (PKS) and are the most abundant of all fungal secondary metabolites.
These type I polyketide synthases are multidomain proteins that bear homology to
eukaryotic fatty-acid synthases.

Aflatoxin, lovastatin, and the yellow spore pigment

intermediate naphthopyrone (WA) from A. nidulans are among the best genetically
characterized polyketides [2].

Multidomain, multimodular enzymes, known as non-

ribosomal peptide synthetases (NRPS) are responsible for creating non-ribosomal peptides
[2, 3]. Module-specific amino acids are recognized and activated by NRPSs, which results
in the formation of a covalent bond between each amino acid and the 4’phosphopantetheine cofactor, through a conserved serine.

Tethered amino acids form

peptide bonds and the resulting peptide is subsequently released.

Penicillin,

cephalosporin, and gliotoxin all fall within this class of fungal secondary metabolites [2].
Terpenes, best known as odoriferous plant metabolites, such as camphor and
turpentine, are composed of several isoprene units. Terpene cyclases, which are essential
for the production of terpenes, share structural homology, but exhibit low primary sequence
similarity, suggesting these cyclases have been subject to rapid divergent evolution.
Fungal terpenes include carotenoids, gibberellins, and trichothecenes [2]. Tryptophan and
dimethylallylpyrophosphate commonly serve as precursors for indole alkaloids, although
this is not absolute.

One of the best characterized pathways synthesizes ergotamine,

although other tryptophan-derived alkaloids include fumigaclavines and fumitremorgens
from A. fumigatus [2].

3

Figure 1.1. The main classes of fungal secondary
metabolites.
Reprinted by permission from Macmillan
Publishers Ltd: Nature Reviews Microbiology [2], copyright
2005.
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1.2 Cluster-specific Regulation of Secondary Metabolism
Originally, eukaryotic genes involved in functionally related pathways were believed
to be unlinked in the genome. Owing to the discovery of gene clusters in fungi involved in a
variety of mechanisms, such as nutrient use, mating type, pathogenicity, and secondary
metabolism, this dogma of unlinked pathways was abandoned [2].

It is now widely

accepted that genes involved in these various primary and secondary metabolic processes
are indeed frequently found as clusters [1-3, 8].

Furthermore, secondary metabolism

clusters have more recently been shown to be oftentimes located in subtelomeric positions
[12].

These clusters are typically coordinately regulated, being almost completely

dependent on induction from transcription factors located within the clusters themselves [2,
3, 8, 13, 14]. Aside from these pathway-specific transcription factors, there are numerous
other regulatory elements that affect the expression of secondary metabolite clusters.
Nutritional and environmental factors, as well as developmental processes, have been
shown to affect secondary metabolite production in multiple fungal species [2, 3].

1.2.1 Transcription Factors Located within Clusters
Secondary metabolism gene clusters often contain regulatory elements that are
essential for the coordinate expression of the biosynthetic enzymes and transport proteins
encoded within the cluster [2, 3].

Zinc binuclear (Zn(II)2Cys6) transcription factors are

uniquely found in fungi and represent the most common type of regulators located within
these clusters [2, 3, 15, 16]. AflR, a Zn2Cys6 transcription factor, is located within the
aflatoxin/sterigmatocystin gene cluster and is required for production of both metabolites [2,
3, 11].

The aflatoxin and sterigmatocystin gene clusters contain most of the same

enzymes, except the sterigmatocystin gene cluster lacks the genes necessary for the final
5

biochemical steps, therefore, sterigmatocystin is a precursor to aflatoxin [11]. A. nidulans
produces sterigmatocystin, while A. flavus and A. parasiticus produce aflatoxin.
Aflatoxin/sterigmatocystin production is abolished when aflR is disrupted or mutated and
amplified when aflR is over-expressed [2, 3, 11, 17].
Zn2Cys6 transcription factors, like aflR, generally recognize and bind as homodimers
to palindromic sequence motifs, such as CGG(Nx)CCG [15-18]. Interestingly, although the
palindromic sequences of these binding motifs can be similar or identical for multiple
Zn2Cys6 transcription factors, the length and base composition of the linker sequence is
highly variable.

Therefore, this linker sequence greatly contributes to the specificity of

binding for each individual transcription factor [16, 18, 19]. For instance, Gal4 and Ppr1 are
two Zn2Cys6 transcription factors in Saccharomyces cerevisiae that regulate different
pathways. Gal4 is responsible for transcription of various galactose-inducible genes and
Ppr1 activates transcription of genes in the pyrimidine metabolic pathway [16, 18, 19]. Both
transcription factors recognize binding sites that are flanked by CGG palindromic repeats,
but have differently sized linker sequences, Gal4 recognizes an 11 bp linker and Ppr1
recognizes a 6 bp linker. Even though the CGG repeats, which are crucial for Gal4 or Ppr1
binding, are identical, these two proteins do not recognize the other’s binding site and
therefore remain specific to their respective pathways [16, 18, 19].
Although Zn2Cys6 transcription factors represent the most common type of in-cluster
regulatory elements, other types of cluster-specific transcription factors have been
identified.

TRI6 and MrTRI6 are C2H2 transcription factors that control production of

trichothecene in Fusarium sporotrichiodes and Myrothecium roridum, respectively [2, 8, 20].
Cochliobolus carbonum contains an ankyrin repeat protein, ToxE, which regulates HC-toxin
production.

Furthermore, CPCR1 and AcFKH1, which are members of subfamilies of

6

winged helix transcription factors, are required for the production of cephalosporin C in
Acremonium chrysogenum [2, 8, 20].

1.2.2 Alternative Pathway-specific Regulation
Aside from cluster-specific transcription factors, there are members of secondary
metabolite clusters that have been shown to affect expression of other genes within the
cluster. For example, gliP encodes an NRPS in the gliotoxin cluster and catalyzes the first
step in the biosynthesis of gliotoxin. Not only does loss of gliP abolish gliotoxin production,
but it also causes a significant decrease in the other gliotoxin-specific genes [21-24]. In
addition, disruption of sirA, the ABC transporter for the sirodesmin biosynthetic cluster in
Leptosphaeria maculans, positively affects the expression of sirP, the NRPS of the
sirodesmin cluster [25, 26]. Although gene clusters are often coordinately regulated by the
cluster-specific transcription factor, some members can be independently regulated. For
example, gliT encodes an oxidoreductase of the gliotoxin biosynthetic cluster, which is
required for self-protection against gliotoxin. Even though gliT expression is decreased
when the Zn2Cys6 transcription factor, gliZ, is deleted, exogenous gliotoxin induces the
expression of gliT, even in a ∆gliZ background [3, 27].

1.3 Fungal Development and Secondary Metabolism
Within the genus Aspergillus are between 260 and 837 species, which are classified
into ten different teleomorph genera based on their sexual stages [28]. For example, A.
nidulans belongs to the teleomorph genus Emericella, while A. flavus and A. fumigatus are
categorized into the Petromyces and Neosartorya genera, respectively [28].

7

Many

Aspergillus species can reproduce both asexually, by developing conidia, and sexually, via
ascospore development [28]. Vegetative growth of filamentous fungi entails germination of
conidia or ascospores into hyphae, which can lead to the formation of mycelial colonies,
development of biofilms, initiation of asexual development (conidiation), or initiation of
sexual development, among other things, depending on external stimuli [28, 29].
Environmental cues, such as light, oxygen, salt, and nutrients, can affect the expression of
genes involved in regulating the different developmental programs [28, 30]. Oftentimes, the
environmental signals that promote a certain developmental program will also affect
secondary metabolite production [31]. For instance, asexual development can be induced
in submerged liquid cultures by nutrient starvation or stress, which can also positively
influence production of secondary metabolites [28]. Conversely, exposure to constitutive
darkness will promote sexual development, which also enhances secondary metabolism
[30, 32].

1.3.1 Fungal Development
The process of germination can be divided into three stages. In the first stage, a
spore will abandon the dormant state in response to environmental cues, such as exposure
to water and air, sometimes in addition to inorganic salts, amino acids, or fermentable
sugars [28, 33]. In the second stage, spores begin to swell isotropically due to water
uptake, which decreases the microviscosity of the cytoplasm. Moreover, cellular functions
are directed to the synthesis of new plasma membrane and cell wall components [28]. The
third stage is reached when the spore initiates polarized growth to form a germ tube, which
requires redirection of morphogenetic machinery to the site of polarization [28] (Fig. 1.2).

8

Figure 1.2. Growth and germination of A. fumigatus. (A)
Dormant conidia (0 hrs growth). (B) Swollen conidia at
the beginning of germ-tube formation (3 hrs growth). (C)
Germling with newly formed septum (white arrow) (6 hrs
growth). (D) Hyphal tip. (E-G) Examples of hyphae with
mature septa (white arrows). Modified and reprinted by
permission from American Society for Microbiology:
Eukaryotic Cell [34], copyright 2008.
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When grown at 37°C, A. fumigatus can achieve germ tube formation within 4.5
hours of inoculation. Protein synthesis is important in these early stages of germination, as
there is an up-regulation of genes involved in protein synthesis in germinating spores of A.
fumigatus.

Furthermore, isotropic growth of conidia can be prevented by the protein

synthesis inhibitor cyclohexamide, but not by inhibitors of the cytoskeleton or nucleotide
synthesis [28, 33].
Once germination is initiated, germlings undergo hyphal proliferation. Hyphae are
tube-like structures that consist of repeated elongated cellular units. Hyphae proliferate by
polarized growth at the apex of the tip cell, similar to germ tube formation, which involves
expansion of the plasma membrane and biosynthesis of cell wall components [1, 35] (Fig.
1.2c). Elongated cells within hyphae are separated by porous walls, called septae, through
which cytoplasm and also entire nuclei can migrate towards the growing tip [1] (Fig. 1.2).
One conidial cell or ascospore will generally give rise to multiple hyphal extensions as a
result of apical branching [35].

Vegetative growth is a required precursor to other

developmental programs in filamentous fungi, with the exception of dimorphic fungi [1] (Fig.
1.3). Differentiation capability is defined by the ability of vegetative hyphae to reach a
competence state [35]. In A. nidulans, competence can be reached between 12 and 20
hours after germination of the spore, depending on the growth rate [1]. In A. fumigatus,
developmental competence is reached 9 to 10 hours after inoculation in rich medium [36].
When vegetative hyphae have reached a competence state, asexual development
(conidiation) is initiated, which involves the formation of the conidiophore [1, 35]. The
process of conidiation can be divided into several distinct phases, beginning with the
outgrowth of a stalk from a specialized, thick-walled foot cell within the mycelium [1, 28, 30].
Once the stalk has fully extended (in A. nidulans, stalks reach a height of about 100 µM
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Figure 1.3. The different developmental stages of A. nidulans. Vegetative growth is a
necessary precursor for either asexual development or sexual development. External
and internal signals both contribute to the switch from vegetative growth to unique
developmental programs. Reprinted by permission from John Wiley and Sons: FEMS
Microgiology Reviews [1], copyright 2011.
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[28]), the tip of the stalk swells to form a multinucleate vesicle, from which sterigmata bud
[1, 28, 30, 35, 37]. In uniserate organisms, such as A. fumigatus, there is only one layer of
sterigmata, termed phialides, however, in biserate fungi, such as A. nidulans and A. niger,
two layers of sterigmata form from budding: (1) metulae and (2) phialides [28]. Finally,
phialides generate multiple chains of single-celled conidia from asymmetric mitotic division,
with the possibility of more than 10,000 conidia arising from a single conidiophore [28, 30,
35] (Fig. 1.4a-e).

Exposure to light serves as a major activation signal for asexual

development [30]. In addition, conidiophore formation generally occurs upon exposure to
an air interface, which is thought to activate internal signals that regulate the genes involved
in conidiation [28, 30, 35]. In some instances, though, conidiophore development can occur
in submerged cultures, in response to external stress or nutrient limitations [28]. Once fully
mature, conidia can be widely dispersed through the air or by water, contributing to fungal
survival by widespread distribution [1, 28].
Although researchers have only observed a sexual cycle in about one-third of
known Aspergillus species, genomic analysis has revealed the presence of genes
specifically involved in sexual development in most of these fungi, indicating that they too
may be capable of sexual development [28]. For instance, A. fumigatus has just recently
been shown to form sexual fruiting bodies under experimental conditions, although this
process took an extended period of time [28, 38]. With respect to sexual reproduction, a
fungal organism is either homothallic, containing both mating types and therefore able to
undergo sexual reproduction without a compatible partner, or heterothallic, containing only
one mating type and thus requiring a compatible partner to undergo sexual reproduction [1,
28]. A. fumigatus is heterothallic, while A. nidulans is homothallic [1, 28]. The beginning of
sexual development is represented by the formation of Hülle cells, which is followed by
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Figure 1.4. Images of asexual and sexual structures
in A. nidulans shown by scanning electron
micrograph. (a) Conidiophore stalk. (b) Vesicle
formation at the tip of the stalk. (c) Developing
metulae (primary sterigmata).
(d) Developing
phialides (secondary sterigmata) (black arrows). (e)
Strains of conidia on a mature conidiophore.
Modified and reprinted by permission from American
Society for Microbiology:
Microbiology and
Molecular Biology Reviews [35], copyright 1998. (f)
Mature cleistothecium (CI) (sexual fruiting body)
surrounded by Hülle cells (H).
Modified and
reprinted by permission from American Society for
Microbiology: Eukaryotic Cell [39], copyright 2012.
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hyphal fusion and the emergence of a dikaryon. These Hülle cells surround the dikaryon
and pack into a “nest”, eventually differentiating into thick-walled globose cells believed to
provide both protection and nutrition to the maturing cleistothecium, or sexual fruiting body
[1, 28] (Fig. 1.4f). Nuclear fusion followed by meiosis and post-meiotic mitosis gives rise to
eight nuclei, which are separated by membranes to become spores. Ascospores become
binucleate through a second post-meiotic mitosis. A single cleistothecium can contain a
high number of asci, which each contain eight ascospores [28].

1.3.2 Secondary Metabolism and Asexual Development
There are three categories of secondary metabolites that are often associated with
conidiation: (1) metabolites required to activate conidiation (the extracellular sporulationinducing factor [ESID], (2) pigments important for conidiophore development (melanin), and
(3) mycotoxins [5].

Although production of certain mycotoxins does not appear to be

essential for conidiation (for instance A. nidulans mutants deficient in sterigmatocystin
production still undergo asexual development) a relationship between asexual development
and mycotoxin production has been established. A number of studies have reported that
Aspergillus mutants deficient in conidiation also display a deficiency in aflatoxin production
[5, 40].
FluG, which produces an ESID in response to external signals, activates
downstream targets to induce asexual development, one of these targets being FlbA [5, 28,
30, 35, 40-43] (Fig. 1.5). Loss of either fluG or flbA abolishes conidiophore formation and
promotes hyperproliferative vegetative growth or the “fluffy” phenotype. FlbA is an RGS
(regulator of G-protein signaling) protein that negatively regulates FadA, a Gα subunit of a
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Figure 1.5. Model of upstream and central genetic regulators of asexual development.
Reprinted from Current Opinion in Microbiology, Vol. 15/No. 6, Hee-Soo Park and JaeHyuk Yu, Genetic Control of asexual sporulation in filamentous fungi, pg. 669-677,
2012, with permission from Elsevier [30].
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heterotrimeric G-protein complex that promotes vegetative growth and represses asexual
development [5, 28, 30, 35, 40, 42, 44] (Fig. 1.5), therefore a constitutively active form of
FadA resembles a ∆flbA mutant [43]. In A. nidulans, loss of fluG or flbA also abolishes
sterigmatocystin production [2, 5, 40, 45, 46]. Interestingly, although over-expression of
flbA in A. nidulans results in premature sterigmatocystin production, over-expression of fluG
in submerged culture does not [5, 40]. Furthermore, in a ∆flbA mutant, over-expression of
aflR does not reinstate sterigmatocystin production, indicating that these regulatory
networks can be complex [5]. A mutant expressing a dominant active form of FadA also
loses the ability to produce sterigmatocystin, suggesting that FluG activates FlbA, which
supports the inactivation of FadA and subsequent sterigmatocystin production through
induction of AflR [5, 40, 43, 45].
While FadA negatively regulates sterigmatocystin production, it positively regulates
penicillin production in A. nidulans [2, 5, 47]. Furthermore, a FadA homologue in Fusarium
sporotrichioides positively regulates trichothecene production, as expression of a dominant
active form of FadA increases trichothecene biosynthesis [2, 5, 47]. Contrary to what is
observed with a FadA dominant active mutant in A. nidulans, loss of either SfaD, the Gβ
subunit, or GpgA, the Gγ subunit, causes reduced sterigmatocystin production [5, 43]. To
positively regulate vegetative growth, FadA G-protein signaling induces the production of
cAMP, which promotes PKA activation [5, 28, 45, 48]. Not surprisingly, over-expression of
pkaA in A. nidulans represses conidiophore development and blocks sterigmatocystin
production [2, 5, 45]. StuA, a transcriptional modifier of asexual development, has now
been associated with regulation of secondary metabolism in several fungi, such as P.
chrysogenum and F. graminear [9].
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1.3.3 Secondary Metabolism and Sexual Development: Light vs. Dark
Secondary metabolite production is also associated with sexual development [1,
49]. When A. nidulans is grown in light, sterigmatocystin production is minimal, but when
grown in the dark, which induces sexual development, levels of sterigmatocystin increase
[30].

This differential expression has been linked to the formation of a heterotrimeric

complex, called the Velvet complex, composed of VeA, VelB, and LaeA, which regulates
the balance between sexual and asexual development [1, 28, 30, 50, 51]. Regulatory
proteins that are in the velvet family, VeA, VelB, VosA, and VelC, are highly conserved
among ascomycetes and basidiomycetes [1]. Velvet family proteins all contain a conserved
velvet domain, which comprises 150 amino acids [1, 30].
An N-terminal-truncated mutant of VeA (veA1) produces more conidia and less
sexual fruiting bodies than a wild-type strain. Furthermore, A. nidulans requires red light to
induce conidiation, but the veA1 mutant allows conidial development in the absence of light,
suggesting that a domain in the N-terminus of VeA is responsible for light-mediated VeA
activity [1, 28, 35]. A strain in which veA or velB has been deleted does not produce any
sexual fruiting bodies in any conditions.

In addition, over-expression of veA results in

constitutive formation of sexual fruiting bodies, regardless of light exposure [1, 28]. LaeA is
a putative methyltransferase that was identified in a screen for A. nidulans mutants that lost
the ability to produce sterigmatocystin [50, 51]. LaeA contributes to light-dependent support
of asexual development, as loss of laeA in A. nidulans renders the fungus unable to
suppress sexual fruiting body formation in light. This phenotype is opposite of ∆veA, which
cannot produce any sexual fruiting bodies regardless of light or dark exposure [1, 28].
LaeA forms a trimeric complex with VeA and VelB, which coordinates sexual development
in darkness. This complex is low in concentration in light, as VeA and VelB remain in the
cytoplasm and LaeA is confined to the nucleus [28]. Upon exposure to darkness, VeA
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levels are increased and VeA forms a complex with VelB, which translocates to the nucleus
(Fig. 1.6). It is here that VeA interacts with LaeA to form the trimeric complex with VelB [1,
28].
VeA, VelB, and LaeA are not only important for sexual and asexual development,
but they also control secondary metabolism. Indeed, loss of veA in A. nidulans, results in a
loss of penicillin and sterigmatocystin production [1].

This link of VeA to secondary

metabolism has also been shown in other fungal species, such as A. flavus and A.
parasiticus, which lose the ability to produce aflatoxin when veA is deleted, and F.
verticilloides, which is unable to produce fumonisin and fusarins in a ∆ve1 (veA homologue)
background [1].

Additionally, deletion of vel1 in F. fujikuroi represses fumonisins and

fusarins, deletion of velA in P. chrysogenum negatively affects penicillin biosynthesis, and
deletion of veA in A. chrysogenum drastically reduces expression of cephalosporin
biosynthesis genes [1, 9]. VelB also plays a role in secondary metabolite production, as
loss of velB from A. nidulans results in a decrease in sterigmatocystin [52]. A shift to dark
increases sterigmatocystin production in this deletion strain, but only to light-exposed wildtype levels of sterigmatocystin production [52]. LaeA is a global regulator of secondary
metabolism, as loss of laeA abolishes overall production of secondary metabolites in
numerous Aspergillus species [1, 51, 53]. Not surprisingly, over-expression of laeA leads to
an abundance of penicillin and lovastatin in A. nidulans and A. terreus, respectively [50, 51].
With the presence of the SAM methyltransferase domain, LaeA has been proposed to
affect secondary metabolism by counteracting H3K9 methylation in the sterigmatocystin
cluster [1, 53].
FphA is a phytochrome-like receptor that senses and responds to red light, while
LreA and LreB constitute the blue-light sensing apparatus [30, 54, 55]. FphA interacts with
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Figure 1.6. Model of light vs. dark regulation of sexual development and secondary
metabolism. Reprinted by permission from John Wiley and Sons: FEMS Microgiology
Reviews [1], copyright, 2011.
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VeA, as well as LreA and LreB [1, 30] (Fig. 1.6).

FphA acts to promote asexual

development, but represses sterigmatocystin production.

Alternatively, LreA and LreB

promote sexual development, as well as the production of sterigmatocystin [1, 56].
Interestingly, the opposite effect is seen for penicillin production in A. nidulans, as loss of
fphA reduces penicillin production and mutations in lreA and lreB cause a slight increase in
penicillin production [1, 56].

1.4 Regulation of Secondary Metabolism in Response to Environmental Factors
Fungal organisms are extremely versatile with respect to abiotic growth conditions.
Fungi can grow in a wide range of conditions and utilize a variety of substrates for
nutritional requirements [28]. Global regulatory proteins have been identified that react to
specific environmental cues. These proteins generally regulate large sets of genes that are
involved in degradation of alternative nutrient sources or protection of intracellular
processes against environmental extremes [20, 57]. For instance, to degrade pectin within
plant material, fungi synthesize and secrete pectinases; to degrade starch, fungi synthesize
and secrete amylases; and to degrade elastin in the human lung, infectious fungi can
synthesize and secrete elastase [28]. Interestingly, optimal growth conditions favor lower
levels of secondary metabolite production, perhaps to save energy when defense is not
necessary.

Conversely, nutrient starvation or harsh environmental factors induce

production of secondary metabolites.

This could be a result of the need to eliminate

competition so as to have access to whatever alternative nutrient sources are available. A
link has been established between the activity of many of these global regulatory elements
and the expression of gene clusters responsible for producing secondary metabolites [3]
(Fig. 1.7).
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Figure. 1.7. Environmental and developmental global regulatory elements involved in
secondary metabolite production. Reprinted by permission from Macmillan Publishers
Ltd: Nature Reviews Microbiology [3], copyright 2013.
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1.4.1 Nitrogen Metabolite Repression
Metabolite repression occurs in response to nitrogen source, which has been
studied in great detail. AreA, the global positive regulator of nitrogen metabolite repression
in A. nidulans and A. fumigatus, induces genes involved in alternative nitrogen source
utilization [58-60]. In the presence of a preferred nitrogen source, such as ammonium or
glutamine, AreA is repressed by various mechanisms, physical interaction with the
repressive element NmrA being one of them [58, 60-62]. When preferred nitrogen sources
are not available, AreA is released from NmrA to activate its targets, some of which include
secondary

metabolism

clusters,

generally

in

conjunction

with

pathway-specific

transcriptional activators [59-61].
AreA is a member of the GATA family of transcription factors and posesses a DNA
binding domain that contains a single Cys2/Cys2-type zinc finger motif [1, 58-60]. These
types of DNA binding proteins are so named because they recognize binding sites that
contain a core GATA sequence (e.g. AreA binds to 5’-HGATAR-3’) [1, 58-60, 62]. In A.
nidulans, areA is highly expressed in the presence of non-preferred nitrogen sources,
yielding three different mRNA transcripts of 3.9, 3.6, and 3.2 kb [60]. There are numerous
micro open reading frames (µORFs) and 13 GATA binding elements upstream of the areA
start site, suggesting that AreA is under transcriptional control (by autoregulation) and posttranscriptional control [60]. Furthermore, the 3’ untranslated region (UTR) of areA affects
mRNA stability and the turnover rate of the areA transcript varies based on nitrogen status
[63]. In wild-type cells, areA mRNA has a half-life of 40 minutes when only non-preferred
nitrogen sources are available, but in the presence of preferred nitrogen sources, the halflife decreases to 7 minutes [60]. In contrast, when part of the 3’ UTR region is deleted from
areA, the half-life of the mRNA transcript is 25 minutes, regardless of the nitrogen sources
available [60]. Further regulation of AreA is achieved through the binding of NmrA to a
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conserved region adjacent to the zinc finger and the 12 carboxyl-terminal residues [60].
Indeed, deletion of nmrA from A. nidulans results in partial derepression of amdS, which
encodes acetamidase and is subject to nitrogen metabolite repression [61]. MeaB, a bZIP
transcription factor, binds to the promoter of nmrA and activates its transcription in both
nitrogen-preferred and non-preferred conditions [58].
The nitrate assimilation system has been extensively studied in A. nidulans and
encodes the structural genes nitrate reductase (niaD) and nitrite reductase (niiA), crnA, a
nitrate transporter, and nirA, the pathway-specific transcription factor that controls induction
of the cluster genes [58, 62, 64-66]. The two structural genes, niaD and niiA, share an
intergenic region and are divergently transcribed, requiring activation from both NirA and
AreA [58, 59, 64]. Interestingly, AreA not only binds to GATA elements within the niaD-niiA
intergenic region to induce nitrate assimilation, but also plays a role in chromatin
remodeling [58, 59].

There are six nucleosomes present in the niaD-niiA bidirectional

promoter when nitrate is absent from surrounding medium.

When nitrate becomes

available, these nucleosomes are remodeled, which creates an “open” chromatin structure.
The chromatin remodeling requires active AreA [58, 59].
As mentioned above, AreA also positively regulates secondary metabolite clusters.
For example, in A. nidulans, sterigmatocystin production is repressed in the presence of
ammonium and induced when nitrate is the sole nitrogen source [1, 5, 67].

Interestingly,

nitrogen sources have the opposite effect in A. parasiticus, where growth in the presence of
ammonium results in higher levels of aflatoxin production [1, 5, 67]. Furthermore, AreA
positively regulates gibberellin production in Gibberella fujikuroi. In Fusarium verticillioides,
however, AreA is required for production of fumonisin B1, as an ∆areA mutant is devoid of
fumonisin B1, even with the addition of ammonium phosphate [3]. This suggests that while
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AreA serves as an activator for most gene clusters, there might be alternate roles for AreA
with secondary metabolite gene expression.

1.4.2 Carbon Catabolite Repression
Carbon catabolite repression via the global transcriptional repressor, CreA, is
present in a wide range of fungal species. When an organism is exposed to a preferred
carbon source, such as glucose, CreA acts to repress genes involved in the degradation
and utilization of alternative carbon sources, such as ethanol [68, 69]. CreA also exerts
repressive effects on secondary metabolism clusters in preferred carbon conditions, as it
has been shown that penicillin production in A. nidulans is carbon catabolite repressed [10,
68].
CreA, a C2H2 transcription factor, was first discovered in A. nidulans in experiments
searching for suppressor mutations for areA loss-of-function mutations [68, 69]. There are
several nutrients, such as acetamide and proline, which can serve as both nitrogen and
carbon sources and are therefore regulated by both CreA and AreA [57, 68]. For example,
growth of A. nidulans on both preferred nitrogen and carbon sources completely represses
proline catabolism. Mutants deficient in areA activity are unable to use proline as a nitrogen
source when exposed to preferred carbon sources, but a shift to a non-preferred carbon will
alleviate this repression and allow proline to be catabolized [57, 68].

CreA generally

recognizes the consensus sequence 5’-SYGGRG-3’ and appears to be self-regulated, as
creA mRNA in A. nidulans is higher when cultures are grown on glycerol or L-arabinose,
compared to growth on glucose [68, 69]. Furthermore, a number of putative CreA binding
sites are present within its own promoter [68].

Interestingly, although several loss-of-

function mutations have been characterized, creA is an essential gene, as deletion of creA
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in A. nidulans is lethal. This suggests that either derepression of certain systems under
CreA control is lethal or CreA has an unknown positive function that is essential to the
fitness of the organism [68].
The repressive activity of CreA is thought to occur to ensure that the energetically
most favorable carbon sources are utilized and to prevent energy waste on the synthesis of
alternate catabolic systems. There are three groups of systems that are regulated by
carbon catabolite repression: (1) genes encoding enzymes involved in catabolism of less
preferred carbon sources, (2) gluconeogenic and glyoxylate cycle enzymes, (3) genes
involved in secondary metabolism [69]. Regulation of ethanol metabolism in A. nidulans is
one of the most extensively studied examples of carbon catabolite repression. CreA affects
ethanol catabolism by repressing alcR, the transcriptional activator of all genes associated
with ethanol catabolism, as well as alcA, encoding alcohol dehydrogenase I, and aldA,
encoding aldehyde dehydrogenase [68]. The binding site of AlcR and CreA overlap in the
alcR promoter and studies have shown that the two proteins compete for binding. AlcR
does not activate ethanol catabolism in the absence of ethanol, but when cultures are
grown in both ethanol and glucose, a smooth transition between repression and induction is
observed [68]. Upon consumption of the glucose, CreA loses affinity for its binding site in
the alcR promoter, allowing binding of AlcR and subsequent activation of ethanol
catabolism genes [68].
As mentioned above, secondary metabolism is also regulated by CreA and carbon
catabolite repression. When A. chrysogenum is grown in high glucose concentrations,
cephalosporin production is reduced, in part by the repression of ipnA and cefEF by Cre1
(CreA homologue) [70].

In addition, glucose represses penicillin production in P.

chrysogenum [10, 70]. Furthermore, penicillin production in A. nidulans is subjected to
carbon catabolite repression, although this may not be entirely based on CreA activity.
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Transcript levels of ipnA mRNA, involved in the production of penicillin, are decreased in
glucose medium and a loss-of-function mutation in creA only slightly depresses ipnA. A
single CreA binding site is present in the promoter region if ipnA, however this binding site
was revealed to be nonfunctional in an ipnA-lacZ expression analysis [10, 68].

1.4.3 pH-mediated Regulation
The ability to respond to a wide range of pH is advantageous to microbial
organisms, as large variations in ambient pH are commonly encountered. Being extremely
versatile, Aspergillus species have been shown to survive in a pH range of 3.0 to 10.5 [28,
71]. This versatility is in part due to the activity of PacC, a global regulatory protein that
responds to ambient pH.

In alkaline pH, PacC induces genes primarily expressed in

alkaline conditions and represses genes primarily expressed in acidic conditions [1, 72].
Secondary metabolism appears to be regulated by PacC, as pH causes differential
expression of a variety of biosynthetic clusters [3, 73].
PacC is a C2H2 zinc finger transcription factor that is activated in alkaline pH
conditions.

PacC is translated as an inactive precursor and is only activated after

proteolytic cleavage, which requires PalH and PalI, two potential plasma membrane pH
sensors, PalB, a signaling protease, PalA, PalC, and PalF [74-76] (Fig. 1.8).

Upon

translation, the C-terminal domain of PacC interacts with two domains upstream, which
creates a “closed” conformation and prevents accessibility of PacC to PalB. When alkaline
pH is sensed, possibly by PalH and PalI, PacC shifts to an “open” confirmation, which
allows PalB to catalyze the proteolytic cleavage of PacC after residues ~493-500, within a
conserved signaling protease box [74-76]. The activity of PalB is assisted by PalA,
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Figure 1.8. Model of the two proteolysis steps required for PacC activation.
This process involves PalI, PalH, PalF, PalC, PalA, and PalB. Reprinted by
permission from American Society for Microbiology: Eukaryotic Cell [75],
copyright 2007.
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binding to two YPXL/I motifs on either side of the signaling protease box, PalC and PalF.
Loss of this C-terminal region, which is crucial for the “closed” conformation, leaves PacC in
an “open” conformation and commits the protein to the second processing step, involving
cleavage at residues ~252-254 [74-76]. The first proteolytic cleavage step is regulated by
ambient pH, while the second cleavage step is not. In its active form, PacC targets genes
through the sequence 5’-GCCARG-3’ [74-76].
Early studies of murine intraperitoneal injection with A. nidulans revealed an
association between alkaline phosphatase production, which is activated by PacC in
alkaline pH, and virulence, which could be partially explained by the fact that changes in pH
affect secondary metabolism [76]. PacC induces penicillin production in A. nidulans in
alkaline conditions [1, 3, 5, 70, 73].

In contrast, PacC represses sterigmatocystin

production in alkaline conditions, as a mutant expressing a constitutively active PacC
protein produces higher levels of penicillin and lower levels of sterigmatocystin [1, 3, 5, 73].
Genes involved in the biosynthesis of ochratoxin A in A. ochraceus are down-regulated in
alkaline pH, which suggests that PacC is regulating this cluster [20].

Furthermore,

fumonisin biosynthesis is negatively regulated by Pac1 (PacC homologue) in F.
verticillioides, as a disrupted Pac1 mutant produced higher levels of fumonisin when grown
on maize kernels [77]. This mutant also produced fumonisin in medium buffered to pH 4.5
or pH 8.4, suggesting that this mutant does not respond to ambient pH [77].

1.4.4 Cross-pathway Control Regulation
Amino acid biosynthesis is vital for metabolic processes in fungi, which is controlled
by a global regulatory system referred to as the general control of amino acid biosynthesis
(Gcn) in S. cerevisiae and as cross-pathway control (Cpc) in filamentous fungi [1, 78, 79].
28

This global regulation enables a fungal organism to synthesize amino acids in conditions of
amino acid starvation.
This regulatory system has been extensively studied in S. cerevisiae, with Gcn4
serving as the transcriptional regulator and Gcn2 serving as the protein kinase, which
recognizes a build-up of uncharged tRNAs [80]. Gcn4 is a member the bZIP-type family of
transcriptional activators, with a leucine-zipper structure important for dimerization and a
basic DNA binding domain at the C terminus [79]. Upon induction, Gcn4 binds to the
recognition element 5’-ATGASTCAT-3’ and activates a variety of gene clusters involved in
amino acid biosynthesis, such as the proline biosynthesis cluster and the arginine
biosynthesis cluster [79]. Gcn4 has been shown to be under translational control due to the
presence of four µORFs in its promoter region. Mutational analysis has revealed that the
first and fourth µORFs are sufficient for the translational regulation. In normal conditions,
these two µORFs are translated, which prevents reinitiation of the translational machinery
at the actual gcn4 ORF.

When cells are starved for amino acids, the translational

machinery scans past the fourth µORF and reinitiates at the actual gcn4 ORF [78-80] (Fig.
1.9).

In addition, a negative regulator, Cpc2, reduces Gcn4 activity in nonstarvation

conditions, independent of the translational regulation [79].
CpcA, the homologue to Gcn4 in A. nidulans, exhibits some of the same attributes
as Gcn4. CpcA has a basic leucine-zipper structure in the C-terminal region, but only one
leucine, as opposed to Gcn4, which has four repeated leucines [79]. Furthermore, cpcA
has only two µORFs in its 5’ UTR, as opposed to gcn4, which has four µORFs, although
only two appear to be sufficient for the translational regulation [79]. The 5’ UTR of cpcA
also contains two CpcA/Gcn4 recognition elements, suggesting that cpcA is autoregulated
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Figure 1.9. Model of post-transcriptional control of gcn4 involving µORFs 1 and 4. (a)
In normal conditions, ribosomal machinery translates µORF 1 and reinitiates at µORF
4, preventing reinitiation and translation at the gcn4 start site. (b) Under amino acid
starvation, ribosomal machinery translates µORF 1, scans past µORF 4 and reinitiates
at the gcn4 start site. Modified and reprinted from Trends in Biochemical Sciences,
Vol. 31/No. 10, Alan G. Hinnebusch, elF3: a versatile scaffold for translation initiation
complexes, pg. 553-562, 2006, with permission from Elsevier [81].
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at the transcriptional level, in addition to the translational regulation. Indeed, when point
mutations were introduced to both µORFs, there was an increase in cpcA mRNA and
protein levels, but when point mutations were additionally added to the recognition
elements, mRNA and protein levels of cpcA were drastically reduced [79].
Not much research has been done to explore the effect of CpcA on secondary
metabolism, although CpcA does appear to negatively regulate the production of
sirodesmin PL in L. maculans. Exposure of wild-type L. maculans to artificially-induced
amino acid starvation did not induce the sirodesmin cluster, as mRNA transcript levels of
sirZ, the cluster-specific transcription factor, and sirP, remained unchanged to those in
normal conditions [82]. However, when cpcA was silenced, mRNA transcript levels of sirZ
and sirP increased in artificially-induced amino acid starvation. Furthermore, sirP mRNA
transcript levels in the cpcA-silenced mutant were higher than those of the wild-type strain
even in normal conditions.

Although CpcA does seem to regulate sirodesmin PL

biosynthesis, it is unknown whether this regulation is a consequence of CpcA directly
binding to promoter regions within the cluster or of an indirect effect of CpcA activity [26,
82].

Furthermore, studies have shown that CpcA negatively regulates penicillin

biosynthesis in A. nidulans, as over-expression of cpcA results in reduced expression of
ipnA and acvA, two genes essential to penicillin biosynthesis [26, 70, 83].

1.5 Additional Regulatory Elements of Secondary Metabolism
An additional complex of proteins that regulates secondary metabolism is the HAPlike CCAAT-binding complex (Fig. 1.7).

This complex is evolutionarily conserved in

eukaryotic organisms and has been designated with various names in different organisms
[2, 3, 5, 20]. For instance, this complex is HAP in S. cerevisiae and Arabidopsis thaliana,
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AnCF (formally PENR1) in Aspergilli, and CBF in Xenopus laevis.

Within the AnCF

complex are three subunits: HapB, HapC, and HapE [2, 3, 5, 20]. Complete formation of
the complex is required for DNA binding and transcriptional regulation. Numerous genes
are positively regulated by this complex, including ipnA and aatA, which are part of the
penicillin biosynthetic cluster in A. nidulans [2, 3, 5, 20]. Furthermore, penicillin production
in a number of fungal species is dependent on the activity of this HAP-like complex [70].
RsmA, a putative YAP-like bZIP protein, was identified in A. nidulans in a multicopy
suppressor screen for restoration of sterigmatocystin production in mutants lacking
members of the velvet complex [84].

Over-expression of AnRsmA partially restores

sterigmatocystin production in ΔlaeA and ΔveA backgrounds and significantly enhances
sterigmatocystin production in the presence of an intact velvet complex.

Furthermore,

mutation of one or both RsmA binding sites, which are present in the AflR-AflJ intergenic
region, reduces sterigmatocystin production [84].

1.6 Aspergillus fumigatus
A. fumigatus is a saprophytic ascomycete that is ubiquitous in nature, thanks to the
dispersion of conidia in air and by water. Conidia are hydrophobic and are generally
between 2 to 3 µm in diameter, giving them buoyancy that aids in dispersion [6]. Any given
environment is estimated to contain between 1 and 100 conidia/m3, which results in
humans experiencing daily exposure to A. fumigatus. Due to the size of conidia, upon
inhalation, they can avoid mucociliary clearance and reach the alveoli of the lungs [6]. A.
fumigatus has the ability to grow in a wide range of temperatures and pH, making it easy for
this organism to adapt to various ecological environments.

For instance, being a

thermophilic organism, A. fumigatus can survive in temperatures as high as 70°C [6, 85].

32

The ability to adapt to harsh environments gives A. fumigatus an advantage over other
organisms and contributes to the infectious nature of the fungus [85].
A. fumigatus, an opportunistic pathogen, is the leading cause of mold infections
worldwide that causes severe problems in immune-compromised populations [6, 86].
These populations include: AIDS patients, cancer patients receiving chemotherapy, solid
organ transplant/skin graft patients and victims of chronic granulomatous disease [13, 21,
87, 88]. Exposure to conidia can cause invasive aspergillosis or severe allergic reactions [6,
85]. Even with current antifungal medications, the mortality rates of infected individuals can
still exceed 50% [21, 22, 32]. Over the past 20 years, hospitals have witnessed an increase
in A. fumigatus infections, possibly due to an increase in patient transplants, widespread
use of immunosuppressive therapies, as well as a higher incidence in HIV or AIDS [89, 90].
Inhalation of conidia through the airways is the primary route of infection for A. fumigatus.
Once inside the alveoli, spores are exposed to alveolar neutrophils and macrophages,
which serve as the first line of defense [6, 89, 90].

In immune-competent individuals,

clearance of spores is quick and further invasive disease is not allowed to occur. However,
immune dysfunction can result in improper elimination and subsequent germination of the
spores [86]. Hyphae of A. fumigatus can penetrate tissue, allowing for a more severe or
disseminated infection [86]. There are numerous virulence factors produced by this fungus
that contribute to its pathogenesis. True virulence factors contribute to the damage the
fungus can inflict upon the host, but do not greatly affect growth of the fungus. Among these
are secondary metabolites or mycotoxins that can possess carcinogenic or immunemodulating properties [8].

33

1.7 Aspergillus fumigatus and Secondary Metabolism
A. fumigatus is predicted to contain 30 secondary metabolism clusters, the majority
of which have not been characterized [53, 91]. There has been debate on the number of
secondary metabolism clusters, which are usually predicted based on the presence of a
PKS, NRPS, or the like.

In 2007, one group published data defining 22 secondary

metabolism clusters in A. fumigatus, at least 50% of which were regulated by LaeA [91]. In
2012, another paper was published, which listed 34 PKS and NRPS genes, possibly
defining 9 additional secondary metabolism clusters in A. fumigatus, based on web-based
programs specifically designed to define these clusters through algorithms [53]. Among the
secondary metabolites that have been identified are melanin, gliotoxin, fumagillin,
fumitremorgen B, pseurotin A, gibberellin, helvolic acid, and aflatoxin [4, 6]. As seen in
other organisms, secondary metabolism cluster dispersal in A. fumigatus displays a bias
towards sub-telomeric regions of the chromosome [12, 91] (Fig. 1.10). Evidence suggests
that secondary metabolites produced by A. fumigatus contribute to its virulence, which is
supported by the fact that loss of laeA, a global regulator of secondary metabolite
production, severely attenuates the virulence of this fungus in a murine model of infection
[24, 53]. One of the most well-studied secondary metabolites produced by A. fumigatus is
gliotoxin, which is also produced by Eurotium chevalieri, Gliocladium fimbriatum, and
several other Aspergillus species, Trichoderma species, and Penicillium species [14, 24,
25, 92].
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Figure 1.10. Schematic of A.
fumigatus chromosomes with
locations
of
secondary
metabolite
gene
clusters
(indicted as black bars). Red
arrows identify clusters that are
partially or completely regulated
by LaeA [91].
Open-access
article.
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1.7.1 Gliotoxin
Gliotoxin (C13H14N2O4S2) is a member of the epipolythiodioxopiperazine (ETP) class
of toxins, which are characterized by a disulfide bridge across a dioxopiperazine ring [14,
21-25, 53, 87, 88, 93-95]. The oxidized form of gliotoxin is taken up into host immune cells
in a glutathione- dependent fashion, where it is rapidly reduced to the dithiol form [26, 94]
(Fig. 1.11). Constant redox cycling causes accumulation of this dithiol form within the target
cell, with only a small percentage of gliotoxin existing in the oxidized form at any given time
[26, 53]. The oxidized form is thought to be the biologically active form, but some scientists
believe the reduced form has activities of its own [92]. Once inside target cells, gliotoxin is
able to affect cellular functions essential to the immune response. For instance, gliotoxin
has been shown to prevent neutrophils from engulfing surrounding fungal cells by targeting
the actin cytoskeleton and can prevent the generation of superoxide anions by targeting the
activation of NADPH oxidase [24, 25, 87, 95, 96]. Gliotoxin has recently been shown to
inhibit angiogenesis [92, 97]. In addition, gliotoxin is able to inhibit NFkB via prevention of
IkB degradation in several cell types [24, 88, 92, 98]. This leads not only to apoptosis, but
also a loss of cytokine production, therefore the cell cannot signal to other cells of the
immune system about the fungal invasion [24, 88, 94]. Several other actions of gliotoxin
result in apoptosis of the host cell, such as the activation of BAK via conformational
changes and the production of reactive oxygen species via redox cycling [24, 26, 99].
Being a redox active toxin, gliotoxin can also induce internal disulfide bond formation of
cysteine residues in the host cell, which results in inhibition of protease activities. [24, 87,
88, 93-96]. Once the target cell begins the process of apoptosis and glutathione levels are
depleted, gliotoxin is converted back to its oxidized form and exits the target cell, after
which uptake into surrounding target cells occurs [93]. Gliotoxin has been detected in lungs
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Figure 1.11. Redox cycling of gliotoxin between the oxidized (disulphide) form and the
reduced (dithiol) form. This continuous process generates reactive oxygen species.
Reprinted with permission of Society for General Microbiology: Microbiology [100],
copyright 2005.
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and sera of mice and humans suffering from aspergillosis [24, 101]. Furthermore, out of
100 clinical and environmental strains of A. fumigatus, more than 96% produced gliotoxin
[102].

1.7.2 Regulation of Gliotoxin
As with other secondary metabolites, most of the genes responsible for the
production and transport of gliotoxin exist within a gene cluster. The gliotoxin biosynthesis
cluster was first identified based on its homology to the sirodesmin PL biosynthesis gene
cluster in the ascomycete L. maculans [7, 14, 25, 26] (Fig. 1.12). Within this cluster lies a
Zn2Cys6 binuclear finger transcription factor, GliZ, thought to be responsible for general
gliotoxin induction and regulation. Indeed, over-expression of gliZ leads to an increase in
gliotoxin production and deletion of gliZ results in loss of gliotoxin production [13, 24, 92]. A
DNA binding site has been proposed for GliZ (TCGGN3CCGA), but has not been tested.
This site is present within the promoter region of every gene within the gliotoxin cluster,
except gliZ and gliA [15]. Gliotoxin itself positively regulates expression of the genes within
the gliotoxin cluster, as deletion of gliP, the non-ribosomal peptide synthetase (NRPS)
responsible for the first step in the biosynthetic pathway for gliotoxin, virtually eliminates
expression of the other genes in the cluster [22, 24, 27]. This loss in gene expression can
be reversed by the addition of exogenous gliotoxin to culture medium [22, 24, 27].
Interestingly, gliT, encoding an oxidoreductase required for resistance of the fungus to
gliotoxin, is induced by exogenous gliotoxin even in the absence of gliZ [27]. In addition,
FlbA, mentioned above, negatively regulates gliT expression, as a ∆flbA mutant in A.
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Figure 1.12. Layout of the sirodesmin biosynthetic gene cluster from L. maculans and
the gliotoxin biosynthetic gene cluster from A. fumigatus. Homologues between the two
clusters are colored. Reprinted with permission of Society for General Microbiology:
Microbiology [100], copyright 2005.
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fumigatus displays an accumulation of gliT mRNA and protein, without affecting gliZ
expression or overall gliotoxin production [103]. This demonstrates regulation of genes
within the cluster that are independent of the coordinate regulation by GliZ.
LaeA, mentioned above, has also been shown to regulate the gliotoxin cluster, as
gliotoxin is among the secondary metabolites that are lost with deletion of laeA [32, 50, 51].
Furthermore, loss of vel1 in T. virens (homologous to VeA in Aspergilli) results in a loss in
gliotoxin production [104].

This is not surprising, since VeA, VelB, and LaeA form a

heterotrimeric complex that regulates secondary metabolism and sexual development in
several fungal species [1, 28, 30, 50, 51]. SfaD and GpgA, encoding the only Gβ subunit
and Gγ subunit, respectively, in A. fumigatus, are involved in spore germination and
vegetative growth. In addition, SfaD and GpgA contribute to gliotoxin production, as loss of
either protein reduces gliotoxin synthesis [105]. FlbB, a bZIP transcription factor involved in
asexual development, is required for gliotoxin production in liquid submerged cultures, but
not in air-exposed solid cultures [106]. Additionally, StuA, involved in asexual development,
appears to partially regulate the gliotoxin cluster, as loss in stuA results in a downregulation of several genes within the gliotoxin cluster [107].
RsmA positively regulates the gliotoxin cluster through LaeA and GliZ, as loss of
either protein abolishes the inducing effects of RsmA over-expression [108]. Interestingly,
over-expression of RsmA is able to partially restore sterigmatocystin production in a ∆laeA
background in A. nidulans, but this is not the case in A. fumigatus. In addition, loss of rsmA
negatively affects sterigmatocystin production in A. nidulans, but has no effect on gliotoxin
production in A. fumigatus [84, 108].

Map kinase signaling is another element that is

important for gliotoxin production, as a strain lacking mpkA, the map kinase in the cell wall
integrity pathway, is significantly reduced in gliotoxin production [109]. Nutrient starvation,
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murine infection, and exposure of germlings to neutrophils have also been shown to upregulate the gliotoxin biosynthesis cluster through microarray analysis [12, 24].
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Chapter 2:
Materials and Methods
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All primers used in this study are listed in Table 2.1.
2.1 Strains and Growth Conditions
All strains used in this study and genotypes are listed in Table 2.2. I maintained
Af293.1, Af293.1-GL, 1160, Af293.1-SD1, and Af293.1-SD2 on YAG medium supplemented
with uridine and uracil (0.5% yeast extract, 1% glucose, trace elements and vitamin mix as
modified [110], 10 mM MgCl2, 1.5% agar, 5 mM uridine, and 10 mM uracil,). I grew Ama.G,
Ama.Z, Ama.A, Ama-gliZ.G, Ama-gliZ.Z, Ama-gliZ.A, Ama-gipA.G, Ama-gipA.Z, AmagipA.A, Ama-gipB.G, Ama-gipB.Z, and Ama-gipB.A on YAG medium with 400 µg/ml
hygromycin. I maintained all other strains on YAG medium. Unless otherwise noted, I grew
all strains at 37°C for 48 hrs. For phenotypic growth assays of high-copy and deletion
strains, I inoculated approximately 1000 spores of each strain onto MMVAT (1× MM salts
[20 mM ammonium tartrate, 7 mM KCl, 2 mM MgSO4·7H2O], 1% glucose, 12 mM KPO4 pH
6.8, trace elements, vitamin mix as modified [110], and 1.25% agar), MMVAT with 10 µg/ml
gliotoxin, and YAG. MMVAT plates were incubated for 72 hours. I repeated plate growth
assays twice for a total of three independent tests. I measured radial growth of each colony
and scanned plates on the final day of growth. For spore counts, I evenly spread 1x1010
spores onto YAG medium and incubated plates for 48 hours at 37°C. I collected all spores
from the plate with 1x Tween-20 solution and counted total spores with a hemocytometer. I
calculated spores/cm2 based on the surface area of the medium.

2.2 Genetic Screen
I used fusion PCR (f-PCR) to create a gliAP-lacZ-gliAT construct.

For the first

reaction, I created three cassettes: gliAP, lacZ, and gliAT, using primer pairs GliA F1 and
GliA 5’ R, lacZ F and lacZ R, and GliA 3’ F and GliA R, respectively. I obtained these three
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Name
GliA F1
GliA 5’ R
lacZ F
lacZ R
GliA 3’ F
GliA R
GliZ attB 1
GliZ attB 2
AMA-NotI F
AMA-NotI R
6g01910 F
6g01910 R
4g00320 F
4g00320 R
M13F
M13R
01910 5’ F
01910 5’ R
01910 3’ F
01910 3’ R
gipA 3kb F
gliZ 5’ F
gliZ 5’ R
gliZ 3’ F
gliZ 3’ R
gipA C2H2 F
gipA C2H2 R
SDMut1 F
SDMut1 R
SDMut2 F
SDMut2 R

Sequence
5’-ggggacaagtttgtacaaaaaagcaggctaagatagcaacagtagccaatgt-3’
5’-cgtaatcatggtcataatggtcgatgtcagtagagagctg-3’
5’-ctgacatcgaccattatgaccatgattacggattcactgg-3’
5’-gtttcgaccagatacttatttttgacaccagaccaactgg-3’
5’-tggtgtcaaaaataagtatctggtcgaaacatgtctgctt-3’
5’-ggggaccactttgtacaagaaagctgggtctaagctcgggatggagtgatt-3’
5’-ggggacaagtttgtacaaaaaagcaggctgcgaccgcagctgattggag-3’
5’-ggggaccactttgtacaagaaagctgggtcgattccctttgtgccgcc-3’
5’-aaataagcttgcatgcgc-3’
5’-gccagtgaattcgagctc-3’
5’-ggggacaagtttgtacaaaaaagcaggctgcgggtttggtttggttgttgtgctt-3’
5’-ggggaccactttgtacaagaaagctgggtcgagggcgtggtgaacgttc-3’
5’-ggggacaagtttgtacaaaaaagcaggctgccagcagaccattctcgtttgcattc-3’
5’-ggggaccactttgtacaagaaagctgggtcttcgaggaacctgggttgcg-3’
5’-cgccagggttttcccagtcacgacg-3’
5’-ggaaacagctatgaccatga-3’
5’-ggggacaactttgtatagaaaagttgaaGCGGCCGCgcttacttacagtacggagtacgg-3’
5’-ggggactgcttttttgtacaaacttgcgcccggcggaggaat-3’
5’-ggggacagctttcttgtacaaagtggaatccgttttctacgagcattgttctc-3’
5’-ggggacaactttgtataataaagttgcttcatggtgccgtgctcg-3’
5’-ggggacaagtttgtacaaaaaagcaggctgcaccccgtttttgtggttgcgc-3’
5’-ggggacaactttgtatagaaaagttgaaGCGGCCGCgggagtcgagagatgcatgaa-3’
5’-ggggactgcttttttgtacaaacttgctgtggatgtcggggacga-3’
5’-ggggacagctttcttgtacaaagtggaagctgttctcacctcttttttttttttt-3’
5’-ggggacaactttgtataataaagttgccgagctcgtcgaccagta-3’
5’-ggggacaagtttgtacaaaaaagcaggctgccagcaaatgtacggcgggca-3’
5’-ggggaccactttgtacaagaaagctgggtctcagctgtgcccattggtatcaacg-3’
5’-gacttaacggagactctgccgccacgccgaatcacagcgg-3’
5’-ccgctgtgattcggcgtggcggcagagtctccgttaagtc-3’
5’-gacttaacggagactttgggtgagcgccgaatcacagcgg-3’
5’-ccgctgtgattcggcgctcacccaaagtctccgttaagtc-3’

Table 2.1. Oligonucleotides used throughout this study. Bolded regions are att
sites. Underlined regions are extensions for fusion PCR. Uppercase regions are
NotI sites.
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Strain
Af293
Af293.1
Af293.1-GL
AMA.GL
AMA-gliZ.GL
AMA-gipA.GL
AMA-gipB.GL
1160
1160G
∆gliZ
∆gipA
gipA(R)
∆gipB
gipB(R)
∆gipA.0
∆gliZ/∆gipA
∆gipB.0
∆gipA/∆gipB
Af293.1-SD1
Af293.1-SD2
Af293.1-SD3
AMA.SD1
AMA-gliZ.SD1
AMA-gipA.SD1
AMA.SD2
AMA-gliZ.SD2
AMA-gipA.SD2
pyrG+
∆gliZ.1
∆gipA.1
AMA.G
AMA-gliZ.G
AMA-gipA.G
AMA-gipB.G
AMA.Z
AMA-gliZ.Z
AMA-gipA.Z
AMA-gipB.Z
AMA.A
AMA-gliZ.A
AMA-gipA.A
AMA-gipB.A

Genotype
Wild type
pyrG1
pyrG1; pDHGL
pyrG1; pDHGL; pDONR AMA
pyrG1; pDHGL; pDONR AMA-gliZ
pyrG1; pDHGL; pDONR AMA-gipA
pyrG1; pDHGL; pDONR AMA-gipB
pyrG1; nkuB::AfpyrG; pyrG::5FOA
pyrG1; nkuB::AfpyrG; pyrG::5FOA; pDONR G
pyrG1; nkuB::AfpyrG; pyrG::5FOA; pDHGL; gliZ::pyrG
pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipA::pyrG
pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipA::pyrG; pDONR HPH-gipA
pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipB::pyrG
pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipB::pyrG; pDONR HPH-gipB
pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipA::pyrG; pyrG::5FOA
pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipA::pyrG; pyrG::5FOA; gliZ::pyrG
pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipB::pyrG; pyrG::5FOA
pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipB::pyrG; pyrG::5FOA; gipA::pyrG
pyrG1; pDHSD1
pyrG1; pDHSD2
pyrG1; pDHSD3
pyrG1; pDHSD1; pDONR AMA
pyrG1; pDHSD1; pDONR AMA-gliZ
pyrG1; pDHSD1; pDONR AMA-gipA
pyrG1; pDHSD2; pDONR AMA
pyrG1; pDHSD2; pDONR AMA-gliZ
pyrG1; pDHSD2; pDONR AMA-gipA
pyrG1; AnpyrG
pyrG1; gliZ::pyrG
pyrG1; gipA::pyrG
pyrG1; pyrG; pDONR AMA/HPH
pyrG1; pyrG; pDONR AMA/HPH-gliZ
pyrG1; pyrG; pDONR AMA/HPH-gipA
pyrG1; pyrG; pDONR AMA/HPH-gipB
pyrG1; gliZ::pyrG; pDONR AMA/HPH
pyrG1; gliZ::pyrG; pDONR AMA/HPH-gliZ
pyrG1; gliZ::pyrG; pDONR AMA/HPH-gipA
pyrG1; gliZ::pyrG; pDONR AMA/HPH-gipB
pyrG1; gipA::pyrG; pDONR AMA/HPH
pyrG1; gipA::pyrG; pDONR AMA/HPH-gliZ
pyrG1; gipA::pyrG; pDONR AMA/HPH-gipA
pyrG1; gipA::pyrG; pDONR AMA/HPH-gipB

Table 2.2. Genotype of all strains used in this study.
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Origin
FGSC
This Lab[111]
This Study
This Study
This Study
This Study
This Study
FGSC[112]
This Lab
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study
This Study

fragments by PCR using e2TAK DNA polymerase (Takara Bio Inc., Otsu, Shiga, Japan),
following manufacturer recommendations. The gliAP fragment had a 3’ extension identical
to the first 15 base pairs of lacZ. The lacZ fragment had a 5’ extension identical to the last
15 base pairs of gliAP and a 3’ extension identical to the first 15 base pairs of gliAT. The
gliAT fragment had a 5’ extension identical to the last 15 base pairs of lacZ. I used Af293
genomic DNA as template for the gliAP and gliAT regions and λGT11 as template for lacZ.
For the second reaction, I fused the three fragments together using GliA F1 and GliA R as
primers. I amplified a 50 µl reaction containing 50 fmol of each fragment, 0.3 µM of each
primer, 500 µM of deoxynucleoside triphosphates, buffer 3 at a 1X concentration, and 1 µl
of Expand Long DNA Template Mix (Roche Applied Science, Indianapolis, IN) per
manufacturer’s instructions (briefly, 94°C for 2 min, 10 cycles of 94°C for 10 sec, 62°C for
30 sec, 68°C for 4.5 min and 15 cycles of 94°C for 15 sec, 62°C for 30 sec, 68°C for 4.5
min, increasing the final extension time by 20 sec with each cycle).
I cloned the fusion product into pDONR HPH A using a BP recombination reaction
(Invitrogen, Grand Island, NY). I transformed the reaction mix into TOP10 cells (Invitrogen,
Grand Island, NY) by electroporation, as recommended by the manufacturer. I grew the
transformation mix on LB (1% Tryptone, 0.5% yeast extract, 1X SOB salts [10mM NaCl,
2.5mM KCl], 1.5% agar) + 50 µg/ml kanamycin at 37ºC overnight. I picked colonies and
transferred to 2 ml of LB liquid + 50 µg/ml kanamycin to grow overnight in a 37ºC shaking
incubator. I isolated plasmid DNA from each culture using a miniprep kit (Qiagen, Hilden,
Germany). I digested plasmid DNA with specific enzymes to verify the correct insertion. I
designated this vector as pDHGL.
I grew Af293.1 in MAG medium (2% malt extract, 0.2% peptone, 1% glucose, trace
elements and vitamin mix as modified [110]) supplemented with 5 mM uridine and 10 mM
uracil. I performed the transformation as previously described [113], keeping pDHGL as a
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circular vector. I grew transformants on MMVAT supplemented with 5 mM uridine, 10 mM
uracil, 0.2 M sucrose, and 400 µg/ml hygromycin at 37ºC for 3-5 days. I identified the
presence of pDHGL by Southern hybridization [114] of the lacZ coding region (Fig. 2.1a). I
also streaked transformants onto MMVSN supplemented with uridine and uracil (as
described above for MMVAT, except 1xMM salts contain 20mM sodium nitrate instead of
ammonium tartrate) and 40 µg/ml X-gal to grow at 37°C for 2 days.

I screened for

transformants that grew in the presence of hygromycin and developed a blue pigment on 5bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal), signaling that lacZ expression was
working properly (Fig. 2.1b). I designated this strain as Af293.1-GL.
For the first round of the high-copy inducer screen, I grew Af293.1-GL in MAG
supplemented with uridine and uracil. I transformed the AMA1-Not1 A. fumigatus genomic
library [115] into Af293.1-GL as described previously [113], but with changes. I combined
each transformation mix with 50 ml CM top agar (MMVAT, as described above, 0.1% yeast
extract, 0.2% peptone, 0.1% tryptone, 1% CM supplement [27 mM adenine HCl, 33.5 mM
methionine, 173 mM arginine, and 1.3 mM riboflavin], and 1% agar) supplemented with 1 M
sucrose and spread the mixture over 10 plates (5 ml/plate). I grew transformants on CM
supplemented with 0.2 M sucrose and 40 µg/ml X-gal at 37°C for 3-5 days. I screened for
transformants that were both prototrophic for uridine and uracil and producing blue pigment.
I prepared genomic DNA from transformants [51] and transformed 1 µl of genomic DNA into
TOP10 cells (Invitrogen, Grand Island, NY) by electroporation, as recommended by the
manufacturer.

I grew the transformation mix on LB + 100 µg/ml ampicillin at 37ºC

overnight. I picked colonies and transferred to 2 ml of LB liquid + 100 µg/ml ampicillin to
grow overnight in a 37ºC shaking incubator. I isolated plasmid DNA from each culture
using a miniprep kit (Qiagen, Hilden, Germany) and digested it with KpnI to identify
individual plasmids.
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Figure 2.1. Presence and activity of lacZ expression cassette in
Af293.1-GL transformants. (a) Southern hybridization of Af293.1GL transformants. Genomic DNA was digested with EcoRI
overnight at 37°C then run on a 0.8% agarose gel. The lacZ
coding region was used as the probe. WT is wild-type (Af293.1)
and is expected to have no band. Proper transformants should
only have one band of unknown size. Lanes with asterisks are
transformants that produced blue pigment when grown on
MMVSN U/U (non-repressing) medium with X-gal. (b) Example of
blue pigment production in Af293.1-GL transformants. The left
panel shows activation of the lacZ expression cassette, while the
right panel displays colonies that are not induced for lacZ
expression.
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For the second round of the high-copy inducer screen, I grew Af293.1-GL in MAG
supplemented with uridine and uracil. I transformed each individual plasmid isolated from
the first round of the genetic screen as described above, but with the following changes. I
plated two amounts of protoplasts (20 µl and 100 µl) each in 4 ml MMVAT top agar (as
described above but with 1% agar) supplemented with 1 M sucrose. I grew transformants
on MMVAT supplemented with 0.2 M sucrose and 40 µg/ml X-gal at 37°C for 3-4 days and
put plates in the 4°C refrigerator to facilitate blue pigment production. Plasmids causing at
least 80% of colonies to turn blue were sequenced using primers AMA-NotI F and AMANotI R. I also grew transformants in 10 ml CM at 37°C stationary overnight. I collected
mycelia, froze in liquid nitrogen, and lyophilized overnight. I collected total protein and
performed β-galactosidase assays to measure LacZ levels quantitatively (detailed below).
For the third round of the high-copy inducer screen, I PCR amplified individual
genes from genomic library plasmids, flanked by native 5’ and 3’ non-coding regions
(NCRs). For gipA (Afu6g01910) and gipB (Afu4g00320) I used the primer pair 6g01910 F
and 6g01910 R and the primer pair 4g00320 F and 4g00320 R, respectively.

I amplified

the fragments from Af293 genomic DNA using e2TAK DNA polymerase (Takara Bio Inc.,
Otsu, Shiga, Japan) and following manufacturer recommendations.

I cloned the PCR

fragments into pDONR AMA with a BP recombination reaction (Invitrogen, Grand Island,
NY). I transformed the reaction mix into TOP10 cells (Invitrogen, Grand Island, NY) by
electroporation, as recommended by the manufacturer. I grew the transformation mix on
LB + 100 µg/ml ampicillin at 37ºC overnight. I picked colonies and transferred to 2 ml of LB
liquid + 100 µg/ml ampicillin to grow overnight in a 37ºC shaking incubator. I isolated
plasmid DNA from each culture using a miniprep kit (Qiagen, Hilden, Germany). I digested
plasmid DNA with specific enzymes to verify the correct insertion.

I designated these

vectors as pDONR AMA-gipA and pDONR AMA-gipB. I created a control vector, pDONR
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AMA-gliZ, which contained the gliZ coding region flanked by promoter and terminator
regions. I generated this vector as described above for pDONR AMA-gipA and pDONR
AMA-gipB using primers GliZ attB 1 and GliZ attB 2.
I grew Af293.1GL in MAG medium, supplemented with uridine and uracil.

I

performed the transformation as previously described [113], with changes, using pDONR
AMA, pDONR AMA-gliZ as controls. After the 3 hour incubation of protoplasts, I carried out
all reactions at half the specified volume. I used 500 ng – 750 ng of circular vector DNA for
each reaction. I plated two amounts of protoplasts (20 µl and 50 µl) each in 4 ml of MMVAT
top agar supplemented with 1 M sucrose.

I grew transformants on MMVAT medium

supplemented with 0.2 M sucrose at 37ºC for 2-3 days.

To measure LacZ levels

quantitatively, I grew transformants in 10 ml CM at 37°C stationary overnight. I collected
mycelia, froze in liquid nitrogen, and lyophilized overnight. I collected total protein and
performed β-galactosidase assays (detailed below). I chose three strains to use for future
analysis: AMA.GL, AMA-gliZ.GL, and AMA-gipA.GL.

2.3 λ Phage Library Screen
I isolated gipA and gipB cDNA clones from a λ phage library constructed with the
UniZAP vector and poly(A)+ mRNA, as described by the manufacturer (Stratagene, La
Jolla, California). I performed a primary screen of the λ phage library as recommended by
manufacturer (Stratagene, La Jolla, California), with changes. I plated 6 plates (150 mm)
for primary screening with host strain LE392 (Stratagene, La Jolla, California) and the λ
phage library at 40,000 plaque-forming-units (pfu)/plate (3 plates) and 60,000 pfu/plate (3
plates). I lifted plaques with nylon membranes and crosslinked the DNA to the membranes
by baking for 2 hours in an oven. I prehybridized and hybridized membranes at 42°C for 6
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hours and overnight, respectively. I used gipA and gipB genomic DNA PCR products for
probes [114]. I excised plugs containing positive plaques and placed them in SM (.1 M
NaCl, 10 mM MgSO4·7H2O, 50 mM Tris·HCl [pH 7.5], and .01% gelatin) at 4°C overnight.
After determining pfu concentration of plaques, I performed a secondary screen, as
performed for the primary screen, with changes. I combined 500-1000 pfu with LE392 and
spread over 8 plates (100 mm). I hybridized membranes using gipA and gipB genomic
DNA as probes [114].

I plated excised phagemids as recommended by manufacturer

(Stratagene, La Jolla, California) and plated on LB + 100 µg/ml ampicillin to grow at 37°C
overnight. I PCR amplified cDNA from excised phagemids using e2TAK DNA polymerase
(Takara Bio Inc., Otsu, Shiga, Japan) and following manufacturer recommendations. I used
M13 F and M13 R as primers for the reaction. Based on the PCR band sizes, I picked
colonies from selected plates and transferred to 2 ml of LB liquid + 100 µg/ml ampicillin to
grow overnight in a 37ºC shaking incubator. I isolated plasmid DNA from each culture
using a miniprep kit (Qiagen, Hilden, Germany) and sequenced the cDNA insert using M13
F and M13 R primers.

I used DNASTAR software (DNASTAR Inc., Madison, WI) to

assemble and analyze the sequences obtained from the library screen.

2.4 RNA Dot Blot Analysis
For all dot blot assays, I grew stationary cultures in 25 ml CM (repressing)
(described above) or CD (non-repressing) (87.6 mM sucrose, 35.3 mM Na2NO3, 5.8 mM
K2HPO4, 2 mM MgSO4·7H2O, 6.7 mM KCl, and 0.025 mM (NH4)2Fe(SO4)2·6H2O) at a
concentration of 5x106 spores/ml at 37ºC for 48 hours. I included 400 µg/ml hygromycin in
dot blot assays involving Ama.G, Ama.Z, Ama.A, Ama-gliZ.G, Ama-gliZ.Z, Ama-gliZ.A,
Ama-gipA.G, Ama-gipA.Z, Ama-gipA.A, Ama-gipB.G, Ama-gipB.Z, and Ama-gipB.A.
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I

prepared total RNA from freeze-dried mycelia using the TRIzol method [110]. I incubated
total RNA with denaturing solution (50% formamide, 16% formaldehyde, 1X borate buffer
[20X borate buffer:

0.4 M Boric Acid, 4 mM EDTA, pH 8.3 with NaOH], 0.025%

bromophenol blue) for 10 minutes at 65°C. I quenched samples on ice for 10 minutes, then
added equal volume 20x SSC (3 M NaCl, 0.3 M C6H5O7Na3 •2H2O, pH 7.0). I placed a
nylon membrane that had been equilibrated in 10x SSC for 10 minutes into a 96-well dot
blot apparatus attached to a vacuum manifold. I collected samples, each containing 3 µg of
RNA unless otherwise noted, in 100 µl volumes by aspiration. I aspirated 50 µl of 10x SSC
through the membrane in duplicate immediately before and after samples were collected.
Once all samples were aspirated, I air dried nylon membranes overnight and then baked
them in an oven for 2 hours.

For prehybridization and hybridization, I sealed nylon

membranes in a bag using a heated sealer. I prehybridized membranes for 4-6 hours at
42°C and hybridized membranes overnight at 42°C. For DNA probes, I only used the
coding region of each gene of interest (gliA, gliP, gliZ, gliT, gipA, gipB, actin). I used
different combinations of these probes in different experiments, which is noted in the figure
legends. After hybridization, I washed membranes as I would for Southern hybridization
[114] and exposed them to a Typhoon 8600 PhosphorImager (GE Healthcare Life
Sciences, Pittsburgh, PA) overnight.

I quantified the intensity of hybridization using

ImageQuant5.1 software (GE Healthcare Life Sciences, Pittsburgh, PA).

2.5 Gliotoxin Extraction and HPLC Analysis
I extracted spent culture medium from RNA dot blot assays in 15 ml chloroform for
30 minutes at room temperature on an orbital shaker set to 250 rpm. I transferred the
chloroform phase to a 50 ml conical tube (BD Biosciences, San Jose, California) and
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repeated the extraction twice for a total of 45 ml chloroform. I dried open tubes under a
hood until the chloroform was completely evaporated. I added 15 ml chloroform to each
tube and mixed, to concentrate the extracted material at the bottom. I dried open tubes
under a hood until chloroform was completely evaporated. I added 1 ml methanol to each
tube and mixed to dissolve all methanol-soluble substances and transferred extracts to
microcentrifuge tubes (Fisher Scientific, Pittsburgh, PA). I dried open tubes under a hood
until all methanol was completely evaporated.
I dissolved extracts in 50 µl of dimethyl sulfoxide (DMSO), spun tubes to pellet
insoluble debris, and transferred DMSO to fresh microcentrifuge tubes.

I quantified

gliotoxin levels by running samples through a reverse-phase high performance liquid
chromatography (RP-HPLC) system with a Waters 996 photodiode array detector (Waters,
Milford, MA). I ran samples through a Sonoma 2.1 x 250 mm C18 column (100 Å pore size)
packed with 5 µM particles (VWR, Radnor, PA). The mobile phase consisted of H2O, 0.1%
TFA (solution A) and 100% Acetonitrile, 0.1% TFA (solution B): 10% B up to 80% B over
30 minutes. The injection volume was 10 µl and flow rate was set at 0.4 ml/min. Gliotoxin
eluted from the column at 14.7 minutes and absorbance was read at 268 nm wavelength. I
determined gliotoxin concentrations by interpolation from a 9 point standard curve (39 ng to
10 µg) prepared using purified gliotoxin (Sigma-Aldrich Corp., St. Louis, MO).

2.6 Microarray
The DNA amplicon microarray for Af293 was created previously [116].

I grew

AMA.GL and AMA-gipA.GL in 25 ml CM (described above) at 37°C for 24 hours in
stationary cultures. The spore concentration was 5x106 spores/ml. I used two independent
biological replicates for AMA.GL and AMA-gipA.GL growth assays. I prepared total RNA
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from freeze-dried mycelia using the TRIzol method [110].

I carried out RNA labeling

reactions and hybridizations as described in the J. Craig Venter Institute Microarray
Protocols (http://pfgrc.jcvi.org/index.php/microarray/protocols.html).

I repeated all the

hybridizations in dye-swap sets. I scanned and analyzed hybridized slides as described
previously [116]. I averaged all replicates for the official data used in our analysis.

2.7 Virulence Assays with Toll-deficient Drosophila melanogaster
I injected the dorsal side of the thorax of CO2-anesthetized, adult, Toll-deficient D.
melanogaster flies with a sterile 0.25 mm needle that had been dipped in a solution
containing 107 spores/ml of A. fumigatus conidia. I infected 20-25 flies per strain for each
virulence assay, which was repeated at least twice. Flies were kept in a 29°C incubator to
maximize susceptibility to microbial challenge and monitored for 7 days. Flies that died
within 3 hours of the injection were not included in the survival graph, as these flies most
likely died as a result of the puncture wound.

2.8 Deletion and Complementation of gipA and gipB in Af1160
I amplified the 5’ flanking region (FR) and the 3’ FR from gipA using primers 01910
5’ F, 01910 5’ R, 01910 3’ F, and 01910 3’ R and gipB using primers 00320 5’ F, 00320 5’
R, 00320 3’ F, and 00320 3’ R. I engineered a unique NotI site into 01910 5’ F and 00320
5’ F to linearize the final deletion constructs. I amplified the fragments from Af293 genomic
DNA using e2TAK DNA polymerase (Takara Bio Inc., Otsu, Shiga, Japan) and following
manufacturer recommendations. I cloned the gipA 5’ FR and gipB 5’ FR into pDONR P4P1R and I cloned the gipA 3’ FR and gipB 3’ FR into pDONR P2R-P3, using BP
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recombination reactions (Invitrogen, Grand Island, NY). I transformed BP reaction mixes
into TOP10 cells (Invitrogen, Grand Island, NY) by electroporation, as recommended by the
manufacturer. I grew transformed cells on LB (described above) + 50 µg/ml kanamycin at
37ºC overnight. I picked colonies and transferred to 2 ml LB liquid + 50 µg/ml kanamycin to
grow overnight in a 37ºC shaking incubator. I isolated plasmid DNA from each culture
using a miniprep kit (Qiagen, Hilden, Germany). I digested plasmid DNA with specific
enzymes to verify the correct fragment orientation.
To create the deletion constructs, I combined pDONR P4-P1R-gipA 5’ FR, pDONR
P2R-P3-gipA 3’ FR, and pDONR 221-AnpyrG for the gipA construct and pDONR P4-P1RgipB 5’ FR, pDONR P2R-P3-gipB 3’ FR, and pDONR 221-AnpyrG for the gipB construct in
two LR recombination reactions with pDEST R4-R3 as the destination vector (Invitrogen,
Grand Island, NY) [117]. I transformed the LR reaction mixes into TOP10 cells (Invitrogen,
Grand Island, NY) by electroporation, as recommended by the manufacturer.

I grew

transformed cells on LB + 100 µg/ml ampicillin at 37ºC overnight. I picked colonies and
transferred to 2 ml LB liquid + 100 µg/ml ampicillin to grow overnight in a 37ºC shaking
incubator. I isolated plasmid DNA from each culture using a miniprep kit (Qiagen, Hilden,
Germany). I digested plasmid DNA with specific enzymes to verify the correct fragment
orientation. I grew bacterial cultures containing the correct plasmids in 250 ml LB liquid +
100 µg/ml ampicillin overnight in a 37ºC shaking incubator. I purified plasmid DNA by
banding on cesium chloride ethidium bromide gradients [114]. I designated the plasmids
pDEST R4-R3-gipA 5’ FR-AnpyrG-gipA 3’ FR and pDEST R4-R3-gipB 5’ FR-AnpyrG-gipB
3’ FR.
I grew A. fumigatus 1160 (obtained from FGSC) in MAG supplemented with uridine
and uracil (described above). I performed the transformation as previously described [113],
linearizing both deletion constructs with NotI to facilitate homologous recombination. I grew
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transformants on MMV (described above) supplemented with 0.2 M sucrose at 37ºC for 3-5
days. I screened for mutants that were prototrophic for uridine and uracil. I prepared
genomic DNA from transformant strains [51], and I identified deletion mutants by Southern
blot analysis (Fig. 2.2a & b) [114]. I made two DNA probes using the gipA 5’ and 3’ FRs
and the gipB 5’ and 3’ FRs to verify ΔgipA and ΔgipB, respectively.
To create a vector for complementation, I PCR amplified the gipA coding region,
flanked by a 3 kilobase promoter region and 500 base pair terminator region, using primers
gipA 3kb F and 6g01910 R. I used primers 4g00320 F and 4g00320 R to isolate the gipB
coding region. I amplified the fragments from Af293 genomic DNA using e2TAK DNA
polymerase (Takara Bio Inc., Otsu, Shiga, Japan) and following manufacturer
recommendations. I cloned the PCR products into pDONR HPH B, as described previously
for pDHGL. I designated these vectors pDONR HPH-gipA and pDONR HPH-gipB. I grew
∆gipA and ∆gipB in MAG medium (as described above). I performed the transformations
as previously described for pDHGL. For Southern hybridization, I made DNA probes using
the coding region of gipA and gipB (Fig. 2.3a&b). I designated these strains as gipA(R) and
gipB(R). I obtained controls (1160G and ∆gliZ) for growth assays deletion mutants. I
created 1160G by transforming pDONR G into Af1160 and I created ∆gliZ by transforming
pDEST R4-R3-gliZ 5’ FR-AnpyrG-gliZ 3’ FR into Af1160, performed as described above for
∆gipA. I created the gliZ deletion construct as described previously for ∆gipA using primers
gliZ 5’ F, gliZ 5’ R, gliZ 3’ F, and gliZ 3’ R. I used gliZ 5’ and 3’ flanking regions as a DNA
probe for Southern hybridization (Fig. 2.2c).
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Figure 2.2. Southern hybridizations
of gipA, gipB, and gliZ deletion
mutants. Samples were run on a
0.8% agarose gel. WT is wild-type
(Af1160). (a) ∆gipA transformants
digested with PstI. WT should
have a 4769 bp band and a 3275
bp
band,
while
correct
transformants are expected to
have one 8627 bp band. The gipA
5’ FR and 3’ FR was used as a
probe. (b) ∆gipB transformants
digested with ClaI. WT should
have a 11488 bp band and a 3852
bp
band,
while
correct
transformants should have one
13619 bp band. The gipB 5’ FR
and 3’ FR was used as a probe.
(c) ∆gliZ transformant digested
with KpnI. WT should have one
8775 bp band, while correct
transformant should have a 6314
bp band and a 2945 bp band. The
gliZ 5’ FR and 3’ FR was used as a
probe.
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Figure
2.3.
Southern
hybridizations of gipA(R)
and gipB(R) transformants.
WT is wild-type (Af1160).
(a) gipA(R) transformants
digested with SphI. WT
should have two bands,
one at 4131 bps and one
at 3404 bps (the lower
band is extremely light).
The ΔgipA mutant should
not display any band.
Correct
transformants
should display two bands
at 3404 bps and 1967 bps,
which
indicates
5’
integration
of
the
complement plasmid. (b)
gipB(R)
transformants
digested with EcoRI. WT
should display two bands
at 5423 bps and 1225 bps.
The ΔgipB mutant should
not display any band, while
correct
transformants
should display two bands
at 7793 bps and 1225 bps,
indicating 5’ integration of
the complement plasmid.

2.9 Construction of ∆gliZ/∆gipA and ∆gipA/∆gipB
I grew ∆gipA on YAG supplemented with uridine and uracil (described above) + 1
mg/ml 5-Fluororotic acid (5-FOA) at 37ºC. Colonies that reverted to a pyrG- phenotype
grew as outgrowths from the original streak. I prepared genomic DNA from these pyrGfans [51] and tested them for the presence of gipA by Southern hybridization (Fig. 2.4a)
[114]. I used the gipA coding region as a DNA probe. I designated this mutant as ∆gipA.0.
I transformed pDEST R4-R3-gliZ 5’ FR-AnpyrG-gliZ 3’ FR into ∆gipA.0, as described above
for ∆gipA. I used the gliZ, gipA, and gipB coding regions as a DNA probe for Southern
hybridization (Fig. 2.5a).
I grew ΔgipB on 5-FOA medium, as described above for ∆gipA.0, and designated
this strain as ΔgipB.0. I prepared genomic DNA from these pyrG- fans [51] and tested them
for the presence of gipB by Southern hybridization (Fig. 2.4b) [114]. I used the gipB coding
region as a DNA probe. I transformed pDEST R4-R3-gipA 5’ FR-AnpyrG-gipA 3’ FR into
∆gipB.0, as described above for ∆gipA. I used the gipA and gipB coding regions as a DNA
probe for Southern hybridization (Fig. 2.5b).

2.10 Protein Binding Microarray
I amplified the C2H2 DNA binding region from gipA using primers gipA C2H2 F and
gipA C2H2 R.

I used Af293 as template and AccuPrime Pfx DNA polymerase (Life

Technologies Grand Island, NY) and per manufacturer’s recommendations. I cloned the
PCR product into pDONR 221 using a BP recombination reaction (Invitrogen, Grand Island,
NY). I transformed the reaction mix into TOP10 cells (Invitrogen, Grand Island, NY) by

59

a

WT

∆A

1

b

2

WT

∆B

1

2

10 kb
7 kb

Figure 2.4. Southern hybridization of ∆gipA and ∆gipB
mutants treated with 5-FOA. Samples were run on a
0.8% agarose gel. WT is wild-type (Af1160) and ∆ is the
untreated deletion strain. (a) ∆gipA.0 mutants digested
with EcoRV and probed with the gipA coding region. Only
WT should display a band, which is 7616 bp. (b) ∆gipB.0
mutants digested with ScaI and probed with the gipB
coding region. Only WT should display a band, which is
13828 bp.
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Figure 2.5. Southern hybridization of ∆gliZ/∆gipA and
∆gipA/∆gipB double mutants. Samples were run on a
0.8% agarose gel.
WT is wild-type (Af1160).
(a)
∆gliZ/∆gipA transformants digested with SacI and probed
with the gliZ, gipA, and gipB coding regions. WT should
display three bands, which are 11712 bps (gipB), 7474
bps (gipA), and 4566 bps (gliZ). The ∆gipA control should
display two bands, which are 11712 bps (gipB) and 4566
bps (gliZ). Correct transformants should display only one
band at 11712 bps, for gipB.
(b) ∆gipA/∆gipB
transformants digested with SacI and probed with the gipA
and gipB coding regions. WT should display two bands,
which are 11712 bps (gipB) and 7474 bps (gipA). The
∆gipA control should display one band at 11712 bps for
gipB and the ∆gipB control should display one band at
7474 bps for gipA. Correct transformants should not
display any bands.
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electroporation, as recommended by the manufacturer. I grew the transformation mix on
LB + 50 µg/ml kanamycin at 37ºC overnight. I picked colonies and transferred to 2 ml of LB
liquid + 50 µg/ml kanamycin to grow overnight in a 37ºC shaking incubator. I isolated
plasmid DNA from each culture using a miniprep kit (Qiagen, Hilden, Germany). I digested
plasmid DNA with specific enzymes to verify the correct insertion. I recombined the gipA
C2H2 region into pDEST 15 using an LR recombination reaction (Invitrogen, Grand Island,
NY). I transformed the reaction mix into TOP10 cells (Invitrogen, Grand Island, NY) by
electroporation, as recommended by the manufacturer. I grew the transformation mix on
LB + 100 µg/ml ampicillin at 37ºC overnight. I picked colonies and transferred to 2 ml of LB
liquid + 100 µg/ml ampicillin to grow overnight in a 37ºC shaking incubator. I isolated
plasmid DNA from each culture using a miniprep kit (Qiagen, Hilden, Germany). I digested
plasmid DNA with specific enzymes to verify the correct insertion. This vector, pDEST 15gipA C2H2, was used in a protein binding microarray analysis as previously described [118].

2.11 Mutagenesis of the GipA DNA Binding Site in the gliA Promoter
I created mutated gipA DNA binding sites in pDHGL using a QuikChange II XL SiteDirected Mutagenesis Kit (Agilent Technologies Inc., Santa Clara, CA), as recommended
by the manufacturer. I utilized primers SDMut1 F and SDMut1 R, SDMut2 F and SDMut2 R
to create vectors pDHSD1 and pDHSD2, respectively. I transformed pDHGL, pDHSD1 and
pDHSD2 into Af293.1, as previously described for Af293.1-GL, except I plated
transformants on YAG supplemented with uridine and uracil (described above), 0.2 M
sucrose, and 300 µg/ml hygromycin.

I verified correct transformants by Southern

hybridization using the lacZ coding region as a probe (Fig. 2.6). I designated these strains
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Figure 2.6. Southern hybridizations of promoter mutagenesis transformants. Samples
were digested with EcoRI and run on a 0.8% agarose gel. WT is wild-type (Af293.1) and
GL is Af293.1-GL. The lacZ coding region was used as the probe. WT should not display
a band and GL should have a single band ~6500bps. Correct transformants should
display a single band, any size. (a) First group of Af293.1-SD1 transformants. Isolate 5
was chosen for experiments. (b) First group of Af293.1-SD2 transformants. Isolate 4 was
chosen for experiments. (c) Second group of Af293.1-GL and Af293.1-SD1 transformants.
Isolate 6 and 4 were chosen for experiments, respectively. (d) Second group of Af293.1SD2 transformants. Isolate 6 was chosen for experiments. Notice that isolates chosen for
independent experiments for Af293.1-SD1 and Af293.1-SD2 display different sized bands,
indicating that the pDHSD1 and pDHSD2 plasmids integrated in different places in the
genome, respectively.
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as Af293.1-GL, Af293.1-SD1 and Af293.1-SD2, respectively. I repeated transformations
until I obtained two independent isolates for experiments, therefore, I used the AMA.GL,
AMA-gliZ.GL, and AMA-gipA.GL obtained from the high-copy library screen for one set of
experiments and made a new Af293.1-GL strain (Fig. 2.6c) for the second set of
experiments. To test the effect of the different gipA binding site mutants, I transformed
pDONR AMA, pDONR AMA-gliZ, and pDONR AMA-gipA into two independent isolates of
Af293.1-GL, Af293.1-SD1 and Af293.1-SD2, as described above for AMA-gipA.GL, except I
grew transformants on YAG supplemented with 0.2 M sucrose. I designated the promotermutated strains as AMA.SD1, AMA-gliZ.SD1, AMA-gipA.SD1, AMA.SD2, AMA-gliZ.SD2
and AMA-gipA.SD2.

2.12 β-galactosidase Assays
I ground 50 µl lyophilized mycelia to a fine powder with acid-washed glass beads
(400-650 µm) (Sigma-Aldrich Corp., St. Louis, MO). I suspended the ground powder in 200
µl protein extraction buffer (PEB) (60mM Na2HPO4·7H2O, 40mM NaH2PO4·H2O, 10mM KCl,
1mM MgSO4·7H2O, 1mM EDTA, and 20µM PMSF [added fresh], pH 7.0) by vortexing and
incubated the samples on ice for 15 minutes, with additional vortexing every 5 minutes. I
spun tubes for 15 minutes at 15,600 x g at 4°C to pellet cellular debris and beads. I
transferred supernatants, containing total protein, to fresh tubes on ice and measured
protein concentration using a Bio-Rad protein assay kit (Bio-Rad, Hercules, CA).

In a 96-

well plate, I added 10 µl of protein in PEB and 90 µl Z Buffer (60mM Na2HPO4·7H2O, 40mM
NaH2PO4·H2O, 10mM KCl,

1mM MgSO4·7H2O, 50mM β-mercaptoethanol [added fresh],

pH to 7.0). For samples grown in repressing conditions (CM), the total protein added was 1
µg. For samples grown in non-repressing conditions (CD), the total protein added was 0.1
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µg.

To begin the β-galactosidase assay, I added 20 µl of 2-Nitrophenyl-β-D-

galactopyranoside (ONPG) (Sigma-Aldrich Corp., St. Louis, MO), at a concentration of 4
mg/ml in Z Buffer, and placed the 96-well plate in a 37°C incubator. I timed reactions and
stopped samples with 50 µl 1 M Na2CO3. I measured absorbance at OD420 and calculated
Units of β-galactosidase activity/mg protein with the following equation:

(OD420 x

TV)/(0.0045 x T x V x C), where TV is total volume of the reaction in ml, T is time in
minutes, V is volume of protein added in ml, and C is concentration of protein used in µg/µl.

2.13 Creation of Strains for High-copy Gene Expression in Deletion Backgrounds
I grew Af293.1 in MAG supplemented with uridine and uracil (described above). I
transformed pDEST R4-R3-gliZ 5’ FR-AnpyrG-gliZ 3’ FR and pDEST-gipA 5’ FR-AnpyrGgipA 3’ FR into Af293.1, as previously described for ∆gipA, except I plated transformants on
YAG supplemented with 0.2 M sucrose. I used gliZ 5’ and 3’ FRs and gipA 5’ and 3’ FRs
for Southern hybridization and designated these strains ∆gliZ.1 and ∆gipA.1 (Fig. 2.7). I
chose one strain from the ∆gliZ transformation that did not show homologous
recombination at the gliZ locus, but was prototrophic for uridine and uracil. I designated this
strain pyrG+. I collected total RNA and performed dot blot analysis on pyrG+, ∆gliZ.1, and
∆gipA.1 to verify loss of gliZ and gipA, respectively (described above) (Fig. 2.8). I cloned
gliZ, gipA, and gipB into pDONR AMA/HPH, as described above for pDONR AMA-gliZ,
pDONR AMA-gipA, and pDONR AMA-gipB, respectively, except I used primers gipA 3kb F
and 6g01910 R for the gipA cassette. I designated these plasmids pDONR AMA/HPH-gliZ,
pDONR/HPH-gipA, and pDONR AMA/HPH-gipB. I transformed these plasmids, along with
pDONR AMA/HPH empty vector, into pyrG+, ∆gliZ.1, and ∆gipA.1, as described above for
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Figure 2.7. Southern hybridizations of ∆gliZ.1 and
∆gipA.1 transformants. Samples were run on a
0.8% agarose gel. WT is wild-type (Af293.1). (a)
∆gliZ.1 transformants digested with KpnI. WT
should display a 8775 bp band and correct
transformants should display two bands at 6314
bps and 2945 bps. The gliZ 5’ and 3’ FRs were
used as a probe.
(b) ∆gipA.1 transformants
digested with PstI. WT should display two bands at
4769 bps and 3275 bps, while correct
transformants should display one band at 8627 bps.
The gipA 5’ and 3’ FRs were used as a probe.
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a

b

Figure 2.8. Verification of ΔgliZ and ΔgipA mutants in an Af293.1
background. (a) Cultures were grown in non-repressing conditions
at 37°C for 48 hrs. Total RNA was collected and dot blot analysis
was performed in triplicate with 3 µg RNA/spot. RNA levels are
relative to pyrG+. The results of one representative experiment of
two biological replicates are shown. The asterisk ( ) indicates a
statistically significant difference (p-value <0.05), compared to
PyrG+, calculated by one-way ANOVA and Tukey comparison test.
(b) Gliotoxin was measured with RP-HPLC.
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AMA-gipA.GL, except I grew transformants on YAG supplemented with uridine and uracil
(described above), 0.2 M sucrose, and 400 µg/ml hygromycin. I designated these strains
as AMA.G, AMA-gliZ.G, AMA-gipA.G, AMA-gipB.G, AMA.Z, AMA-gliZ.Z, AMA-gipA.Z,
AMA-gipB.Z, AMA.A, AMA-gliZ.A, AMA-gipA.A, and AMA-gipB.A.
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Chapter 3:
Identification of High-copy Inducers of gliA
Expression
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3.1 Introduction
Although a number of proteins have been shown to affect gliotoxin production in a
generalized way, no direct regulation through promoter binding has been experimentally
proven. Not even the cluster-specific transcription factor, GliZ, has been experimentally
shown to bind to any promoter regions within the cluster [15]. To identify novel proteins that
possibly directly regulate the gliotoxin biosynthesis cluster, I performed a high-copy inducer
screen to identify genes that, when present in extra copies, induced the gliotoxin
biosynthesis cluster in repressing conditions. I used a LacZ reporter system, under the
control of the gliA promoter, for the screen.

GliA encodes an efflux pump within the

gliotoxin cluster. I chose gliA for several reasons. First, it has been shown that expression
of gliA peaks when the amount of gliotoxin in surrounding medium is maximal [14, 25].
Second, experiments in the May laboratory have revealed that gliA is induced within 30
minutes of A. fumigatus germlings being exposed to human neutrophils (Fig. 3.1). These
data led me to conclude that gliA expression would be an excellent indicator of gliotoxin
cluster expression, as well as gliotoxin production.

3.2 Results
3.2.1 Creation of an Expression Cassette for the High-copy Inducer Screen
I created a gliAP-lacZ-gliAT cassette with fusion PCR and cloned this into pDONR
HPH A, creating vector pDHGL. This cassette contained 588 base pairs (bp) of the gliA 5’
non-coding region (NCR) (gliAP), immediately upstream of the start codon, and 386 bp of
the gliA 3’ NCR (gliAT), immediately downstream of the stop codon. I transformed pDHGL
into Af293.1 and screened for transformants that contained only a single copy of lacZ by
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Min:

0

30

60

gliA mRNA

Figure 3.1. Northern analysis of gliA mRNA transcript levels in
response to human neutrophils. Af293 germlings were exposed
to human neutrophils (1:2) in RPMI with HEPES for 60 min.
RNA was collected for each time point. The top panel is the
Northern hybridization with the gliA coding region used as a
probe. The bottom panel is an image of the RNA gel for loading
control.
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Southern hybridization (Fig. 2.1a).

This strain was designated Af293.1-GL.

I further

screened transformants for the ability to produce a blue pigment when grown on nonrepressing medium with X-gal (Fig. 2.1b). This indicated to us that the lacZ cassette was
functional and responded to induction of the gliotoxin cluster.

3.2.2 High-copy Inducer Screen: First Round
The first round of the high-copy inducer screen involved transforming an A.
fumigatus genomic library into Af293.1-GL (Fig. 3.2a). This library was cloned into pRG3AMA1-NotI, which is an autonomously replicating plasmid [115]. Due to the presence of
AMA1 from A. nidulans, this plasmid does not insert into the genome, but remains as a
circular plasmid [119, 120]. This facilitates the recovery of the plasmid by transformation of
fungal genomic DNA into bacteria. This plasmid is also present in anywhere from 10 to 30
extra copies on average in each haploid genome. Therefore, this genomic library was an
ideal choice for our high-copy inducer screen. I grew transformants on repressing medium
with X-gal and screened for colonies that produced a blue pigment. This indicated that the
AMA1-NotI plasmid within the genome was inducing the gliA-lacZ reporter in repressing
conditions. I recovered plasmids from 70 colonies.

3.2.3 High-copy Inducer Screen: Second Round
For the second round of the high-copy inducer screen, I transformed 70 individual
plasmids, isolated in the first round of the high-copy inducer screen, into Af293.1-GL (Fig.
3.2b). I again grew transformants on repressing medium with X-gal and screened for
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Figure 3.2. Schematic of the three rounds of the high-copy inducer screen. (a) Round
one: transformation of the genomic library into Af293.1-GL. (b) Round two:
transformation of single plasmids from the genomic library into Af293.1-GL. (c) Round
three: transformation of single genes into Af293.1-GL.
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colonies with blue pigment production. For this round, I transformed individual vectors to be
sure that the effect I observed from the first round was the result of only one plasmid and
not multiple plasmids.

Since I transformed single plasmids, I also expected plates to

contain a high number of colonies producing blue pigment. I sequenced all 70 plasmids to
identify what genes were contained within the insert, using primers that flanked the insert
cloning site (Ama NotI F and Ama NotI R). To measure LacZ levels in a more quantitative
manner, I isolated total protein from transformants and measured β-galactosidase activity
(Fig. 3.3).

I transformed the pDONR AMA empty vector and pDONR AMA-gliZ as a

negative control (AMA.GL) and positive control (AMA-gliZ.GL), respectively. Based on
results, I grouped vectors into three categories: extreme inducing (>70-fold lacZ induction),
moderate inducing (5 to 70-fold lacZ induction), and low inducing (<5-fold lacZ induction).
This was based on fold change relative to the AMA.GL negative control.

Of the 70

plasmids tested, 7 were in the extreme inducing category and 7 were in the moderate
inducing category (Figure 3.4/Table 3.1).

3.2.4 High-copy Inducer Screen: Third Round
The third round of the high-copy inducer screen entailed isolating the individual
genes from each AMA1-NotI library plasmid and transforming them into Af293.1-GL (Fig.
3.2c).

For this process, I decided to focus on the extreme inducing plasmids.

Most

plasmids had anywhere from 1 to 4 genes. I amplified each gene and cloned it into pDONR
AMA. For this round, I did not screen for blue pigment formation, but rather I collected total
protein from transformants and measured β-galactosidase activity (Fig. 3.5).

The two

genes that induced lacZ the most were a C2H2 transcription factor (Afu6g01910) and a
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Figure 3.3. β-galactosidase assays from the second round of the high-copy inducer
screen. Data is presented as fold-change relative to AMA. The results of one
representative experiment of three independent experiments are shown as mean ±
SD.
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Figure 3.4. β-galactosidase assays of the extreme inducing group (left panel) and the
moderate inducing group (right panel). Data is presented as fold-change relative to AMA.
The results of one representative experiment of three independent experiments are
shown as mean ± SD.
Extreme LacZ Inducing Plasmids
Plasmid

S15

S20

Locus

S21
L7
L8

L12

L13

Gene

Afu1g10860

Hypothetical

Afu1g10870

Cyanamide
Hydratase

Afu3g11430

Arginase

Afu3g11440

Glutamyl-tRNA
amidotransferase
Rab geranlygeranyl
transferase

Afu7g04460

Moderate LacZ Inducing Plasmids
Plasmid

S16

L14

Locus

Gene

Afu1g11890

Serine
palmitoyltransferase 2

Afu1g11990

PQ Loop repeat protein

Afu6g08360
Afu6g08370

Thiazole biosynthesis
enzyme
Neutral
shingomyelinase

Afu6g08380

WD Repeat protein

Afu7g04470

Hypothetical

Afu6g08390

Conserved hypothetical

Afu7g04480

DNA mismatch repair
protein (Msh3)

Afu2g01110

Hypothetical

Afu5g10940

Conserved hypothetical

Afu2g01120

DNA Repair protein

Afu6g10650

ATP Citrate lyase subunit 1

Afu2g01130

Ubiquitin conjugating
enzyme (UbcJ)

Afu6g10660
Afu6g01900
Afu6g01905

ATP Citrate lyase

Afu2g01140
Afu3g02560
Afu3g02570

GPI Anchored protein

Afu6g01910

C2H2 Zinc finger domain
protein

Afu2g01700

Serine/threonine
protein kinase (Snf1)

Afu4g00300

Hypothetical

Afu2g01710

GPI Anchored protein

Afu4g00310

Hypothetical

Afu6g13370

SSU processome
component (Utp10)

Afu4g00320

Sensor histidine
kinase/response regulator

Afu4g00330

Hypothetical

L17

L18

Hypothetical

Hypothetical

L19
L21

L24

Hypothetical
Polyketide synthase

Afu6g13380

Hypothetical

Afu6g06760

Eukaryotic translation
initiation factor 3
subunit (EifCj)

Afu6g06770

Enolase

Table 3.1. Genes that were represented in the extreme inducing and moderate
inducing categories.

76

a

b

Figure 3.5. β-galactosidase assays for individual genes from extreme inducing
plasmids. Data is presented as fold-change relative to AMA. (a) All genes from
the extreme inducing plasmids. The results of one representative experiment of
three independent experiments are shown as mean ± SD. (b) Activity of AMAgliZ.GL, AMA-gipA.GL, and AMA-gipB.GL, relative to AMA.GL. The data
presented is an average of three biological replicates. The asterisk ( ) indicates a
statistically significant difference (p-value <0.05), compared to AMA.GL,
calculated by one-way ANOVA and Tukey comparison test.
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hybrid sensor kinase (Afu4g00320); I have designated them gipA and gipB, respectively, for
gliotoxin inducing protein. As shown in Figure 3.5b, AMA-gipA.GL, which has extra copies
gipA, induced a 400-fold increase in LacZ levels and AMA-gipB.GL, which has extra copies
of gipB, induced a 50-fold increase in LacZ levels, compared to the empty vector control.
The level of lacZ in our positive control, AMA-gliZ.GL, was almost 30-fold higher than the
empty vector control, AMA.GL, indicating that GipA and GipB positively regulate gliA
expression, similar to GliZ.

3.2.5 Isolation and Sequencing of gipA and gipB cDNA
Since gipA and gipB are novel genes, I confirmed the gene structure and protein
sequence through isolation and sequencing of cDNAs for each. As shown in Figure 3.6a,
gipA has an open reading frame (ORF) of 1314 bp with one intron and is predicted to
encode a 419 amino acid protein. There are two C2H2 regions at the 3’ end, the first as X2C-X2-C-X12-H-X3-H and the second as X2-C-X2-C-X12-H-X5-C. The 5’ untranslated region
(UTR) of gipA is unusually long (at least 877 bp) with three µORFs and the 3’ UTR of gipA
consists of at least 360 bp, which indicates that gipA is under post-transcriptional control,
possibly due to reduced translational efficiency and mRNA stability. I confirmed the length
of the 5’ and 3’ UTR using a λ phage library screen, which does not always reveal the full
length mRNA transcript, but Northern analysis of total RNA verified that the size of the gipA
transcript is around 2.4 kb, which supports the size I predicted (3.6b). A Blastp search of
the entire protein sequence revealed that there are only a few proteins that are homologous
to GipA, the closest being a C2H2 transcription factor in N. fischeri, a close relative to A.
fumigatus (Fig. 3.7a). The rest of the proteins from the Blastp search were from other
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a

b

WT

ΔZ

ΔA

A(R)1

A(R)2

ΔB

B(R)1 B(R)2

6 kb

gipB
mRNA

4 kb
3 kb

gipA
mRNA
2 kb

Figure 3.6. Characterization of gipA and gipB mRNA. (a)
Schematic of mRNA size and composition. Yellow bars signify
µORFs. For gipA, the green bars display the two zinc finger
domains. For gipB, the pink bar is the histidine kinase A
domain, the grey bar is the GHKL domain, and the green bar is
the response regulator domain. Sizes indicated for the coding
regions include introns. (b) Northern hybridization of gipA and
gipB from total RNA. WT is wild-type (Af1160), Δ signifies
deletion strains, and (R) signifies complemented strains.
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a

b
Figure 3.7. Cladograms of GipA and GipB homologues. (a) Afu6g01910 is
GipA, NFIA is N. fischeri, ACLA is A. clavatus, PDIP is P. digitatum, Pc is P.
chrysogenum, ANI and AN is A. niger, AK is A. kawachii, AO is A. oryzae, and
AF is A. flavus. (b) Afu4g00320 is GipB, NFIA is N. fischeri, ACLA is A.
clavatus, and ANIA is A. nidulans.
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Aspergillus species and a few Penicillium species, which suggests that GipA is not highly
conserved at the primary sequence. The coding region of gipB is 3618 bp with two introns
and is predicted to encode a protein of 1170 amino acids. Within the coding region is a
histidine kinase A (phospho-acceptor) domain, a GHKL (ATPase) domain, and a response
regulator receiver domain. Results from the λ phage library screen indicated that the 5’
UTR of gipB is 150 bp and contains two µORFs and the 3’ UTR of gipB is 204 bp (Fig.
3.6a), suggesting that gipB is also possibly under post-transcriptional regulation. However,
gipB mRNA appeared to be over 4 kb in size from Northern analysis, indicating that gipB
could encode UTRs that are longer than what was predicted from the λ phage library
screen (Fig. 3.6b). As with gipA, only a few proteins show a high level of similarity to GipB,
the closest being from N. fischeri, suggesting that GipB is not highly conserved at the
primary sequence (Fig. 3.7b).

3.2.6 Model of gliA Regulation
I offer a model for gliA induction, involving GliZ, the Zn2Cys6 binuclear finger
transcription factor located within the gliotoxin cluster, GipA, the novel C2H2 transcription
factor I identified, and AreA, the positive-acting global regulator of nitrogen metabolite
repression (Fig. 3.8) I propose that GliZ and GipA work together to induce gliA transcription,
not in a linear pathway, but interdependently. I also posit that AreA acts as a co-activator of
gliA expression in nitrogen-specific non-repressing conditions. To achieve this, AreA likely
induces gliZ, which is required for the complete induction of the cluster.

Figure 3.9a

illustrates an example of the differential gene expression observed in the repressing and
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a

b

Figure 3.8. Model for gliA regulation involving GliZ, GipA, and AreA. (a) I propose that
GliZ and GipA both work interdependently to induce gliA. (b) Furthermore, I propose
that in nitrogen-specific non-repressing conditions, AreA acts to further enhance the
expression of gliA, likely through induction of gliZ.
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a

b

Figure 3.9. Regulation of gliA and other gliotoxin cluster genes. (a)
Differential mRNA transcript levels of gliotoxin cluster genes in
repressing (CM) and non-repressing (CD) media used in this study.
(b) Differential mRNA transcript levels of gliotoxin cluster genes in
nitrogen-specific non-repressing (SN) and nitrogen-specific repressing
(AT) media. mRNA levels are displayed relative to actin. The results
of one representative experiment of three independent experiments
are shown as mean ± SD.
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non-repressing conditions used in this study.

Figure 3.9b shows an example of the

differential gene expression when cultures are grown in nitrogen-specific repressing or
nitrogen-specific non-repressing conditions, implicating AreA in the regulation of the
gliotoxin cluster. I present this model as a product of the experiments I describe in the
chapters to follow. Although this model does not include GipB, the hybrid sensor kinase
from this study, I will discuss later how GipB could be involved in the regulation of gliA.

3.3 Summary
I performed a high-copy library screen in a strain of A. fumigatus that contains a
lacZ expression plasmid under the control of the gliA promoter. I screened for plasmids
that induce lacZ expression in repressing conditions. Of the 70 plasmids I recovered from
the screen, 7 were extreme-inducing (>50-fold lacZ induction) and 7 were moderateinducing (50 to 5-fold lacZ induction) (Fig. 3.4/Table 3.1).

From the extreme-inducing

plasmids, I chose two genes for further studies: gipA, a C2H2 transcription factor, and gipB,
a hybrid sensor kinase. High-copy expression of GipA induced lacZ over 400-fold and highcopy expression of GipB induced lacZ 50-fold, compared to AMA.GL (Fig. 3.5b).
Upon sequencing, I discovered that gipA has an unusually long 5’ UTR, which
contains three µORFs. This suggests that gipA is under post-transcriptional control, most
likely involving translational regulation through one or all of the µORFs. The 3’ UTR of gipA
is also longer than what is seen on average in fungi (200 bps). This could be involved in
targeting of the gipA transcript for Nonsense Mediated Decay (NMD) [121]. Being a C2H2
transcription factor, gipA contains two DNA binding regions at the 3’ end, the first as X2-CX2-C-X12-H-X3-H and the second as X2-C-X2-C-X12-H-X5-C (Fig. 3.6). There are two µORFs
in the 5’ UTR of gipB, raising the possibility that gipB, like gipA, is under some form of post84

transcriptional regulation. As gipB is a hybrid sensor kinase, three domains are present
that are involved in signal transduction: histidine kinase A (phospho-acceptor) domain, a
GHKL (ATPase) domain, and a response regulator receiver domain (Fig. 3.6).

At the

protein sequence level, neither GipA nor GipB appear to be highly conserved, as only a few
proteins in other fungal species showed a high level of similarity, the most conserved being
in N. fischeri for both proteins (Fig. 3.7). This does not mean that there are not proteins in a
variety of other fungal species that function similar to GipA or GipB, as research has shown
that primary sequences evolve much more rapidly than tertiary sequences. Therefore,
there could be a protein in another fungal organism that has a completely dissimilar
sequence to GipA, but has the exact same folding pattern and consequently functions in a
similar manner.
Based on experiments performed in this study, I propose a model for GipA-mediated
regulation of gliA, involving GliZ, the Zn(II)2Cys6 transcription factor located within the
gliotoxin cluster, and AreA, the global positive regulator of nitrogen metabolite repression
(Fig. 3.8). My model depicts a situation where GliZ and GipA are both binding to the same
site, or within close proximity, and interdependently regulating expression of gliA. I propose
that AreA is also contributing to the overall induction of gliA by inducing gliZ in nitrogenspecific non-repressing conditions.
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Chapter 4:
Characterization of GipA
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4.1 Introduction
C2H2 DNA binding regions of transcription factors are the most common type of zinc
finger domains, which are stabilized when bound to a zinc ion [122, 123]. The C2H2 DNA
binding domain, which forms a ββα structure when folded, is so named for the conserved
cysteine and histidine residues that bind to the zinc ion (Fig. 4.1).

The consensus

sequence for the zinc finger domain of these transcription factors is (F/Y)-X-C-X2-5-C-X3(F/Y)-X5-Ψ-X2-H-X3-4-H, where X is any amino acid and Ψ is any hydrophobic residue,
although natural variants that contain a cysteine instead of a histidine as the final zincchelating residue (C2HC) produce the same structure (not to be confused with the C-X2-CX4-H-X4-C class of zinc finger proteins, which folds into a completely different structure)
[122, 123]. One transcription factor can contain multiple zinc finger domains, which are
often clustered together. C2H2 zinc finger domains, ubiquitous to all kingdoms, are one of
the most commonly found domains within eukaryotes.

In fact, recent reports have

estimated that 3% of genes within humans contain C2H2 zinc finger domains, securing their
spot as the second most common protein motif [122, 123]. Typically assumed to take part
in DNA binding, C2H2 zinc finger domains have also been proposed to be capable of
interacting with RNA and protein [122, 123].

4.2 Results
4.2.1 High-copy Expression of gipA and Its Effect on Gliotoxin Production
As previously shown, high-copy expression of gipA induces lacZ expression, under
the control of the gliA promoter, which suggests that GipA positively regulates gliA. Since
the gliotoxin cluster is co-regulated, I predicted that the other genes within the cluster would
also be induced in a high-copy gipA strain. To verify this, I grew AMA.GL,
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Figure 4.1. The canonical structure of the C2H2 zinc finger domain. A
ribbon diagram representing the third C2H2 domain from TFIIIA in
Xenopus laevis, which shows the stabilization of the ββα fold by the
interaction of a zinc ion (yellow) with the two cysteine residues (green)
and two histidine residues (blue). Reprinted with permission of
Springer Science and Business Media:
Cell Biochemistry and
Biophysics [122], copyright 2008.
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AMA-gliZ.GL, and AMA-gipA.GL in repressing conditions and isolated total RNA from
mycelia. I quantified RNA levels of multiple genes within the gliotoxin biosynthesis cluster
with RNA dot blot analysis. I also measured gliotoxin levels via RP-HPLC. As expected,
AMA-gipA.GL had higher levels of gliA mRNA, compared to AMA.GL, at both 24 and 48
hours. Transcript levels of gliA in AMA-gipA.GL were 7-fold higher and 4.5-fold higher,
compared to AMA.GL, at 24 and 48 hours growth, respectively (Fig. 4.2a & b). The mRNA
levels of the other gliotoxin-specific genes tested were also significantly higher in AMAgipA.GL, compared to AMA.GL, as gliZ was induced 2-fold and 12-fold, gliP was induced
4.5-fold and 5-fold, and gliT was induced 8-fold and 2-fold, at 24 and 48 hours of growth,
respectively.

Gliotoxin levels reflected what was seen with RNA, as AMA-gipA.GL

produced gliotoxin at higher levels than AMA.GL (7-fold by 24 hours) (Fig. 4.2c). AMAgliZ.GL was the positive control and showed the same pattern as AMA-gipA.GL, with
respect to induction of the gliotoxin biosynthesis cluster. Therefore, high-copy expression
of gipA causes an increase in gliotoxin production in conditions where gliotoxin production
is repressed.

4.2.2 High-copy Expression of gipA and Its Effect on Growth and Virulence of A. fumigatus
Producing extra gliotoxin could possibly prove advantageous to the fungus with
respect to evading the immune system in a model host, although it could also have
disadvantages. For instance, over-expression of gliZ displays a trend of increased death in
an immune-suppressed murine model of infection [13], but A. fumigatus, if not properly
protected, is sensitive to the toxic effects of this secondary metabolite, therefore too much
gliotoxin could harm the fungus rather than help it [27]. Since high-copy expression of gipA
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a
Figure
4.2.
High-copy
expression of gipA induces
gliotoxin production.
All
cultures were grown in
repressing
conditions.
Total RNA was isolated
and quantified by dot blot
analysis
in
triplicate.
Gliotoxin
levels
were
quantified by RP-HPLC.
(a) mRNA transcript levels
of several gliotoxin cluster
genes after 24 hours of
growth. Each data set is
normalized to AMA.GL (b)
mRNA transcript levels of
several gliotoxin cluster
genes after 48 hours of
growth. Each data set is
normalized to AMA.GL. (c)
Gliotoxin levels in growth
medium, normalized to
AMA.GL. The asterisk ( )
indicates a statistically
significant difference (pvalue <0.05), compared to
AMA.GL, calculated by
one-way
ANOVA
and
Tukey comparison test.
The
results
of
one
representative experiment
of
three
independent
experiments are shown as
mean ± SD.

b

c
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results in increased gliotoxin production, I aimed to test whether this affected growth or
virulence of A. fumigatus. For growth assays, I inoculated spores of each strain onto rich
medium (YAG) and minimal medium (MMVAT), as well as minimal medium with exogenous
gliotoxin. AMA.GL, AMA-gliZ.GL, and AMA-gipA.GL all grew similarly on all medium tested,
indicating that growth of the fungus is not affected by high-copy expression of gliZ or gipA
(Fig. 4.3).

For virulence studies, I infected Toll-deficient D. melanogaster fruit flies by

needle puncture.

This system has been suggested to mimic a steroid-treated, non-

neutropenic murine model [23, 124]. Neither AMA-gipA.GL nor AMA-gliZ.GL showed a
statistically significant difference in virulence in the Toll-deficient D. melanogaster model
system, compared to AMA.GL (Fig. 4.4). These data suggest that the high-copy expression
of gipA is not sufficient to alter the mortality in this model system.

4.2.3 Microarray Analysis of GipA regulation
To expand our view of GipA regulation, a microarray analysis of AMA-gipA.GL vs.
AMA.GL, grown in repressing conditions for 24 hours, was performed. Of the 9,436 total
genes analyzed, 443 genes were up-regulated > 2-fold and 75 genes were down-regulated
> 2-fold in the AMA-gipA.GL strain, compared to the AMA.GL control. There were several
genes common to secondary metabolism clusters (e.g. transporters, oxidoreductases,
methyltransferases, nonribosomal peptide synthetases and polyketide synthases) upregulated (Table 4.1).

30 secondary metabolism clusters have been proposed using

genomic mapping and microarray techniques [53, 91]. Of these 30 potential secondary
metabolism clusters, 20 contained at least one gene that was up-regulated > 2-fold in
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Figure 4.3. High-copy expression of gipA does not significantly affect
growth of A. fumigatus. 1000 spores were spotted onto each plate and
incubated at 37°C for 48 hours (YAG) or 72 hours (MMVAT).
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Figure 4.4. High-copy expression of gipA does not significantly affect
virulence of A. fumigatus. Toll-deficient D. melanogaster fruit flies were
infected by needle puncture and incubated at 29°C for 7 days. This
graph includes three independent virulence assays.
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Genes
Transporters/Pumps
NRPS/PKS
Oxidoreductase
Methyltransferase
Acetyltransferase
C6 Transcription Factors

Number up-regulated >2-fold
20
9
5
4
1
8

Table 4.1. Genes commonly found to be involved in secondary metabolism possibly
regulated by GipA.

Cluster
1
2

Cluster range*
Afu1g17710-Afu1g17740
Afu2g05730-Afu2g05840

3

Afu2g17930-Afu2g18060

4
5
6

Afu3g01400-Afu3g01560
Afu3g02570-Afu3g02640
Afu3g02670-Afu3g02760

7

Afu3g03280-Afu3g03580

8
9
10
11
12
13
14
15
16
17
18
19
20

Afu3g12770-Afu3g13000
Afu3g14690-Afu3g14880
Afu3g15250-Afu3g15290
Afu4g00210-Afu4g00260
Afu4g14440-Afu4g14730
Afu5g09940-Afu5g10220
Afu5g12720-Afu5g12840
Afu6g08540-Afu6g08560
Afu6g09580-Afu6g09740
Afu6g12040-Afu6g12160
Afu7g00120-Afu7g00180
Afu8g00100-Afu8g0280
Afu8g02350-Afu8g02460

Product
Unknown
Unknown
Ergot alkaloids: Festuclavine, Elymoclavine,
Fumigaclavines A, B, and C
Unknown
Unknown
Unknown
Possibly two compounds:
(a siderophore and a distinct toxin)
Putative ETP
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Gliotoxin
Unknown
Unknown
Fumitremorgen B
Unknown

Table 4.2. Secondary metabolism clusters I predict to be positively regulated by GipA.
*Cluster ranges were predicted using SMURF [125] and can be found at
http://jcvi.org/smurf/index.php.
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AMA-gipA.GL, compared to AMA.GL (Table 4.2). Based on microarray data obtained
previously [91], loss of laeA, a global regulator of secondary metabolism, affected 13 of 22
identified secondary metabolite clusters. This suggests that GipA is not specific to the
gliotoxin cluster, but potentially acts on numerous other secondary metabolism gene
clusters in A. fumigatus, similar to LaeA.

4.2.4 Deletion of gipA and Its Effect on Gliotoxin Production
Since GipA can induce gliotoxin production, I sought to discover if loss of gipA has
any effect on the gliotoxin cluster. I replaced the coding region of gipA with pyrG and
designated this strain as ΔgipA.

I created a complemented strain, gipA(R), using

hygromycin (hph) as the selective marker. I also created a gliZ deletion strain as a control,
since previous studies have shown that loss of gliZ results in a significant decrease in RNA
levels of gliotoxin-specific genes [13]. As shown in Figure 4.5a, loss of gipA caused a
significant decrease in mRNA levels of gliA, gliZ, gliP, and gliT in non-repressing conditions,
as most genes exhibited close to a 50% reduction. The gliotoxin biosynthesis cluster is not
completely dependent on gipA, as there was still RNA being made for the genes I tested.
The gipA deletion mutant also produced significantly less gliotoxin than the 1160G control
strain (50% reduction) (Fig. 4.5b), which suggests that gipA may be an important positive
regulator of gliotoxin production.

Gliotoxin-specific gene expression and gliotoxin

production of gipA(R) were restored beyond wild-type levels, which demonstrates that the
effect I observed with the gipA deletion was due to the absence of gipA. As expected, loss
of gliZ caused almost a complete loss in gene expression for gliA, gliP, and gliT and
abolished gliotoxin production.
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a

b

Figure 4.5. Loss of gipA negatively affects gliotoxin production. All cultures
were grown for 48 hours in non-repressing conditions. Total RNA was
isolated and quantified by dot blot analysis in triplicate. Gliotoxin levels were
quantified by RP-HPLC. (a) mRNA transcript levels of several gliotoxin
cluster genes. Each data set is normalized to 1160G. The results of one
representative experiment of three independent experiments are shown as
mean ± SD. (b) Gliotoxin levels in growth medium, normalized to 1160G.
The results of one representative experiment of three independent
experiments are shown. The asterisk ( ) indicates a statistically significant
difference (p-value <0.05), compared to 1160G, calculated by one-way
ANOVA and Tukey comparison test.
96

4.2.5 Deletion of gipA and Its Effect on Growth and Virulence of A. fumigatus
As gipA is important for gliotoxin production, I sought to determine if loss of gipA
would affect the growth or pathogenicity of A. fumigatus. Loss of gliT, which plays a role in
self-protection of the fungus against gliotoxin, results in the inability of A. fumigatus to grow
in the presence of exogenous gliotoxin [27]. Loss of gipA causes a significant decrease in
gliT mRNA transcript levels, which could adversely affect the ability of the fungus to grow in
the presence of exogenous gliotoxin. Furthermore, deletion of gliP, which is required for
the biosynthesis of gliotoxin and consequently abolishes gliotoxin production, was found to
cause a significant attenuation in virulence of A. fumigatus in a Toll-deficient D.
melanogaster model system [23]. Therefore, a significant reduction in gliotoxin production
from loss of gipA could negatively affect the virulence of A. fumigatus in this model system.
Growth of ΔgliZ and ΔgipA on minimal and rich media was comparable to the 1160G
control, indicating that loss of either gliZ or gipA does not adversely affect radial growth or
conidiation on the medium tested.

Addition of exogenous gliotoxin (10 µg/ml) did not

significantly affect the growth of either deletion strain, compared to the 1160G control (Fig.
4.6). These data support previous findings that gliT is independently regulated and does
not require GliZ for self-protection [27].

Furthermore, even though gliotoxin is being

produced at significantly reduced levels in both ΔgliZ and ΔgipA, there was no statistically
significant difference in virulence of either deletion strain, compared to 1160G, in a Tolldeficient D. melanogaster model system (Fig. 4.7), suggesting neither gene is essential for
A. fumigatus pathogenicity in this model system. This does not rule out the possibility that
GipA may affect the ability of A. fumigatus to modulate immune-cell functions, but any
effects that might be there are not enough to alter the overall mortality rate in the model
system I tested.
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Figure 4.6. Loss of gipA does not significantly affect growth of A.
fumigatus. 1000 spores were spotted onto each plate and
incubated at 37°C for 48 hours (YAG) or 72 hours (MMVAT).
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Figure 4.7. Loss of gipA does not significantly affect virulence of A.
fumigatus. Toll-deficient D. melanogaster fruit flies were infected by
needle puncture and incubated at 29°C for 7 days. This graph includes
three independent virulence assays.
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4.2.6 Identification of a DNA Binding Site for GipA
Since GipA is a C2H2 transcription factor, it is highly likely that GipA is directly
binding to DNA. I sought to identify a consensus sequence and to discover if this sequence
was present within the gliotoxin biosynthesis cluster. I fused a GST tag onto the 5’ end of
the DNA binding region of GipA for a protein-binding microarray analysis (done by Tim
Hughes’ Laboratory), which identified a consensus DNA binding sequence for GipA (5’TNNVMGCCNC-3’) (Fig. 4.8). This putative sequence is 10 nucleotides, which coincides
with one complete turn of the DNA double helix. The protein-binding microarray verified
direct DNA binding of GipA, as the purified DNA-binding region, and not whole cell extract,
was analyzed in the microarray.

I analyzed the genomic sequence of the gliotoxin

biosynthesis cluster to locate potential GipA binding sites. Indeed, I found variations of this
consensus sequence scattered throughout the gliotoxin biosynthesis cluster.

In fact, I

identified a possible GipA binding site within the intergenic region of gliA (5’TTGCCGCCAC-3’ 315 bp upstream of the start site), as well as all other gliotoxin-specific
genes, except gliM.

4.2.7 gliA Promoter Mutagenesis
To verify that GipA was in fact exerting its effects through this sequence, I mutated
the GipA binding site on pDHGL, which contains lacZ flanked by the gliA 5’ and 3’ NCRs. I
created two mutated binding sites: SD1 (TTGCCGCCAC  CTGCCGCCAC) and SD2
(TTGCCGCCAC  TTGGGTGAGC).

I transformed these plasmids into an Af293.1

background and then transformed pDONR AMA, pDONR AMA-gliZ, and pDONR AMA-gipA
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Figure 4.8. Consensus sequence representing the putative DNA
binding site for GipA obtained by protein binding microarray analysis.
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into each strain. Therefore, each version of the binding site was exposed to extra copies of
gliZ (AMA-gliZ.GL, AMA-gliZ.SD1, and AMA-gliZ.SD2), extra copies of gipA (AMA-gipA.GL,
AMA-gipA.SD1, and AMA-gipA.SD2), or a pDONR AMA empty vector control (AMA.GL,
AMA.SD1, and AMA.SD2). The pDONR AMA empty vector control served as a negative
control. I grew these strains in both repressing and non-repressing conditions. Under
repressing conditions, expression would be based solely on extra copies of the gene within
the pDONR AMA plasmid or any other transcriptional activator present, while under nonrepressing conditions, expression would show induction of lacZ in response to the
nutritional environment, as well as the pDONR AMA plasmids.

Two different patterns

emerged between LacZ levels that were normalized to actin and LacZ levels that were
additionally normalized to the pDONR AMA control. The LacZ levels that are normalized to
actin depict the overall expression of lacZ in each strain, which could be affected by GliZ or
GipA specifically, but also any other regulatory elements. By further normalizing data to
pDONR AMA, I was able to observe induction of lacZ based solely on extra copies of GliZ
or extra copies of GipA.
In Figure 4.9a, I present lacZ expression levels of AMA.GL, AMA.SD1, and
AMA.SD2, relative to actin. I did not include the data for the pDONR AMA-gliZ or pDONR
AMA-gipA strains, because all three pDONR AMA strains followed the same pattern,
regardless of which pDONR AMA vector was being expressed. In AMA.GL, which harbors
the wild-type binding site, there was a moderate level of LacZ in repressing conditions.
This could be due to the presence of endogenous GliZ or GipA, as well as any other
endogenous inducers specific to gliA expression.

When AMA.GL was grown in non-

repressing conditions, LacZ levels increased 30-fold, compared to repressing conditions
(Fig. 4.9a). This is to be expected because the gliotoxin cluster is being induced in these
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a

b

Figure 4.9. GipA and GliZ both induce gliA through the GipA binding site. Strains
were grown in stationary cultures. Total protein was collected from lyophilized
mycelia and β-galactosidase activity was measured. (a) LacZ levels of AMA.GL
in both repressing and non-repressing conditions.
The results of one
representative experiment of three independent experiments are shown as mean
± SD. (b) LacZ levels of each strain in repressing conditions, relative to the AMA
control. The results of one representative experiment of six independent
experiments are shown as mean ± SD. The asterisk ( ) indicates a statistically
significant difference (p-value <0.05) for each data set, compared to the AMA
control strain, calculated by one-way ANOVA and Tukey comparison test.
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conditions. Furthermore, carbon sources used in all conditions are known to suppress
endogenous β-galactosidase activity, therefore the β-galactosidase activity reported in
these experiments should be specific to the gliAP-lacZ expression plasmid.

AMA.SD1

displayed decreased expression of lacZ (8-fold in repressing conditions and 4-fold in nonrepressing conditions), compared to AMA.GL (Fig. 4.9a). This suggests that mutation of
the single 5’ T residue interferes with the binding of an unknown transcriptional activator.
This could also be a result of a lower affinity of GipA for the binding site, instead of an
unidentified transcriptional activator, however if this were the case, I would expect
AMA.SD2 to have lower β-galactosidase activity, similar to AMA.SD1. In fact, LacZ levels
of AMA.SD2 were higher than those of AMA.GL (5-fold in repressing conditions and almost
2-fold in non-repressing conditions), supporting my hypothesis that an unidentified
transcriptional activator is being displaced by mutation of the 5’ T residue (Fig. 4.9a). Since
the 5’ T residue is present in AMA.SD2, the binding of an unknown transcriptional activator
would be restored and LacZ levels would increase. AMA.SD2 harbors a mutation in the
core region of the GipA binding site, so the increased levels of LacZ in AMA.SD2,
compared to AMA.GL, could be due to the loss of some form of repression. The fold
changes in non-repressing conditions were not as robust as those in repressing conditions,
but this is to be expected as gliA is also being induced in response to nutritional sources in
the non-repressing medium.
Figure 4.9b depicts lacZ expression relative to AMA.GL in repressing conditions.
With the wild-type binding site, the presence of pDONR AMA-gipA increased LacZ levels
13-fold, relative to the pDONR AMA control, as to be expected from previous results (Fig.
4.9b). With the SD1 binding site, pDONR AMA-gipA also induced lacZ significantly (53fold), relative to the pDONR AMA strain (Fig. 4.9b).

The magnitude of induction was

enhanced with the SD1 mutation when compared to the wild-type binding site (13-fold vs.
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53-fold, respectively), possibly due to background LacZ levels being lower. This difference
in magnitude could also due to an increased affinity of GipA to the DNA binding site, as a
result of mutating the 5’ T residue to C. With the SD2 binding site, in which the core region
has been mutated, the pDONR AMA-gipA strain only weakly induced lacZ (4-fold), as the
fold-change relative to pDONR AMA was greatly reduced, compared to the wild-type
binding site (13-fold vs. 4-fold, respectively) (Fig. 4.9b). This suggests that mutation of a
core sequence in the binding site significantly reduces the ability of GipA to induce lacZ,
likely as a result of decreased binding affinity. When grown in non-repressing conditions,
LacZ levels of the pDONR AMA-gipA strain were comparable to the pDONR AMA empty
vector control in all binding site backgrounds (data not shown). This indicates that induction
of gliA, in response to nutrient availability, is already sufficiently robust, so extra copies of
gipA add no further induction. Interestingly, expression of lacZ in the pDONR AMA-gliZ
strains followed a similar pattern to that of the pDONR AMA-gipA strains (Fig. 4.9b).
Therefore, lacZ was induced by GliZ with the wild-type binding site (19-fold) and the SD1
binding site (93-fold).

The level of induction was enhanced by the SD1 binding site,

compared to the wild-type binding site (19-fold vs. 93-fold, respectively). Furthermore, lacZ
was only weakly induced by GliZ, relative to the pDONR AMA control, when exposed to the
SD2 binding site (4-fold). Therefore, mutation of the GipA binding site is also affecting the
ability of GliZ to induce gliA.

4.3 Summary
As a high-copy gipA strain was able to induce lacZ, under the control of the gliA
promoter, in repressing conditions, I sought to identify what effects this transcription factor
has on the gliotoxin cluster. Being a C2H2 transcription factor, I also wanted to determine if
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GipA is binding to the gliA promoter region to elicit the response I observed. High-copy
expression of gipA not only induced gliA, the efflux pump of the gliotoxin cluster, but also
induced several other genes within the gliotoxin cluster and enhanced production of
gliotoxin in repressing conditions at both time points, suggesting that GipA plays a positive
role in regulating the cluster (Fig. 4.2).

This did not significantly affect growth of A.

fumigatus, nor did it change the virulence of the fungus in a toll-deficient D. melanogaster
model system, indicating that artificially inducing the gliotoxin cluster through gipA does not
render the fungus growth deficient or more virulent in the model tested (Fig. 4.3 & 4.4).
Microarray data revealed that 20 out of 30 possible secondary metabolism clusters in A.
fumigatus, including the gliotoxin cluster, are also possibly induced in a high-copy gipA
strain, revealing the possibility that GipA is not strictly regulating the gliotoxin cluster, but
may be acting as a general regulator of secondary metabolism, similar to LaeA (Table 4.2).
Furthermore, loss of gipA negatively affected the expression of several gliotoxinspecific genes, as mRNA transcript levels were reduced close to 50%, compared to a wildtype strain (Fig. 4.5a). Gliotoxin production was also significantly reduced in a ∆gipA strain
in non-repressing conditions, indicating that GipA is important for full induction of the
gliotoxin cluster in the conditions I tested, but not essential (Fig. 4.5b). Growth was not
significantly affected by the loss of gipA, indicating that gipA is not essential to the growth
rate of the fungus (Fig. 4.6). The ∆gipA strain did not show an alteration in virulence in a
Toll-deficient D. melanogaster model, signifying that GipA is not essential to the virulence of
A. fumigatus, although this does not rule out the possibility that GipA is important in the
fungal virulence at the cellular level (Fig. 4.7).
A consensus sequence was identified for GipA in vitro (5’-TNNVMGCCNC-3’), and
verified in vivo using a gliAP-lacZ expression plasmid and mutagenesis of the GipA DNA
binding site (Figs. 4.8 & 4.9). Mutation of the 5’ T residue did not eliminate GipA-mediated
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lacZ expression, however, mutation of a core region almost completely abolished the ability
of GipA to induce lacZ. Interestingly, GliZ-mediated induction of lacZ was also dependent
on the core region, suggesting that GliZ and GipA signal through the same binding site, or
at least in close proximity. Even though the mutation of the 5’ T residue did not negatively
affect the ability of GipA or GliZ to induce lacZ, it did reduce background levels of lacZ
expression, suggesting that disrupting the T residue altered binding of an unidentified
activator. Cultures were grown in conditions that promote suppression of endogenous βgalactosidase activity, indicating that my observations were based on lacZ expression
specifically from the gliAP-lacZ plasmid.
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Chapter 5:
Characterization of GipB
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5.1 Introduction
Hybrid sensor kinases are involved in two-component signaling in response to
external stimuli. These proteins are termed hybrid sensor kinases because they contain
both a histidine kinase domain and a response regulator domain [126, 127].

Two-

component systems were first discovered in prokaryotes and entail two elements: (1) a
sensor histidine kinase that is autophosphorylated, in response to external signals, at a
conserved histidine residue and (2) a response regulator that obtains the activation signal
from the sensor histidine kinase via phosphorylation of a conserved aspartate residue [126,
127]. Although these two-component systems remain highly similar in different genera,
fungal two-component systems are different, in that they involve three elements: (1) a
hybrid sensor kinase, which is composed of a histidine kinase domain and a response
regulator domain, (2) a histidine-containing phosphotransfer (HPt) domain, and (3) a
separate response regulator [126, 127].
As

with

bacterial

two-component

systems,

the

histidine

kinase

domain

autophosphorylates at a conserved histidine residue, after which the phosphate is relayed
to an aspartate residue located in the response regulator domain of the same protein [126,
127]. The phosphate is then relocated to the HPt protein, at a conserved histidine residue,
and is subsequently transferred to the second response regulator, again to an aspartate
residue.

Downstream targets of this two-component signaling network can either be

directly modulated by the second response regulator protein or they can be activated by a
signaling cascade, oftentimes a MAPK pathway, responding to the response regulator
protein [126, 127] (Fig. 5.1).

This system of two-component phosphorelay has been

reported in prokaryotes and lower eukaryotes, but not the animal kingdom, as sensor-type
histidine kinases have not been discovered, making these proteins unique targets for
antimicrobial therapies [126, 127].
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Figure 5.1. General regulatory mechanism of a fungal hybrid
sensor kinase, involving the HOG MAPK pathway.
Abbreviations: HK, histidine KD; RR, response regulator receiver
domain; S/T kinase, Ser/Thr protein KD; SBD, Ssk2/Ssk22
binding domain; HDS, Hog1 docking site; S/T-Y KD, Ser/Thr and
Tyr dual-protein KD. Reprinted with permission of American
Society for Microbiology: Eukaryotic Cell [127], copyright 2008.
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One of the best-characterized fungal two-component systems is the Sln1-Ypd1Ssk1 phosphorelay system in S. cerevisiae. Sln1, a transmembrane hybrid sensor kinase
that serves as an osmosensor, transfers a phosphoryl group to Ypd1, the HPt protein [55,
126, 127]. Under normal conditions, Ssk1, the response regulator, remains constitutively
phosphorylated via Sln1 and Ypd1, which renders it inactive. However, under hyperosmotic
shock, Ssk1 becomes dephosphorylated, through down-regulation of the Sln1-Ypd1dependent phosphorylation, which allows Ssk1 to activate the HOG pathway via interaction
with the MAPKKK, Ssk2 [55, 126, 127]. Some hybrid sensor kinases are transmembrane
domains, while others lack transmembrane regions and therefore remain cytosolic. Of the
cytosolic hybrid sensor kinases that have been studied so far in filamentous fungi, most
appear to be more important in regulating morphogenesis and developmental processes
than the transmembrane histidine kinases [127].

5.2 Results
5.2.1 High-Copy Expression of gipB and Its Effect on Gliotoxin Production
Similar to what is seen with gipA, high-copy expression of gipB induces lacZ
expression, under the control of the gliA promoter, which suggests that GipB positively
regulates gliA. Since the gliotoxin cluster is co-regulated, I predicted that the other genes
within the cluster would also be induced in a high-copy gipB strain. To test the effect of
gipB on the gliotoxin cluster, I performed RNA dot blot analysis and measured gliotoxin
production as described for gipA. Comparable to what I observed with gipA, extra copies of
gipB (AMA-gipB.GL) caused an increase in transcription of several genes within the
gliotoxin cluster at 24 hours, but not after 48 hours of growth (Fig. 5.2a). Furthermore,
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a
Figure
5.2.
High-copy
expression of gipB induces
gliotoxin production at 24
hours growth, but not 48
hours growth. All cultures
were grown in repressing
conditions. Total RNA was
isolated and quantified by
dot blot analysis in triplicate.
Gliotoxin
levels
were
quantified by RP-HPLC. (a)
mRNA transcript levels of
several gliotoxin cluster
genes after 24 hours of
growth.
(b)
mRNA
transcript levels of several
gliotoxin cluster genes after
48 hours of growth. Each
data set for (a) and (b) is
normalized to AMA.GL.
The
results
of
one
representative experiment
of
three
independent
experiments are shown as
mean ± SD. (c) Gliotoxin
levels in growth medium,
normalized to AMA.GL.
The
results
of
one
representative experiment
of
three
independent
experiments are shown.
The asterisk ( ) indicates a
statistically
significant
difference (p-value <0.05),
compared
to
AMA.GL,
calculated
by
one-way
ANOVA
and
Tukey
comparison test.

b

c
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gliotoxin was made at higher levels in AMA-gipB.GL at both time points, compared to the
AMA.GL control (Fig. 5.2b). The lack of induction of gliotoxin-specific genes after 48 hours
growth suggests that GipB is not activated during the later phase of asexual development.
Although gene expression was not affected by high-copy expression of gipB after 48 hours
growth, a higher amount of gliotoxin was detected in the surrounding medium, compared to
the AMA.GL strain (Fig. 5.2c). This is not surprising as high-copy expression of gipB did
induce gliotoxin production after 24 hours growth, therefore the gliotoxin detected at 48
hours growth was likely produced at an earlier time point. The level of induction was not as
robust as in AMA-gipA.GL, which is to be expected, as GipB is a hybrid sensor kinase
possibly acting upstream of several proteins.

5.2.2 High-copy Expression of gipB and Its Effect on Growth and Virulence of A. fumigatus
Since high-copy expression of gipB results in increased gliotoxin production at 24
hours, I aimed to test whether this affected growth or virulence of A. fumigatus, as
dysregulation of the gliotoxin cluster could cause adverse effects.

Furthermore, over-

expression of gliZ displays a trend towards increased death in an immune-suppressed
murine model of infection [13]. For growth assays, I inoculated 1000 spores of each strain
onto rich medium (YAG) and minimal medium (MMVAT), as well as minimal medium with
exogenous gliotoxin. AMA-gipB.GL grew similarly on all medium tested, indicating that
high-copy expression of gipB does not affect radial growth of A. fumigatus (Fig. 5.3). For
virulence studies, I infected Toll-deficient D. melanogaster fruit flies by needle puncture.
This system has been suggested to mimic a steroid-treated, non-neutropenic murine model
[23, 124].

There was no statistically significant difference in virulence between
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Figure 5.3. High-copy expression of gipB does not significantly
affect growth of A. fumigatus. 1000 spores were spotted onto
each plate and incubated at 37°C for 48 hours (YAG) or 72
hours (MMVAT).
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AMA-gipB.GL and AMA.GL, which suggests that gipB does not contribute to the virulence
of A. fumigatus in this model system (Fig. 5.4).

5.2.3 Deletion of gipB and Its Effect on Gliotoxin Production
I also wanted to test the effects of gipB deletion on gliotoxin production. As with
gipA, I created a gipB deletion strain by replacing the coding region of gipB with pyrG. I
designated this mutant as ΔgipB.

I also created a strain complemented for gipB

expression, gipB(R). As shown in Figure 5.5a, loss of gipB did not drastically reduce the
RNA levels of the gliotoxin cluster genes I tested. There was a 10% reduction for gliA and
gliZ mRNA, a 30% reduction for gliT mRNA, and almost a 2-fold increase in gliP mRNA.
Gene expression was restored to 1160G control levels in the gipB(R) strain, indicating that
the effects I observed were specific to the loss of gipB. Furthermore, gliotoxin levels were
reduced by 10% in the ΔgipB mutant, compared to the 1160G parent strain and the gipB(R)
complement (Fig. 5.5b). These data suggest that gipB is important for full induction of the
gliotoxin cluster, but not essential. The minor level of reduction observed with the genes
tested is not surprising as GipB is likely acting upstream of several proteins and could
possibly be redundant for another hybrid sensor kinase. Furthermore, GipB is possibly only
activated during earlier phases of conidiation, making it likely that its activity is not essential
to gliotoxin production in later phases of conidiation or other conditions.
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Figure 5.4. High-copy expression of gipB does not significantly affect
virulence of A. fumigatus. Toll-deficient D. melanogaster fruit flies were
infected by needle puncture and incubated at 29°C for 7 days. This
graph includes three independent virulence assays.
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a

b

Figure 5.5. Loss of gipB does not significantly affect gliotoxin production. All
cultures were grown for 48 hours in non-repressing conditions. Total RNA was
isolated and quantified by dot blot analysis in triplicate. Gliotoxin levels were
quantified by RP-HPLC. (a) mRNA transcript levels of several gliotoxin cluster
genes. Each data set is normalized to 1160G. The results of one representative
experiment of three independent experiments are shown as mean ± SD. (b)
Gliotoxin levels in growth medium, normalized to 1160G. The results of one
representative experiment of three biological replicates are shown. The asterisk ( )
indicates a statistically significant difference (p-value <0.05), compared to 1160G,
calculated by one-way ANOVA and Tukey comparison test.
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5.2.4 Deletion of gipB and Its Effect on Growth and Virulence of A. fumigatus
Even though loss of gipB did not exhibit a dramatic effect on gliotoxin production, I
aimed to determine if GipB is important for growth and virulence of A. fumigatus.

I

inoculated 1000 spores of 1160G, ∆gliZ, ∆gipB, and gipB(R) onto rich medium (YAG),
minimal medium (MMVAT), and MMVAT with exogenous gliotoxin. Deletion of gipB did not
drastically affect growth of A. fumigatus, which suggests that GipB does not play a major
role in growth of the fungus (Fig. 5.6). For virulence studies, I infected Toll-deficient D.
melanogaster fruit flies by needle puncture, as described previously. Loss of gipB did not
affect virulence of A. fumigatus in a Toll-deficient D. melanogaster model system, compared
to the 1160G parent strain, indicating that loss of gipB does not attenuate the virulence of
this fungus (Fig. 5.7). This does not rule out the possibility that loss of gipB could be
affecting the ability of A. fumigatus to effectively combat host immune cells.

5.3 Summary
To uncover the effects of GipB on gene regulation of the gliotoxin cluster and
gliotoxin production, I measured mRNA transcript levels of several genes within the cluster,
as well as gliotoxin levels in the surrounding medium.

High-copy expression of gipB

increased mRNA levels of several genes in the gliotoxin cluster after 24 hours growth in
repressing conditions, compared to the control strain, although this effect was not observed
after 48 hours growth (Fig. 5.2a). Furthermore, gliotoxin was produced at higher levels with
high-copy expression of gipB, compared to the control strain (Fig. 5.2b). This indicates that
GipB does act to induce the gliotoxin biosynthetic cluster, but not as strongly as GipA,
which is not surprising as GipB is a hybrid sensor kinase likely acting upstream of other
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Figure 5.6. Loss of gipB does not significantly affect growth of A.
fumigatus. 1000 spores were spotted onto each plate and
incubated at 37°C for 48 hours (YAG) or 72 hours (MMVAT).
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Figure 5.7. Loss of gipB does not significantly affect virulence of A.
fumigatus. Toll-deficient D. melanogaster fruit flies were infected by
needle puncture and incubated at 29°C for 7 days. This graph includes
three independent virulence assays.
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proteins. This could also indicate that GipB is only activated during specific stages of
development, as high-copy expression during the later phase of conidiation did not induce
the gliotoxin cluster.
Deletion of gipB had a slight negative effect on the gliotoxin cluster, as gliotoxin
levels were reduced by 10% in the ∆gipB mutant in non-repressing conditions, compared to
the control strain (Fig. 5.5b). These data suggest that GipB activity is not essential to
gliotoxin production in the conditions tested. Neither the high-copy gipB strain nor the

∆gipB grew differently than the control strain on rich or minimal medium (Fig. 5.3 & 5.6).
Therefore differential expression of gipB does not affect normal growth in A. fumigatus. In
addition, all strains tested were not significantly different in virulence, compared to the
control strain. This indicates that alterations in gipB expression do not make A. fumigatus
significantly more or less virulent in the Toll-deficient D. melanogaster model (Fig. 5.4 &
5.7).
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Chapter 6:
GliZ, GipA, and GipB: Independent or
Interdependent?
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6.1 Introduction
In chapter 3, I presented a model for gliA regulation, involving GliZ, GipA, and AreA
(Fig. 3.8a). In this model, I propose that GliZ and GipA are both binding to the promoter
region of gliA to induce gene expression, not in an independent fashion, but
interdependently, in which both proteins bind in close proximity and require the presence of
the other for signaling. In the conditions tested, non-repressing medium contained sodium
nitrate, instead of ammonium tartrate, releasing nitrogen metabolite repression. As shown
in Figure 3.9b, a non-preferred nitrogen source causes induction of the gliotoxin cluster,
indicating that AreA is acting on the gliotoxin cluster to induce gene expression. This most
likely occurs via AreA-mediated induction of gliZ first, possibly followed by direct binding of
AreA to promoter regions of other genes in the cluster. There is an AreA recognition
sequence in the gliA promoter, 37 base pairs upstream of the ATG start site, which could
indicate that AreA is directly binding to the promoter of gliA, although this may not be likely
as the recognition element is so close to the ATG start site for gliA (Fig. 6.1). This model
was proposed based on the experiments performed for this project.
As discussed in Chapter 4, mutation of the core region within the GipA recognition
sequence in the gliA promoter drastically reduced both GliZ- and GipA-dependent lacZ
expression, indicating that both proteins rely on this binding site for activity. Upon further
examination, I discovered that the GipA recognition sequence is embedded within a
potential GliZ binding site, which supports my proposed model that both proteins are
binding in close proximity (Fig. 6.1).

This does not, however, give evidence of an

interdependent relationship between GliZ and GipA, as these two proteins could possibly
be binding at separate times and inducing gliA independently.
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Figure 6.1. Layout of the GipA/GliZ binding sites in the gliA promoter
region, relative to the gliA start site. GliZ tandem repeats are purple and
the GipA DNA binding site is underlined in orange. The AreA recognition
element is signified by the yellow triangle.
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6.2 Results
6.2.1 A ΔgliZ/ΔgipA Double Mutant and Its Effect on Gliotoxin Production
I created a double deletion mutant, ΔgliZ/ΔgipA and measured RNA levels via dot
blot analysis and gliotoxin production via RP-HPLC in non-repressing conditions. I sought
to determine if GipA and GliZ signal independently of each other or work together within a
pathway.

The gliZ/gipA double deletion mutant revealed a pattern of gene expression

similar to the gliZ single deletion mutant (Fig. 6.2a). Furthermore, gliotoxin production in
the double mutant was abolished, similar to what I observed in the gliZ single deletion strain
(Fig. 6.2b). These results indicate that GipA is signaling cooperatively with GliZ and not
independently, but it’s not completely clear from these data. RNA levels and gliotoxin levels
were already so low with the gliZ deletion strain, an additive effect could be difficult to
identify for the gliZ/gipA double mutant.

6.2.2 A ΔgliZ/ΔgipA Double Mutant and Its Effect on Growth and Virulence of A. fumigatus
Both ΔgliZ and ΔgipA single deletion mutants grew comparable to the control strain,
so I tested the growth of the ΔgliZ/ΔgipA mutant by inoculating 1000 spores onto YAG,
MMVAT, and MMVAT with exogenous gliotoxin.

The growth of ΔgliZ/ΔgipA appeared

comparable to 1160G, signifying that loss of both gliZ and gipA does not adversely affect
growth of A. fumigatus, even in the presence of exogenous gliotoxin (Fig. 6.3).
Furthermore, neither ΔgliZ nor ΔgipA display a statistically significant difference in virulence,
compared to 1160G, so I sought to verify if this would be the same case with a ΔgliZ/ΔgipA
double mutant. Indeed, the ΔgliZ/ΔgipA mutant did not show statistically significant
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a

b

Figure 6.2. Loss of gliZ and gipA negatively affects gliotoxin production. All cultures
were grown for 48 hours in non-repressing conditions. Total RNA was isolated and
quantified by dot blot analysis in triplicate. Gliotoxin levels were quantified by RPHPLC. (a) mRNA transcript levels of several gliotoxin cluster genes. Each data set
is normalized to 1160G. The results of one representative experiment of three
independent experiments are shown as mean ± SD. (b) Gliotoxin levels in growth
medium, normalized to 1160G. The results of one representative experiment of
three biological replicates are shown. The asterisk ( ) indicates a statistically
significant difference (p-value <0.05), compared to 1160G, calculated by one-way
ANOVA and Tukey comparison test.
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Figure 6.3. Loss of gliZ and gipA does not significantly affect growth
of A. fumigatus. 1000 spores were spotted onto each plate and
incubated at 37°C for 48 hours (YAG) or 72 hours (MMVAT).
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attenuation of virulence in a Toll-deficient D. melanogaster model system (Fig. 6.4).
Therefore, no adverse additive effects were observed with respect to virulence in the model
I tested.

6.2.3 A ΔgipA/ΔgipB double mutant and Its Effect on Gliotoxin Production
I created a ΔgipA/ΔgipB double deletion mutant and grew this strain, along with
controls, in non-repressing conditions. I measured RNA levels via dot blot analysis and
gliotoxin levels via RP-HPLC to determine if GipA and GipB are signaling independently of
each other or in a linear pathway.

RNA levels of the gliotoxin-specific genes in the

gipA/gipB double deletion mutant were similar to what I observed in the ΔgipA single mutant
(Fig. 6.5a). Gliotoxin was also being produced in ΔgipA/ΔgipB at an amount comparable to
the ΔgipA single mutant (50% reduction compared to 1160G) (Fig. 6.5b).

These data

suggest that there is no additive effect when removing both GipA and GipB from the
genome, although loss of gipB alone does not produce a significant decrease in gliotoxin
production. Therefore, these two proteins possibly work in a pathway and do not signal
independent of each other.

6.2.4 A ΔgipA/ΔgipB double mutant and Its Effect on Growth and Virulence of A. fumigatus
I sought to determine if the ΔgipA/ΔgipB double mutant would have an abnormal
phenotype on rich or minimal medium. The ΔgipA/ΔgipB mutant grew at a similar rate to
the 1160G control, but loss of both gipA and gipB appeared to negatively affect condiation
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Figure 6.4. Loss of gliZ and gipA does not significantly affect
virulence of A. fumigatus. Toll-deficient D. melanogaster fruit flies
were infected by needle puncture and incubated at 29°C for 7 days.
This graph includes three independent virulence assays.
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a

b

Figure 6.5. Loss of gipA and gipB negatively affects gliotoxin production. All cultures were
grown for 48 hours in non-repressing conditions. Total RNA was isolated and quantified by dot
blot analysis in triplicate. Gliotoxin levels were quantified by RP-HPLC. (a) mRNA transcript
levels of several gliotoxin cluster genes. Each data set is normalized to 1160G. The results of
one representative experiment of three independent experiments are shown as mean ± SD. (b)
Gliotoxin levels in growth medium, normalized to 1160G. The results of one representative
experiment of three biological replicates are shown. The asterisk ( ) indicates a statistically
significant difference (p-value <0.05), compared to 1160G, calculated by one-way ANOVA and
Tukey comparison test.
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(Fig. 6.6).

Indeed, when spores/cm2 was calculated, the ΔgipA/ΔgipB mutant poduced

approximately 50% less spores than the 1160G control when grown on rich medium. This
significant reduction in spore number was not observed for either the ΔgipA or ΔgipB single
deletion mutants, suggesting that in regards to conidiation, gipA and gipB are possibly
involved in separate pathways.

Furthermore, I performed a virulence assay with the

ΔgipA/ΔgipB mutant to establish if loss of both genes affected virulence of A. fumigatus.
The ΔgipA/ΔgipB double mutant did not show a statistically significant attenuation in
virulence in a Toll-deficient D. melanogaster model system, compared to the 1160G control,
indicating that the compound loss of both GipA and GipB does not alter the ability of the
fungus to kill Toll-deficient fruit flies (Fig. 6.7).

6.2.5 High-copy Expression of GipA and GipB in a gliZ deletion background
I performed a series of experiments to determine if GipB or GipA are dependent on
GliZ for signaling. I created two strains in Af293.1: (1) pyrG+ (wild-type background) and
(2) ΔgliZ.1 (∆gliZ background). Into each of these strains, I transformed pDONR AMA
(AMA.G, AMA.Z), pDONR AMA-gliZ (AMA-gliZ.G, AMA-gliZ.Z), pDONR AMA-gipA (AMAgipA.G, AMA-gipA.Z), and pDONR AMA-gipB (AMA-gipB.G, AMA-gipB.Z) to produce
strains with extra copies of GliZ, GipA, or GipB in a wild-type or gliZ deletion background
(strains and genotypes are listed in Table 2.2). High-copy expression of gliZ served as a
control, as extra copies of GliZ would rescue for loss of gliZ. I grew all strains in nonrepressing conditions for 48 hours and quantified RNA levels of gliotoxin-specific genes
(gliA and gliP) by RNA dot blot analysis.

For this experiment, I present data that is

normalized to AMA.G, as this strain is the empty vector control in the wild-type background.
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Figure 6.6. Loss of gipA and gipB negatively affects conidiation in A.
fumigatus. 1000 spores were spotted onto each plate and incubated at
37°C for 48 hours (YAG) or 72 hours (MMVAT).
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Figure 6.7. Loss of gipA and gipB does not significantly affect virulence
of A. fumigatus. Toll-deficient D. melanogaster fruit flies were infected
by needle puncture and incubated at 29°C for 7 days. This graph
includes three independent virulence assays.
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In the pyrG+ background, AMA-gliZ.G, AMA-gipA.G, and AMA-gipB.G had
increased mRNA levels for gliP, while only AMA-gipA.G had increased mRNA levels for
gliA, compared to AMA.G (Fig. 6.8). These changes were slight because growth in nonrepressing conditions already induced these genes to high levels, so having extra copies of
GipA or GipB did not greatly contribute to gene expression. In AMA.Z, mRNA levels for
both gliA and gliP were almost completely undetectable, as to be expected from previous
experiments. High-copy expression of gliZ brought transcript levels of both genes back to
AMA.G levels (Fig. 6.8).

AMA-gipA.Z displayed a reduction in mRNA levels similar to

AMA.Z. For gliA, the level of mRNA present in AMA-gipA.Z was slightly higher (close to 5fold) than what was observed for AMA.Z. However, the level of gliP RNA did not exceed
that of the AMA.Z empty vector control. Therefore, GipA was not able to induce gliA or gliP
in the absence of GliZ. Additionally, transcription of both gliA and gliP in AMA-gipB.Z did
not reach levels above AMA.Z (Fig. 6.8). This suggests that GliZ is required for GipA to
induce both gliP and gliA. Furthermore, the lack of gliA and gliP induction in AMA-gipB.Z
indicates that GliZ is required for GipB-mediated signaling for both genes.

6.2.6 High-copy expression of GliZ and GipB in a gipA deletion background
I created two strains in Af293.1: (1) pyrG+ (wild-type background), and (2) ∆gipA.1
(∆gipA background).

Into each of these strains, I transformed pDONR AMA (AMA.G,

AMA.A), pDONR AMA-gliZ (AMA-gliZ.G, AMA-gliZ.A), pDONR AMA-gipA (AMA-gipA.G,
AMA-gipA.A), and pDONR AMA-gipB (AMA-gipB.G, AMA-gipB.A). AMA-gipA served as a
control, as high-copy expression of gipA should rescue for loss of gipA. As described
above, strains were grown in non-repressing conditions and RNA was quantified by RNA
dot blot analysis. Data presented are normalized to AMA.G.
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a

b

Figure 6.8. GliZ and GipA are dependent on each other for gliA induction. Cultures
were grown in non-repressing conditions and RNA was quantified by dot blot
analysis in triplicate. Data are normalized to AMA.G (pyrG+ background). These
graphs are an average of three biological replicates. (a) mRNA levels of gliA in all
backgrounds. (b) mRNA levels of gliP in all backgrounds. The asterisk ( ) indicates
a statistically significant difference (p-value <0.05), compared to AMA.G, calculated
by one-way ANOVA and Tukey comparison test.
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As expected from previous experiments, mRNA levels in AMA.A of both gliA and
gliP were reduced significantly, 50% and 80%, respectively. RNA levels of gliP in AMAgliZ.A were comparable to those of AMA.G; however RNA levels of gliA were not
significantly higher than background levels (AMA.A) (Fig. 6.8). This indicates that GliZ is
not dependent on GipA for induction of gliP, however induction of gliA by GliZ does appear
to be dependent on GipA. Moreover, RNA levels of both gliA and gliP in AMA-gipB.A were
not significantly higher than those in AMA.A. Although gliP did have a slight increase in
gene expression in AMA-gipB.A (1.5-fold), it did not reach the level of gliP in the wild-type
background (Fig. 6.8b). Therefore, GipB appears to be dependent on GipA for full gliA and
gliP induction. An alternative interpretation of the high-copy gipB results are discussed in
the next chapter.

6.3 Summary
To determine if GliZ, GipA, and GipB are part of a single pathway, I performed a
series of epistasis and bypass suppression experiments.

Transcript levels of several

gliotoxin-specific genes were reduced in the ∆gliZ/∆gipA mutant to the level of the single

∆gliZ strain, as were gliotoxin levels in the surrounding medium (Fig. 6.2). This suggests
that deletion of both gliZ and gipA does not produce an additive effect in gene expression
or gliotoxin production and that signaling of both proteins is through GliZ, although loss of
gliZ causes such as severe reduction in gliotoxin production that an additive effect from the
additional deletion of gipA might be difficult to discern. No additive effects were observed
with regards to the growth of the fungus on different media or with the virulence of the
fungus in a Toll-deficient D. melanogaster model system, further supporting the idea of GliZ
and GipA working interdependently and not separately (Fig. 6.3 & 6.4). In the ∆gipA/∆gipB
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mutant, mRNA transcript levels of the gliotoxin-specific genes tested were comparable to
the single ∆gipA strain, as were gliotoxin levels in the surrounding medium (Fig. 6.5). This
indicates that deletion of both gipA and gipB does not cause an additive effect in gene
expression or gliotoxin production and that GipB acts upstream of GipA, supporting the idea
that they are both involved in a linear pathway with regards to gliotoxin production. Even
though the ∆gipA/∆gipB double mutant grew at a rate similar to the 1160G control strain on
all media tested, sporulation appeared to be negatively affected by loss of both genes on
rich medium (Fig. 6.6). The ∆gipA/∆gipB mutant exhibited a mortality rate similar to the
1160G control in the Toll-deficient D. melanogaster model system, suggesting that
virulence of the fungus is not affected by loss of both genes (Fig. 6.7).
The gliA promoter mutagenesis experiments revealed that both GliZ and GipA are
dependent on a single binding site for induction of gliA expression. Therefore, I sought to
determine if GliZ is dependent on GipA for induction of gliA and vice versa.

I also

measured gliP mRNA transcript levels to determine if what I have observed is unique to gliA
regulation or also affected other genes of the gliotoxin cluster. In a ∆gliZ background, highcopy expression of gipA did not raise mRNA transcript levels of gliP above basal levels,
although it did slightly increase (almost 5-fold) mRNA transcript levels of gliA (Fig. 6.8).
This suggests that GliZ is required for GipA-mediated induction of both gliP and gliA,
although it appears that GipA can stimulate a slight elevation in gliA expression
independent of GliZ. Furthermore, high-copy expression of gipB in a ∆gliZ background did
not result in an increase in gliP or gliA mRNA above basal levels, indicating that GliZ is
required for GipB-mediated induction of both gliP and gliA (Fig. 6.8). These results are not
entirely surprising, as in-cluster transcription factors are usually essential for expression of
other genes in the cluster.
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In a ∆gipA background, high-copy expression of gliZ caused an increase in gliP
mRNA transcript to wild-type levels. Surprisingly, gliA mRNA transcript levels in the highcopy gliZ strain were comparable to basal levels, suggesting that GliZ induces gliP
independent of GipA, but cannot induce gliA in the absence of GipA (Fig. 6.8).
Furthermore, high-copy expression of gipB in a ∆gipA background only slightly increased
gliP mRNA levels above basal levels (1.5-fold) and gliA mRNA levels did not exceed basal
levels, indicating that GipB-mediated induction of both gliP and gliA is dependent on GipA
(Fig. 6.8).
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Chapter 7:
General Discussion
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Although recent studies have revealed gliotoxin intermediates, which have led to a
better understanding of the biosynthesis of gliotoxin, information on regulation of the genes
involved in the biosynthesis pathway is lacking [92]. There have been a number of proteins
shown to affect gliotoxin production, but these have only been studied in a general way [13,
22, 23, 32, 50, 64, 91, 107-109, 128, 129]. No proteins have been demonstrated to bind
directly to the gliotoxin cluster, not even GliZ, the in-cluster transcription factor [15]. The
goal of this project was to uncover novel proteins that regulate gliotoxin production in A.
fumigatus and to possibly piece together a signaling pathway that responds to external or
internal signals. I have performed a high-copy inducer screen and uncovered two proteins,
GipA and GipB, which appear to be involved in the regulation of the gliotoxin cluster.

7.1 Characterization of GipA
GipA is a C2H2 transcription factor, which harbors a long 5’ UTR (at least 877 bps)
and a moderate 3’ UTR (at least 360 bps). Furthermore, there are three µORFs within the
5’ UTR, which suggests that gipA could be under post-transcriptional regulation (Fig. 3.6a).
The length of 5’ UTRs appears to remain invariable between taxonomic classes, ranging
from 100 to 200 nucleotides on average, however 3’ UTRs can be more variable, ranging
from 200 nucleotides in plants and fungi to 800 nucleotides in vertebrates [130]. Many
proteins that are tightly regulated, such as growth factors, transcription factors, or protooncogenes, are encoded by messenger RNAs containing 5’ UTRs that are longer than
average, with µORFs and stable secondary structures that negatively affect translation
efficiency and mRNA stability [130].

RNA levels of gipA remained relatively low in all

growth conditions tested, which further supports controlled regulation of this gene (data not
shown). µORFs can affect translation efficiency in several ways, such as preemptively
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initiating translation, affecting ribosome reinitiation, or causing arrest of translational
machinery [80]. For instance, reinitiation of translation is reduced as the µORF length is
increased, as shown in mammalian systems. In addition, one group demonstrated a linear
relationship between µORF length and translation of downstream ORFs, whereas longer
µORFs decreased translation of the downstream ORFs in human immunodeficiency virus
type 1 [131].
Of the three µORFs within the 5’ UTR of gipA, the first is 7 codons, the second is 33
codons, and the third is 4 codons. Interestingly, the first µORF overlaps with the second,
longer µORF (Fig. 3.6a). Perhaps in certain situations where gipA translation is favorable,
the translational machinery targets the first µORF, causing the second µORF to be passed
over and favoring reinitiation at the gipA start codon, whereas in situations where gipA
translation is unfavorable, the translational machinery targets the second µORF, preventing
reinitiation downstream. This could possibly be tested through mutational analysis of each
µORF in the gipA 5’ UTR, involving either complete deletion of each µORF or mutation of
the AUG of each µORF. Differential µORF translation has been demonstrated for many
genes, one of the most studied being Gcn4 in Saccharomyces cerevisiae. The 5’ UTR of
gcn4 contains 4 µORFs, which modify translation of Gcn4 based on amino acid levels [7880]. Studies have shown that under normal conditions, the translation complex will initiate
translation at µORF1 and then reinitiate at µORF4, which prevents translation of gcn4.
However, in conditions of amino acid limitation, scanning of the translation complex is
leakier and will scan past µORF4 to reinitiate at the gcn4 start site [78-80]. It would also be
advantageous to analyze the mRNA stability of gipA, as both µORFs and 3’ UTR
sequences have been shown to affect mRNA stability through NMD [121]. The mRNA halflife of areA, which is tightly regulated in response to nitrogen source, is 40 minutes in
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nitrogen-non-repressing conditions, but is only 7 minutes in nitrogen-repressing conditions
[60, 63].
GipA positively regulates the gliotoxin cluster, as high-copy expression of gipA in
repressing conditions resulted in increased mRNA levels of several genes within the
gliotoxin cluster, compared to the empty vector control (gliA was induced 7-fold and 4.5fold, gliZ was induced 2-fold and 12-fold, gliP was induced 4.5-fold and 5-fold, and gliT was
induced 8-fold and 2-fold, at 24 and 48 hours of growth, respectively) (Fig. 4.2a).

In

addition, I observed higher levels of gliotoxin in the surrounding medium, compared to an
empty vector control (7-fold higher by 24 hours) (Fig. 4.2b). Although high-copy expression
of gipA did enhance gliotoxin production, neither growth nor virulence in a Toll-deficient D.
melanogaster model was significantly affected (Fig. 4.3 & 4.4). This does not rule out the
fact that high-copy expression of gipA could be enhancing the ability of A. fumigatus to fight
host immune cells, which could be verified by measuring phagocytosis of spores, cytokine
production, apoptosis of immune cells, and neutrophil infiltration at the site of infection.
Based on microarray data, out of 30 potential secondary metabolism clusters, 20
contain at least one gene that was up-regulated >2-fold in a high-copy gipA strain,
compared to an empty vector control (Table 4.2). LaeA, widely accepted as a general
regulator of secondary metabolism in numerous fungal species, has been shown to
regulate 13 out of 22 identified secondary metabolism clusters in A. fumigatus [91]. This
indicates that GipA could possibly also be acting in a general fashion to regulate secondary
metabolism and not specifically on the gliotoxin biosynthetic cluster. Interestingly, LaeA, a
proposed methyltransferase, has been suggested to affect chromatin remodeling when
regulating secondary metabolism. This is supported by studies conducted in A. nidulans on
the sterigmatocystin biosynthesis cluster.

During active growth, histone H3 lysine 9

trimethylation (H3K9me3) and high levels of heterochromatin protein 1 (HepA) are
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detectable at the sterigmatocystin cluster. Upon growth arrest and sterigmatocystin cluster
induction, the levels of H3K9me3 and HepA decrease concurrently with increasing levels of
acetylated histone H3 associated with sterigmatocystin cluster genes. Furthermore, in a
ΔlaeA background, HepA occupancy in the promoter aflR, the sterigmatocystin in-cluster
transcription factor, is significantly increased [3].

These data suggest that the

sterigmatocystin cluster is subject to a repressive chromatin structure through H3K9
trimethylation and HepA binding and that LaeA is involved in the derepression of this
heterochromatic signature inside the cluster. It would be interesting to study the chromatin
structure of the gliotoxin cluster and how it contributes to gene expression. For instance,
nucleosome displacement upon gliotoxin cluster derepression could contribute to higher
gene expression.
As mentioned earlier, AreA is proposed to exhibit chromatin remodeling in
connection to the nitrate assimilation pathway.

In 1999, Claudio Scazzocchio’s group

showed through DNase I and micrococcal nuclease (MNase) digestion that the intergenic
region between two divergently transcribed genes within the nitrate assimilation cluster is
occupied by six nucleosomes in nitrogen-repressing conditions [132]. Therefore, in the
presence of ammonium, these six nucleosomes occupy the intergenic region between the
two genes (niiA and niaD) and contribute to the repression of cluster gene expression.
Upon derepression of the cluster, in response to the loss of ammonium and the addition of
nitrate, multiple nucleosomes in this intergenic region are displaced, creating an “open”
region to facilitate binding of AreA and the in-cluster transcription factor, NirA, followed by
induction of cluster gene expression.

The group reported that this nucleosome

rearrangement is dependent on AreA, as a ΔareA strain did not show the same pattern of
chromatin remodeling at the nitrate assimilation cluster, even in nitrogen-derepressing
conditions [132].

Since nitrogen metabolite repression does affect the gliotoxin gene
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cluster, it would be interesting to test if AreA specifically contributes to any nucleosome
remodeling within the gliotoxin cluster to induce gene expression.
GipA appears to play a considerable role in gliotoxin production, but is not essential,
as mRNA levels of several gliotoxin-specific genes were significantly decreased in a ∆gipA
mutant in non-repressing conditions (Fig. 4.5a). Most genes I tested experienced at least
50% reduction in mRNA levels, compared to the wild-type control. Furthermore, gliotoxin
levels in the surrounding medium were reduced by 50% (Fig. 4.5b). Even though gliotoxin
was drastically reduced in the ΔgipA mutant, loss of gipA did not cause a significant
difference in growth of the fungus, even in the presence of exogenous gliotoxin (Fig. 4.6).
This indicates that loss of gipA does not affect growth or sporulation of A. fumigatus. Loss
of gipA did not affect virulence of A. fumigatus in a Toll-deficient D. melanogaster model,
signifying that gipA is dispensable for virulence of the fungus in the model system I tested
(Fig. 4.7).

It is possible that GipA serves to enhance expression of the gliotoxin cluster in

certain environmental conditions. Both high-copy expression and loss of gipA affects gliZ
expression, so the effects I see for the entire cluster could be the direct consequence of
GipA binding to each promoter region, or an indirect consequence of GipA partially
regulating gliZ, which in turn regulates other genes within the cluster.
Interestingly, GipA does not appear to be highly conserved at the protein level, as
only a few proteins showing high similarity were identified, the closest being a hypothetical
protein in N. fisheri that shares 96% identity (Fig. 3.7a).

There are also a few other

Aspergillus species and some Penicillium species that contain a protein relatively similar to
GipA. Although the gliotoxin biosynthetic cluster is not conserved throughout all Aspergilli,
most of the Aspergillus species that came out of the query are gliotoxin-producing or
contain homologues to gliotoxin genes (e.g. A. niger, A. flavus, A. terreus, A. oryzae and A.
kawachii). Interestingly, A. clavatus also contains a C2H2 protein with sequence similarity to
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GipA. Although a putative gliotoxin cluster has not been identified in A. clavatus, it is
possible that gliotoxin is produced in this fungus. For proteins, primary sequences evolve
and change much more rapidly than do the tertiary structures. There have been numerous
examples where two proteins have low sequence similarity, but once crystallized, exhibit
almost identical folding patterns and subsequently share similar functions [133].

For

example, Gcn4 of S. cerevisiae and CpcA of A. niger share a 35% identity, yet they both
function in amino acid biosynthesis. Furthermore, CpcA is able to complement a Δgcn4
mutant in S. cerevisiae [134]. When solely comparing the putative DNA binding domain of
cpcA, the identity between CpcA and Gcn4 increases to 70% [134]. Therefore, the lack of
homologous counterparts to GipA in other organisms does not necessarily mean that there
is not a protein present in other fungi that functions similarly to GipA. In addition, a search
for homologues to the region containing the C2H2 DNA binding domains of GipA greatly
increases the number of fungal organisms that contain a protein with high similarity (data
not shown).

7.2 Characterization of GipB
GipB is a hybrid sensor kinase, containing a histidine kinase A (phospho-acceptor)
domain, a GHKL (ATPase) domain, and a response regulator receiver domain. Hybrid
sensor kinases are common in fungi, in contrast to bacterial systems, which have mainly
separate sensor kinases and response regulators [126, 127]. Hybrid sensor kinases will
autophosphorylate a Histidine (His) residue in the histidine kinase domain, in response to
external stimuli, followed by a transfer of the phosphate to an Aspartic Acid (Asp) residue in
the response regulator domain [126, 127]. Within the 5’ UTR of gipB are two µORFs, which
implies that gipB may also be under post-transcriptional regulation, as suggested for gipA
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(Fig. 3.6a). Similar to what was observed with gipA, RNA levels of gipB remained low
throughout all growth conditions I tested. Investigation of the protein sequence of GipB did
not reveal any transmembrane domains, thereby presenting GipB as a cytosolic hybrid
sensor kinase. In filamentous fungi, these cytosolic hybrid sensor kinases appear to play
more of a role in controlling morphogenesis and differentiation, compared to
transmembrane histidine kinases [127]. The first cytosolic hybrid sensor kinase identified in
filamentous fungi was Nik-1/Os-1 of Neurospora crassa. Nik-1 is exclusively expressed
during vegetative growth and is nonexistent in the sexual phase of growth. Aberrant hyphal
development is observed when nik-1 is deleted from N. crassa, thereby demonstrating that
Nik-1 positively regulates vegetative growth [127].
GipB positively regulates the gliotoxin cluster, as high-copy expression of gipB
resulted in an increase in mRNA levels for gliA and gliT at 24 hours growth (Fig. 5.2a). In
addition, gliotoxin levels were higher than the empty vector control in repressing conditions
at 24 hours (Fig. 5.2b). At 48 hours, however, mRNA levels of all genes tested in the highcopy gipB strain were comparable to the empty vector control. Gliotoxin was still detectable
in the surrounding medium at levels higher than the AMA.GL control, but this is likely a
result of activation of GipB earlier in the growth phase. This indicates that activity of GipB
may be specific to certain phases of development. The growth conditions I employed
(stationary cultures) were conducive to asexual development and conidiation, as strains
grew heavily at the air interface and conidiated robustly. Therefore, the fact that high-copy
expression of gipB did not induce the gliotoxin cluster at 48 hours of growth suggests that
GipB is not activated through phosphorylation in the later stages of conidiation (Fig. 5.2b).
GipB does not appear to be essential for gliotoxin production, as loss of gipB only
caused a decrease in gliT mRNA levels in non-repressing conditions, compared to the wildtype control, as well as a 10% decrease in gliotoxin levels (Fig. 5.5). Although cytosolic
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hybrid sensor kinases have often been found to regulate fungal morphology and
differentiation, I did not observe any significant growth abnormalities in the ∆gipB mutant or
the high-copy gipB strain, suggesting that either GipB does not regulate vegetative growth
or conidiophore development or that another hybrid sensor kinase shares a redundant role
with GipB (Fig. 5.3 & 5.6). Similarly, I did not observe a significant effect on virulence of A.
fumigatus in a Toll-deficient D. melanogaster model with either the ∆gipB mutant or the
high-copy gipB strain, although the high-copy gipB strain displayed a trend towards
increased death of the fruit flies (Fig. 5.4 & 5.7).

It would be interesting to test a

constitutively-active mutant and a constitutively-inactive mutant of GipB, which might prove
more helpful in uncovering a clear role for GipB activity.

7.3 Model for gliA Regulation
I have devised a model for regulation of gliA that involves GliZ, GipA, and AreA (Fig.
7.1a). I propose that GliZ and GipA work together at the same binding site to induce gliA.
In this model, GipA and GliZ are dependent on each other for inducing gene expression of
gliA. I further posit that AreA contributes to the overall induction of gliA in the presence of
non-preferred nitrogen sources. As shown in Figure 3.8b, a non-preferred nitrogen source
causes increased expression of several genes within the gliotoxin cluster, indicating that
AreA is acting on the gliotoxin cluster to induce gene expression. This most likely occurs
via AreA-mediated induction of gliZ first, possibly followed by direct binding of AreA to
promoter regions of other genes in the cluster. There is an AreA recognition sequence in
the gliA promoter, 37 base pairs upstream of the ATG start site, but the close proximity of
the recognition element in relation to the ATG likely means that AreA does not induce gliA
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a

b

c

Figure 7.1. Model for gliA regulation. (a) I propose that both GliZ and
GipA work together to induce gliA. (b) Furthermore, I propose that
AreA acts to enhance gliA expression in nitrogen-specific nonrepressing conditions. (c) Layout of the GipA/GliZ binding sites in the
gliA promoter region, relative to the gliA start site. GliZ tandem
repeats are purple and the GipA DNA binding site is underlined in
orange. The AreA binding site is signified by the yellow triangle.

148

expression from that site (Fig. 7.1b). Although GipB is not included in this model, there are
several possible models that involve GipB in the regulation of gliA, which are discussed
below.

7.4 GliZ, GipA, and GipB: Independent or Interdependent?
I created two double deletion mutants to verify that either GliZ and GipA or GipA and
GipB are signaling within a pathway and not independently. The ΔgliZ/ΔgipA double mutant
appeared comparable to the ΔgliZ single mutant, with respect to gliotoxin biosynthesis (Fig.
6.2). I did not observe an additive effect, indicating that these two proteins do not signal
through independent pathways and that GipA may signal cooperatively with GliZ. This
supports my model of gliA regulation, in which GliZ and GipA are not independently
activating gliA expression. These data are not completely clear, though, as the decrease in
mRNA levels and gliotoxin production in a ΔgliZ mutant were already so low, there may not
be any possibility of an additive effect, even if GipA and GliZ are independent of one
another.

The possibility of GliZ and GipA acting independently, although not entirely

impossible, is highly unlikely, as transcription factors located within biosynthetic clusters are
often required for induction of other genes within the cluster. There have been examples of
independent gene regulation, though. For instance, gliT is positively regulated by GliZ, as
are all the other genes within the gliotoxin cluster.

However, when A. fumigatus was

exposed to exogenous gliotoxin, gliT was induced, even in the absence of gliZ [27]. This
raises the possibility that based on the toxic nature of some secondary metabolites,
alternative regulation of certain genes within these clusters may have evolved to ensure
protection of the organism from the toxin itself or possibly other toxins with similar
structures that are produced by competing organisms. I did not create a ΔgliZ/ΔgipB double
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mutant, as I hypothesized that the results would not show an additive effect, again because
loss of gliZ already affects gene expression so drastically.
In the ΔgipA/ΔgipB double mutant, mRNA levels of gliotoxin-specific genes were
comparable to the gipA single deletion mutant (Fig. 6.5). Loss of gipA does not reduce
mRNA levels as drastically as ΔgliZ, so I was able to discern if an additive effect was
present in the ΔgipA/ΔgipB strain. Since there was in fact no additive effect, it is possible
that GipA and GipB are part of a linear pathway and that GipA is downstream of GipB.
However, the effect of the gipB single mutant on the gliotoxin cluster was so mild, that an
additive effect may not be possible. One explanation is that there are other hybrid sensor
kinases that are redundant for GipB with respect to gliotoxin production. Neither double
mutant displayed abnormal growth or virulence in a Toll-deficient D. melanogaster model,
indicating that there is not an additive effect with respect to growth rate or virulence of A.
fumigatus (Fig. 6.3, 6.4, 6.6 & 6.7). However, although conidiation was not drastically
affected by loss of either gipA or gipB, the ΔgipA/ΔgipB double mutant displayed a 50%
reduction in spores/cm2 on rich medium, suggesting that GipA and GipB may be involved in
independent signaling pathways in regards to conidiation (Fig. 6.6b).

This raises the

possibility that GipB and GipA are signaling independent of each other for gliotoxin cluster
expression as well.
A possible consensus DNA binding site for GipA was identified through protein
binding microarray (Fig. 4.8), which I verified using in vivo mutagenesis of the gliA promoter
(Fig. 4.9). A few interesting discoveries came out of the in vivo promoter mutagenesis
experiments. First is the possibility of an unknown transcriptional activator binding to a
sequence near the GipA binding site. I propose this based on the fact that mutation of the
single 5’ T residue resulted in a significant decrease (8-fold in repressing conditions and 4fold in non-repressing conditions) in lacZ expression in AMA.SD1 (background LacZ) (Fig.
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4.9a), yet GipA-specific lacZ expression was significantly induced (53-fold), compared to
the empty vector control (Fig. 4.9b). This observation could also be explained by weaker
GipA binding, which is rescued by high-copy expression of GipA. However, when a core
region of the GipA binding site was mutated, I discovered that basal lacZ expression not
only increased, but exceeded the basal levels of the wild-type binding site (5-fold in
repressing conditions and 2-fold in non-repressing conditions) (Fig. 4.9b), yet GipA-specific
lacZ induction was significantly reduced, almost to the level of the empty vector control (Fig.
4.7b). This supports my hypothesis that an unknown transcriptional activator is binding in
close proximity to the GipA binding site and that mutation of the single T residue negatively
affects this.

If there was not an additional transcriptional activator present and both

mutations were only affecting GipA binding, I would expect the basal LacZ levels to remain
low for both binding site mutants. The fact that mutation of the core sequence in the
binding site raised basal LacZ levels higher than they were with the wild-type binding site
suggests two possibilities:

(1) GipA and this unknown transcriptional activator are

competing for binding or (2) GipA and this unknown transcriptional activator play
antagonistic roles in gliA expression. This is further supported by the fact that GipA-specific
induction of lacZ was higher when the single T residue was mutated than it was when
exposed to the wild-type binding site.
The second interesting discovery was the fact that GliZ-specific lacZ induction was
similar to that observed with GipA-specific induction (Fig. 4.9). I expected GliZ-specific
induction of lacZ to be independent of the GipA binding site, but this was not the case.
Upon further examination, I realized that the GipA binding site is embedded within possible
GliZ binding sites (Fig. 7.1c). Although a GliZ binding site has not yet been tested, one has
been predicted (TCGGN3CCGA).

This sequence is present in the intergenic region of

every gene within the gliotoxin cluster, except gliZ and gliA [15]. Studies have shown that
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recognition of these sequences by Zn2Cys6 binuclear finger transcription factors is very
specific and even a slight change to the length or base composition of the linker sequence
can result in reduced binding in vivo [16, 18, 19]. Within the gliA promoter region, there are
four sequences commonly found to be recognized by Zn2Cys6 transcription factors (Fig.
7.1c). The innermost two are inverted repeats with an 8 bp linker sequence, while the outer
two, which are also inverted repeats, contain a 27 bp linker sequence, although the longer
linker sequence seems less likely to be recognized by a Zn2Cys6 transcription factor.
Furthermore, the core sequence of the GipA binding site that I mutated contains the CCG of
the smaller GliZ-like binding site (Fig. 7.1c). Therefore, mutation of the core sequence
changed one of the inverted repeats, likely abolishing GliZ-mediated lacZ induction. From
these data, I cannot distinguish whether GliZ binding is independent of GipA or dependent,
because in the process of mutating the GipA binding site, I also inadvertently mutated an
essential part of a possible GliZ binding site.
To test this, I expressed high-copy plasmids in various deletion backgrounds and
measured RNA levels of gliA, as well as gliP. For gliP regulation, GipA was dependent on
GliZ but GliZ did not require the presence of GipA (Fig. 6.8b). Furthermore, GipB appeared
dependent on both GliZ and GipA to induce gliP (Fig. 6.8b). For gliA regulation, I observed
a different pattern, as GliZ and GipA were dependent on each other to induce gliA (Fig.
6.8a). Dependent dual regulation of two transcription factors has been uncovered in other
organisms. For example, in A. nidulans, FlbB and FlbD both bind in close proximity to the
brlA promoter to regulate asexual development through brlA activation [39, 135]. FlbB, in a
complex with FlbE, induces flbD expression by direct binding to the flbD promoter [135137].

Once FlbD is translated, FlbD and FlbB are both necessary to activate brlA.

Furthermore, FlbB does not bind to the brlA promoter in the absence of FlbD, indicating that
these two transcription factors are dependent on each other for DNA binding and activation
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of brlA [135]. GipB also appeared dependent on both GliZ and GipA for gliA induction (Fig.
6.8a). I did not test the high-copy plasmids in a ΔgipB deletion background. I attempted to
isolate this mutant, but experienced issues that led us to focus on the gliZ and gipA deletion
backgrounds. I created a gipB deletion mutant for earlier experiments, but these were done
in an nkuB deletion background to facilitate homologous recombination. I suspect that in a
ΔgipB background, GliZ and GipA are both able to induce gliA and gliP, as GipB encodes a
hybrid sensor kinase that is likely acting upstream of both proteins.
These data support a model in which GliZ and GipA are working together to regulate
gliA (Fig. 7.1). There appears to be a dependency with regards to gliA expression that I
demonstrated in my experiments. I cannot say if GliZ and GipA are physically interacting
by forming a complex, but the intimate nature of the DNA binding sites suggests this may
be the case. C2H2 transcription factors have been shown to be involved in protein-protein
interactions [138]. One well characterized example of these protein-protein interactions is
that of FOG-1 and GATA-1. FOG-1 is a C2H2 zinc finger transcription factor containing nine
zinc finger domains, only four of which carry the classical C2H2 motif. The other five motifs
harbor the natural variant C2HC motif [139]. Studies have demonstrated that zinc finger
motifs 1, 5, 6, and 9, which all contain the C2HC variant, are involved in the protein-protein
interaction of FOG-1 with GATA-1 [122, 138, 139]. Interestingly, despite the fact that C2H2
domains and C2HC domains display an almost identical folding pattern, these domains are
not interchangeable. This was demonstrated by the fact that mutation of the third cysteine
residue in zinc finger domains 1 and 9 to histidine (C2HC  C2H2) in FOG-1 did not disrupt
their folding, but abolished their ability to interact with GATA-1 in a yeast two-hybrid assay
[122, 138]. This pattern may not apply to all protein-protein interactions involving C2H2 zinc
finger transcription factors, but it does support the possibility that these natural C2HC
variants are involved in protein-protein interactions.
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GipA contains two zinc finger binding domains, one of which is the classical C2H2
motif and the other is the variant C2HC motif. Perhaps GipA and GliZ form a protein-protein
complex, involving the C2HC motif of GipA, to facilitate DNA binding and activation of gliA.
Mutational analysis of the C2HC motif and pull-down assays would possibly be able to
elucidate the presence of such a complex. It would also be interesting to see if mutation of
the GipA binding site, without mutating the GliZ palindromic sequence, would reinstate GliZmediated expression of lacZ, although I suspect this would not be the case as GipA is
required for GliZ-mediated expression of gliA and loss of GipA binding might negatively
affect GliZ binding. This model does not apply to every gene within the gliotoxin cluster, as
no other genes have a GipA binding site embedded within a possible GliZ binding site,
except gliZ, although these sequence are located farther upstream of the gliZ start site (Fig.
7.2). Perhaps GipA serves to aid GliZ in binding to the gliA promoter region, as this binding
site is different from the others present in the gliotoxin cluster.
Although there are possible GipA binding sites in all gliotoxin gene promoters,
except gliM, I cannot say with certainty whether GipA is directly binding to these other
promoter regions or if GipA is simply binding in the gliA promoter in conjunction with GliZ.
This adds to mounting evidence that genes within a gene cluster are typically coordinately
regulated, but can also be individually expressed in response to certain stimuli.

It is

possible that gliT and gliA are both independently regulated to protect the fungus from
exogenous gliotoxin, although gliA was not induced in a ΔgliZ mutant in the presence of
exogenous gliotoxin as gliT was [27].

Another possibility is that gliA is independently

regulated to aid in the transport and/or expression of other secondary metabolism clusters
in A. fumigatus. There has been evidence in other fungal species that crosstalk between
these gene clusters exists [140]. For instance, in A. nidulans, biosynthesis of asperthecin is
enhanced in a strain over-expressing RsmA, a bZIP transcription factor [84]. Interestingly,
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Figure 7.2. Layout of two potential GipA binding sites that are embedded in putative GliZ
binding sites in the gliZ promoter. GliZ putative trinucleotide repeats are purple, the
putative GipA binding sites are signified with orange, and binding cluster 1 additionally
contains an AreA recognition element (yellow).
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asperthecin synthesis is reduced when aflR is deleted in an RsmA over-expression
background.

AflR is a Zn2Cys6 binuclear finger transcription factor necessary for

expression of aflatoxin and sterigmatocystin secondary metabolism clusters. Therefore,
RsmA exerts its effects on the asperthecin biosynthetic cluster through AflR, which is
located in a separate cluster [84].
Interestingly, RsmA has recently been characterized in A. fumigatus. Similar to
what is seen in A. nidulans, over-expression of RsmA results in a significant increase in
gliotoxin production, as well as an increase in mRNA transcript levels of multiple gliotoxinspecific genes [108].

High-copy expression of gipA also induced the gliotoxin cluster

(Fig.4.2), although contrary to what was observed with rsmA, loss of gipA significantly
reduced the level of gliotoxin in surrounding medium (Fig. 4.5). RsmA cannot induce the
gliotoxin cluster in the absence of either gliZ or laeA, suggesting that both proteins are
necessary for RsmA-mediated signaling [108]. I found a similar pattern for GipA-mediated
signaling, as loss of gliZ negatively affected the ability of GipA to induce gliP and gliA,
although there was a slight increase in gliA mRNA transcript levels, compared to basal
levels (Fig. 6.8). Therefore GliZ is essential for complete GipA-mediated induction. I did
not test the high-copy gipA strain in a ΔlaeA background, but this test would be worthwhile,
as chromatin remodeling could contribute to GipA binding. Based on microarray data from
a ∆laeA strain, GipA is not regulated by LaeA, as gipA gene expression was not altered
with loss of laeA, compared to a wild-type strain. Interestingly, GipB showed a moderate
up-regulation in gene expression in the laeA deletion mutant, suggesting that LaeA
negatively regulates GipB, which could be a result of developmental regulation (personal
communication, Nancy P. Keller).
Although the experiments I performed give evidence for my model connecting GliZ
and GipA, additional models further including GipB are more speculative. For instance, one
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model could involve GipB signaling upstream of GliZ and GipA, suggesting that both
transcription factors are required for GipB-mediated gliA expression (Fig. 7.3).

This is

supported by the fact that high-copy expression of gipB could not induce gliA in the
absence of either gliZ or gipA. However, this pattern was also observed with respect to gliP
expression, even though the interdependency of gliZ and gipA was not present.

One

explanation for this pattern is that GipB signals through GliZ and GipA to induce all genes in
the gliotoxin cluster.

An alternative explanation is that the experiment itself was not

conclusive for GipB-mediated induction. As discussed earlier, high-copy expression of gipB
induces the gliotoxin cluster at 24 hours growth, but not 48 hours growth, possibly due to
temporal control of the activation of GipB. The gliA and gliP mRNA levels I measured in
response to high-copy expression of gipB in various deletion backgrounds were collected
after 48 hours growth. Therefore the results could falsely exhibit a dependency of GipB
signaling on GliZ and GipA, when in fact GipB is simply not activated at this time point and
can therefore not induce these gliotoxin genes. A second model would involved GliZ and
GipA acting in an interdependent fashion, as I have proposed, but also involving GipB
positively regulating the gliotoxin cluster independently of GipA, but most likely through GliZ
(Fig. 7.3).
Although the ∆gipA/∆gipB double mutant did not display an additive phenotype with
respect to gliotoxin production, it did exhibit a 50% reduction in sporulation.

This

sporulation defect was not observed with the ∆gipA single mutant or the ∆gipB single
mutant, indicating that it was in fact an additive effect, possibly as a result of GipA and GipB
being involved in separate signaling pathways.

While the ∆gipA single mutant had

significantly reduced gliotoxin production (50%), the loss of gipB did not significantly affect
gliotoxin production, so loss of both might not display an additive reduction in gliotoxin
levels, even if they are both involved in separate pathways. Therefore, the sporulation
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b

Figure 7.3. Possible models for gliA regulation involving GipB, GipA, and
GliZ. (a) In this model, GipB is regulating gliA in a signaling pathway that is
separate from GipA. Furthermore, there is possibly another hybrid sensor
kinase that acts in a redundant fashion to GipB with respect to gliA
expression. (b) In this model, GipB is regulating gliA upstream of both GipA
and GliZ. All three proteins are involved in the same pathway.
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phenotype of the ∆gipA/∆gipB double mutant raises the possibility that GipB plays a role in
regulating the gliotoxin cluster independently of GipA. The fact that the ΔgipB deletion
strain did not significantly reduce gliotoxin production does not rule out the possibility that
GipB is involved in gliotoxin gene cluster expression, as high-copy expression of gipB
induces gliotoxin production. However, it is not clear if the positive effects exerted by GipB
are direct (e.g. through a specific pathway) or indirect (e.g. altering other proteins that
happen to effect gliotoxin production). If GipB is directly regulating the gliotoxin cluster,
there could be other hybrid sensor kinases that play a redundant role in gliotoxin cluster
expression, which would mask any effects from the loss of gipB alone. Further exploring
these possibilities would serve to uncover a stronger model that explains the role of GipB in
regulation of the gliotoxin cluster.

7.5 Future Perspectives
GipB and GipA are novel proteins in A. fumigatus that have not been characterized
before my work.

I originally discovered these proteins in a high-copy inducer screen

searching for genes that induce a gliAP-lacZ expression plasmid and presumably the entire
gliotoxin cluster.

Therefore, the work I completed for this project focused on gliotoxin

production and gliA regulation specifically. Obviously there are many more experiments to
be done to truly understand the mechanism by which GipB and GipA regulate gliA
expression, as well as the gliotoxin cluster as a whole. For instance, as mentioned above,
there are putative GipA binding sites in the intergenic regions upstream of every gliotoxin
cluster gene, except gliM. There is a putative GipA binding site upstream of gliM, but it is
upstream of the stop codon of the preceding gene. I showed from RNA dot blot analysis
that GipA positively regulates multiple genes in the gliotoxin cluster. Although I obtained
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evidence that GipA is directly binding to the gliA promoter, I do not know for certain whether
GipA is regulating other genes in the cluster by directly binding to every promoter or
through modulation of gliZ expression only.

This could be tested through promoter

mutagenesis of each promoter region, as was done for gliA, or through chromatin
Immunoprecipitation.
Interestingly, there are two “binding clusters” in the upstream region of gliZ that
contain a putative GipA binding site embedded within potential GliZ binding sites. I call
these regions “potential GliZ binding sites” because of the presence of CGG trinucleotide
repeats that are common recognition elements of Zn2Cys6 transcription factors, although
the linker sequences are longer than those predicted for GliZ recognition. A potential GliZ
binding site (TCGGN3CCGA) has been proposed and is present upstream of every gliotoxin
cluster gene, except gliZ and gliA, though this has not been experimentally studied [15]. In
addition, these “binding clusters” that include putative binding sites for both GliZ and GipA
are only present in the upstream regions of gliZ and gliA. Both “binding clusters” upstream
of gliZ comprise 6 bp linker sequences, while the “binding cluster” upstream of gliA contains
an 8 bp linker sequence. It would be advantageous to discover if either of the “binding
clusters” in the gliZ upstream region are necessary for or contribute to gliZ expression, as
was shown for the “binding cluster” in the gliA promoter, as would finding out if GipA directly
binds to the promoter regions of the other gliotoxin cluster genes.
In verifying that GipA induces gliA through a particular GipA recognition site, I
inadvertently discovered that GliZ also relies on this site for full gliA induction. Although I
showed that mutation of part of the GipA binding site, which happened to contain a CCG
trinucleotide, reduced GliZ-mediated induction of a gliAP-lacZ expression plasmid, I did not
experimentally verify direct binding of GliZ to this region. Although unlikely, GipA could be
interacting with GliZ and directly binding to the DNA sequence, without GliZ directly binding
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to the DNA. On the other hand, GliZ and GipA could be involved in a protein-protein
interaction, in which, under certain conditions, GipA facilitates the direct binding of GliZ to a
binding site that GliZ would not normally recognize, due to the longer linker sequence
between the trinucleotide repeats. Further studies need to be performed to verify direct
binding of GliZ to the gliA promoter, as well as the presence of a protein-protein interaction
between GliZ and GipA.

C2H2 transcription factors often contain zinc finger domains

harboring the classical C2H2 motif, but some encode a natural variant, C2HC, which displays
an almost identical folding pattern to the C2H2 region [138]. This C2HC variation has been
shown to be involved in protein-protein interactions in other organisms, although this is not
considered to be ubiquitous to all C2HC variants [138]. As discussed above, GipA contains
two zinc finger regions, one being the classical C2H2 motif and the other being the natural
variation of C2HC. Therefore, it is possible that GipA is directly interacting with GliZ through
this C2HC domain.

Uncovering such an interaction would greatly contribute to the

understanding of the GliZ-GipA interdependent relationship with regards to gliA expression,
and possibly gliZ expression as well.
GipB, being a hybrid sensor kinase, likely activates downstream proteins to induce
the gliotoxin cluster. In fungal systems, these hybrid sensor kinases are generally thought
to autophosphorylate in response to certain stimuli, followed by transfer of the phosphate to
an HPt protein and subsequent transfer of the phosphate from the HPt protein to a
response regulator. These response regulators can directly act on transcription factors or
can activate signaling cascades, oftentimes composed of MAP kinase proteins. Therefore,
it is likely that GipB is not directly activating the gliotoxin cluster, but is signaling through
several proteins. Interestingly, research has provided evidence that only one HPt protein
exists in all fungi that have been studied [127]. If GipB does activate downstream targets
through this two-component relay system, it is highly likely that the single HPt protein in A.

161

fumigatus, which has not been characterized, is involved in this process. Research in other
fungal species has suggested that cytosolic hybrid sensor kinases are likely involved in
morphogenesis and development [127]. As the gipB DNA sequence does not show any
obvious transmembrane domains, I predict that GipB is a cytosolic hybrid sensor kinase.
Furthermore, RNA dot blot analysis indicated that GipB is activated during specific stages
of conidiation, as high-copy expression of gipB induced gliotoxin production at 24 hours of
growth, but not at 48 hours, which supports the possibility that GipB is involved in
developmental processes. Studying a constitutively-active or constitutively-inactive form of
GipB would be advantageous in elucidating a specific role for GipB activation.
The effects of nitrogen metabolite repression on gliotoxin production was studied by
growing cultures in different nitrogen sources, however, other environmental regulatory
networks were not researched for my project, including carbon catabolite repression and
pH-mediated regulation. All growth conditions were under carbon catabolite repression, as
repressing carbon sources were used throughout the experiments.

Furthermore, pH-

mediated induction was not observed, as medium was properly buffered preventing any pH
changes to either acidic or alkaline conditions. In all conditions tested, gipB and gipA
mRNA levels remained low, suggesting that nitrogen metabolite repression does not affect
the expression of gipA or gipB. Upon examination of the promoter regions of both genes, I
discovered a multitude of recognition elements belonging to global regulators, such as
Area, CreA and PacC, and developmental regulators, such as AbaA, BrlA, and FlbC (Fig.
7.4). The presence of such recognition elements does not guarantee that they are actively
recognized by the regulatory protein, but it does suggest that GipB and GipA may be under
the control of both environmental global regulators and developmental regulatory networks.
Further work focusing on uncovering specific regulators of gipB and gipA expression could
contribute our understanding of these two novel proteins in A. fumigatus.
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Figure 7.4. Layout of putative regulatory elements in the gipA and gipB promoter regions.
The green bars represent the predicted 5’ UTRs of each mRNA, based on data from the
λ phage library screen. Binding sites displayed: CreA (red), AreA (yellow), PacC (light
green), AbaA(green), FlbD (cyan), BrlA (magenta), and FlbC (purple).
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